UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the fiscal year ended December 31,
2013
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Commission File Number: 001-34212
ORYON TECHNOLOGIES, INC.
(Exact name of registrant as specified
in its charter)
|
|
|
Nevada
|
|
26-2626737
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification Number)
|
4251 Kellway Circle, Addison, Texas 75001
(Address of principal executive offices)
(214) 267-1321
(Registrant’s telephone number,
including area code)
Securities Registered Pursuant to Section
12(b) of the Act
None
Securities Registered Pursuant to Section
12(g) of the Act
Common Stock, Par Value $0.001 Per Share
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes
¨
No
x
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes
¨
No
x
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes
x
No
¨
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files). Yes
x
No
¨
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be
contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference
in Part III of the Form 10-K or any amendment to this Form 10-K.
¨
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definition of “large accelerated
filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
¨
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
x
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
¨
No
x
The aggregate market value of the registrant’s outstanding
Common Stock held by non-affiliates of the registrant computed by reference to the price at which the Common Stock was last sold
as of the last business day of the registrant’s most recently completed second fiscal quarter was $15,071,856.
Indicate the number of shares outstanding of each of the registrant’s
classes of common stock, as of the latest practicable date: As of March 7, 2014, there were 252,333,438 shares of common stock,
par value $0.001 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
None
TABLE OF CONTENTS
|
|
PAGE
|
|
PART I
|
|
ITEM 1.
|
BUSINESS
|
2
|
ITEM 1 A
|
RISK FACTORS
|
14
|
ITEM 1 B
|
UNRESOLVED STAFF COMMENTS
|
23
|
ITEM 2
|
PROPERTIES
|
24
|
ITEM 3
|
LEGAL PROCEEDINGS
|
24
|
ITEM 4
|
MINE SAFETY DISCLOSURES
|
24
|
|
|
|
|
PART II
|
|
ITEM 5
|
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
25
|
ITEM 6
|
SUMMARY SELECTED CONSOLIDATED FINANCIAL DATA
|
32
|
ITEM 7
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
34
|
ITEM 7 A
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
42
|
ITEM 8
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
43
|
ITEM 9
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANT ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
43
|
ITEM 9 A
|
CONTROLS AND PROCEDURES
|
44
|
ITEM 9 B
|
OTHER INFORMATION
|
45
|
|
|
|
|
PART III
|
|
ITEM 10
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
46
|
ITEM 11
|
EXECUTIVE COMPENSATION
|
49
|
ITEM 12
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
54
|
ITEM 13
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
57
|
ITEM 14
|
PRINCIPAL ACCOUNTING FEES AND SERVICES
|
58
|
|
|
|
|
PART IV
|
|
ITEM 15
|
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
|
59
|
SIGNATURES
|
|
|
Cautionary Notice Regarding Forward-looking Statements
This Annual Report on Form 10-K contains certain “forward-looking”
statements (as such term is defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),
Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation
Reform act of 1995) and information relating to the Registrant and its subsidiaries that are based upon beliefs of, and information
currently available to, the Registrant’s management as well as estimates and assumptions made by the Registrant’s management.
When used in this report, the words “anticipate,” “believe,” “estimate,” “expect,”
“future,” “intend,” “plan,” “project,” “continuing,” “ongoing,”
“may,” “will,” “should,” “could,” or the negative of these terms and similar expressions
as they relate to the Registrant or the Registrant’s management, are intended to identify forward-looking statements. Such
statements reflect the current view of the Registrant with respect to future events and are subject to risks, uncertainties, assumptions
and other factors (including the risks contained in the section of this Annual Report on Form 10-K entitled “Risk Factors”)
relating to the Registrant’s industry, the Registrant’s operations and results of operations and any businesses that
may be acquired by the Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions
prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.
Although the Registrant believes that the expectations reflected
in the forward-looking statements are reasonable, the Registrant cannot guarantee future results, levels of activity, performance
or achievements. Except as required by applicable law, including the securities laws of the United States, the Registrant does
not intend to update any of the forward-looking statements to conform these statements to actual results. The following discussion
should be read in conjunction with the Registrant’s financial statements and the related notes filed herewith.
PART I
ITEM 1.—BUSINESS
History of the Company
In the late 1990’s, EL Specialists, Inc. (“ELS”),
a company organized under the laws of Texas, the predecessor company of Oryon, engineered a technological breakthrough and developed
a three dimensional, elastomeric, membranous lamp that eliminated the semi-rigid nature of conventional electroluminescent (“EL”)
lamps. ELS patented and trademarked this process under the name Elastolite
®
.
Elastolite
®
was created to replace conventional
EL with a highly malleable, flexible, and economical elastomeric EL lamp technology that could be applied directly to fabrics for
safety purposes. This concept required lamps that were ultra-thin, extremely flexible, washable, crushable, formable, elastic,
and heat resistant. To accomplish this formidable goal, the ink formulas and manufacturing processes of conventional EL would need
to be restructured.
In 2002, MRM Acquisitions, LLC, a company organized under the
laws of Texas (“MRMA”), acquired the patents and intellectual property (“IP”) of ELS and began preparing
Elastolite
®
for commercialization.
In addition to the textile and related apparel applications
for which it was invented, Elastolite
®
opened multiple new and innovative opportunities for EL lighting in membrane
switches, keypads, compression-molded plastics, athletic apparel, toys, occupational safety, point-of-sale displays, automotive
and household utilitarian and decorative applications. In addition, the acquired IP also contained innovative patents in the biometric
field that management believes, when it is developed, will permit the launch of multiple, high volume, cost effective biometric
applications.
In October 2002, OryonTechnologies, LP, a limited partnership
formed under the laws of the State of Texas, was formed as the operating company charged with exploiting and commercializing the
acquired technology. In October 2004, OryonTechnologies, LP was converted to a limited liability company, OryonTechnologies, LLC,
a Texas limited liability company (“Oryon”), and MRMA subsequently exchanged all the IP and patents held by MRMA for
membership units of Oryon. Oryon spent its first years preparing Elastolite
®
to be marketed.
In management’s opinion, Oryon created the framework to
commercialize and successfully launch Elastolite
®
through multiple innovations Oryon developed through market testing
during the years 2003 through 2011. Oryon test marketed Elastolite
®
in clothing with Marmot Mountain Ltd (2004)
and with Lands’ End in over 100,000 lit textile products (2006). While the test marketing provided Oryon with technical information
leading to the improvement of its technology, insufficient funding prevented Oryon from capitalizing on the resulting new product
developments and Oryon was unable to sustain the relationship with the early customers. In addition, Oryon licensed the technology
to Rogers Corporation to light cell phone keypads which ultimately resulted in the Motorola Razr cell phone which sold over 100,000,000
units (2006-2009) and produced over $8,000,000 in revenues to Oryon. Subsequent innovations in smart phone and touch screen technologies
have eliminated the large market for more expensive keypad-type cellphones that utilized Oryon’s technology.
In 2008, Oryon granted a license to a Fortune 100 company in
the field of occupational safety, spent over a year developing and qualifying Elastolite
®
and the Elastolite
®
electronic system for apparel with a leading global sports apparel with the company’s advanced innovation team for product
launch in 2009-10, and received the first volume production order from them in 2009. Further, Oryon produced light for costumes
used by Disney in the December 2010 3-D release of the movie
Tron Legacy
, established a relationship with Disney Consumer
Products (“DCP”) and has worked with a leading U.S. department store as well as Adidas, Puma and Under Armour, among
others, in the development of lit products. However, without sufficient funding to be able to deliver Elastolite
®
to fulfill large orders, Oryon did not aggressively pursue major transactions with such customers. As a result of the completed
Merger (defined below), the Company had capital resources to develop additional product applications utilizing the Company’s
most updated technology and techniques, although additional capital will be required to enable the Company to fulfill large orders
that might result from such re-engagement.
Based on the successful market testing and customer acceptance
of the innovations developed by Oryon in the commercialization process of Elastolite
®
in the apparel (including
sports apparel and shoes), textile, safety and gear markets, Oryon felt it would be ready to commercially launch Elastolite
®
in 2009. Consequently, in the summer of 2008, it hired an investment banker to raise the capital that would be required to support
the launch of Elastolite
®
and to provide the time for Oryon’s Fortune 100 and 500 potential customers to incorporate
it in their product development process.
Financial offering materials were prepared and a fund raising
process was initiated in September 2008. Unfortunately, at that same time the deepening US financial crisis and the difficult economic
environment made the financing process untenable. Oryon subsequently did not have the funds required to support the development
of new products in conjunction with its customers. Management did not want its customers to launch products at a time when Oryon
could not provide effective and timely customer support. In addition, the Motorola Razr cell phone was approaching its end-of-life
as a product and future revenue from this source could not be counted on. Management of Oryon therefore began to take steps to
(a) reduce overhead, (b) continue application development for potentially high volume future products, (c) hold and maintain its
major customers until adequate funding was available to launch product with them and (d) maintain barriers to entry (Oryon’s
extensive patent portfolio) for potential competition until adequate financial resources could be raised.
To accomplish the above, Oryon raised capital through the issuance
of convertible notes primarily to angel investors, raising investment capital of $888,000 in late 2008 and 2009, $1,000,000 in
December 2009 and early 2010, and $560,000 in 2011. The merger with the Registrant and access to the public financing market did
not provide sufficient capital to permit Oryon to successfully launch Elastolite
®
, but permitted the Company to
continue to build upon the experience and customer relationships developed during the years 2008-2011.
During 2012 and 2013, the Company continued to develop customer
relationships, create samples on behalf of customers and further refine its technology. The Company remained under-capitalized
and was continuously seeking additional financing to enable it to commercially launch its products. In October 2013, the Company
was approached by EFL Tech B.V. (“EFL Tech”), a Netherlands corporation with existing business activities in the EL
industry. EFL Tech proposed a transaction that would provide the Company with $1.5 million in equity financing and other valuable
consideration, including equipment, a royalty-free license for all of EFL Tech’s existing patents and business relationship
support. The Company entered into a subscription agreement with EFL Tech on January 21, 2014, as more fully described in Note 18
“Subsequent Events” to the Financial Statements. Upon completion of the transaction with EFL Tech, the Company will
be in a stronger position to license its technology, as well as EFL Tech’s technology, in international markets and to develop
commercially-viable applications for its technology. The Company will need to significantly increase revenues or obtain additional
financing to be able to continue as a going concern through the 2014 calendar year.
Background of Merger Transaction
The Registrant was organized under the laws of the State of
Nevada on August 22, 2007 to explore mineral properties under the name “Eaglecrest Resources, Inc.” The Registrant
was formed to engage in the exploration of mineral properties for gold. The Registrant had not generated any revenue from its business
operations prior to the closing of the Merger, and the Registrant had been unable to raise sufficient funds to implement its operations.
As a result of the current difficult economic environment and
the Registrant’s lack of funding to explore mineral properties, in 2011, the Registrant’s Board of Directors began
to analyze strategic alternatives available to the Registrant to continue as a going concern. Such alternatives included raising
additional debt or equity financing or consummating a merger or acquisition with a partner that may involve a change in the Registrant’s
business plan. Through an introduction by an investment firm, Balanced Financial Securities, the Board of Directors identified
Oryon as a potential strategic acquisition that the Board believed to be in the best interest of the Registrant and its shareholders.
Oryon was attractive to the Registrant because it is a technology company with certain valuable products and intellectual property
rights and has plans to grow its business. Oryon believed the Registrant to be an attractive business combination partner, due
in part, to the perceived benefits of being a publicly registered company, allowing for increased access to capital. Accordingly,
the parties entered into a letter of intent with respect to the Merger on October 24, 2011, executed the Merger Agreement on March
9, 2012, and closed the Merger on May 4, 2012.
Corporate Structure
As a result of the Merger, the organizational structure of the
Registrant is as follows:
Subsidiaries
As noted in the diagram above, the Registrant owns 100% of the
membership interest of Oryon, which then owns:
|
•
|
100% of the membership interest of OryonTechnologiesDevelopment, LLC (“OTD”), a company organized under the laws
of Texas. OTD currently conducts sales, customer relations, R&D and product development for Oryon. Oryon is evaluating whether
to merge OTD into Oryon.
|
|
•
|
100% of the membership interest of OryonTechnologies Licensing, LLC (“OTLIC”), a company organized under the laws
of Texas. OTLIC currently conducts all licensing for Oryon. Oryon is evaluating whether to merge OTLIC into Oryon.
|
Previously, Oryon owned100% of Oryon Technologies International
Pte, Ltd. (“OTI”), a company organized under the laws of Singapore that was liquidated in November 2012. The operations
of OTI were not material to Oryon. OTI was officially deregistered in Singapore on November 6, 2012. In addition, Oryon owned 51%
of Oryon Asia Pacific Safety, Ltd. (“OAPS”), a company organized under the laws of Hong Kong that was liquidated in
2013. The operations of OAPS were not material to Oryon.
In summary, although there are various subsidiaries and affiliates
currently in existence, the Registrant has only one subsidiary—Oryon. At Closing, Oryon was merged into Merger Sub, which
had no corporate purpose other than to serve as the merger receptacle facilitating the transaction.
Strategy
Oryon acquired and continued to develop and patent an already
highly patented and innovative next-generation technology in EL light. Oryon’s patented technology, trademarked Elastolite
®
,
enables thin, flexible, malleable, crushable, water resistant lighting systems to be incorporated into many product applications
in multiple markets that would not be feasible or, in some cases, even possible with current lighting technology. Elastolite
®
and its operating system, including electronics and harness, has been market tested and validated and is ready to be launched in
support of its multiple market opportunities.
To take advantage of what management considers are its multiple
market opportunities, Oryon intends to raise additional capital to support its growth strategy and its existing pipeline of opportunities.
Even if successful in its capital formation efforts, Oryon will still not be able to take advantage of all the opportunities that
now present themselves.
Oryon recognized during the commercialization process that Elastolite’s
strength of being a platform technology for multiple applications in numerous industries can also be its weakness. Due to the immense
size and divergent requirements of the multiple industries Oryon can target, Oryon must focus and initially limit the applications
and industries in which it can make the most immediate impact. In this manner it can optimize its resources and more readily leverage
the positive results it achieves.
Oryon will initially focus its efforts on apparel, textiles,
shoes and subsequently membrane switches. It, therefore, will evaluate its current opportunities and select those customer applications
which are presently within Oryon’s core technical competence and that present Oryon with both high level volume and profit
potential. Oryon feels opportunities are presently available in the apparel, safety-apparel, textile and membrane switch industries.
To the extent there is adequate available capital, Oryon intends
to (i) support its existing pipeline of opportunities in its target markets with additional application and technical transfer
engineers and customer service personnel and (ii) take advantage of new, but previously identified, market opportunities in apparel,
textiles and shoes. Once traction is achieved in its initial target markets, and planned development of new opportunities are completed,
Oryon will attempt to expand into other targeted opportunities that presently exist with lit molded product applications such as
laptop keypads, remote controls, toys, lit cycling and biking helmets, lit cell phone cases and multiple automotive opportunities.
Subsequently, other opportunities in the following fields will be evaluated at a later date: point-of-sale, outdoor displays, security
systems, household furnishings, decorative floorings, various military applications and molding in all of the above.
Apparel, Textiles, Shoes and Gear
: Within Oryon’s
target textile markets, billions of units are shipped each year. This market includes outerwear, industrial safety, municipal safety,
military, athletic apparel, men’s, women’s and children’s clothing, shoes and gear. These markets generate over
$250 billion annual revenues and are second in size only to the food industry.
When Oryon originally purchased patents for a new evolutionary
EL lamp, trademarked Elastolite
®
, the technology, although functional in the lab, had never been commercially developed
or validated. Oryon needed to obtain corroboration on the soundness of its lamp system on a commercial level. Oryon determined
that its initial marketing with Elastolite
®
should be in the apparel, textile, shoe and gear markets. In 2004, Oryon
began, through normal commercial relationships between itself and its customers, testing the validity of its lamp system with multiple
companies in multiple markets relating to textiles. Oryon obtained the market corroboration and validation in the apparel, textile
and gear arena through its test marketing of Elastolite
®
in over 100,000 apparel and gear items sold by Marmot Mountain
and Lands’ End; through its work with the innovation team of a leading Fortune 500 sports apparel brand; by lighting the
costumes for the Disney film
Tron Legacy
that was released in December 2010 and through its relationship with its Fortune
100 licensee in occupational safety products. Based on Elastolite
®
being sold by these companies in their products
to consumers, used promotionally by these companies promoting their own products and by working with the development teams and
factories from most of the companies that used Elastolite
®
, Oryon was not only able to corroborate its technology
in the uses for which it was intended, but also able to make additional improvements to the Elastolite
®
system.
Until Oryon raised adequate capital to support a larger customer base, it elected not to pursue active further development of products
with the companies mentioned above.
Oryon is actively working with leading companies in their respective
fields in apparel, textiles and gear and selectively re-engaging the companies mentioned above. Oryon will attempt to both grow
and leverage these relationships. Product development time cycles with the larger global companies ranges between 12 and 18 months
and with the smaller companies in a 6 to 8 month time cycle. Oryon will build a marketing, sales and customer service team in addition
to application engineering and research and development teams that will both service and exploit existing customers and develop
and manage new prospects and projects within each segment of the apparel and textile market it undertakes. Oryon currently has
five people engaged in its engineering and research and development team and plans to add incremental personnel as the client base
increases. At present, Oryon’s marketing, business development and customer service is conducted primarily by the Company’s
chief executive officer, with the assistance of the engineering and research team, and Oryon plans to hire several additional people
as the customer base is expanded.
Expansion of its application engineering and research and development
teams will be critical to the future success of Oryon. A large percentage of Oryon’s operating expense is incurred upfront
in the product cycle when Oryon engineers work with Oryon customers in their product development. Further Oryon engineering man
power is also needed once an order has been received (prototype or volume) when Oryon transfers its technology to the customer’s
factories. Without this added engineering support, Oryon will be limited in the rate of growth of its volume.
As sales opportunities present themselves, Oryon will also expand
its marketing and customer support teams. These teams will not only develop new customers and customer opportunities but will spend
time interfacing between Oryon customers and Oryon engineering staff.
As of the current date, Oryon is actively working a prospect
pipeline that management believes represents significant sales opportunities in the apparel and textile markets.
The timeline to market for major brands is approximately 12
to 18 months from inception of product development to shipment to retailer. While the sports apparel markets are prime targets
for Oryon, Oryon will simultaneously develop the occupational safety and corporate identity markets which have a much shorter timeline
to revenue. Oryon will establish strategic distribution and manufacturing relationships in the safety markets through which lit
safety and corporate identity products will be sold.
Oryon is currently building the infrastructure and scalability
required to service its customers in the apparel industry and to have the capability to expand its capacity to serve these customers
as opportunities present themselves.
Membrane Switches, Gauges and Keypads
: The primary applications
in this target segment include appliances, remote controls, telecom equipment, medical instrumentation, industrial controls, gauges
of all types and keypads. To obtain revenues from this target segment, Oryon would have to hire marketing and sales management
to work directly with large customers in these markets and manage the contract sales organizations that Oryon would utilize that
are regionally focused and have existing channels and relationships that Elastolite
®
technology can leverage, complement
and extend.
Compression and In-Molded Products:
To Oryon’s
knowledge, Elastolite
®
is the only lamp technology that has been successfully in-molded. The success of this experiment
opens up multiple applications such as lit cell phone cases, toys, in-molded lit keypads and decorative molding on many products.
Oryon will actively continue its development of this technology for commercialization and launch the new technology as soon as
traction is built in apparel and textiles.
Oryon will initially execute its growth strategy in its target
markets as follows:
|
·
|
Oryon will develop its existing brand name with targeted customers
in specific markets through direct sales, strategic relationships and/or licensing. Oryon’s existing targeted customers are
principally established brands or retailers with proven revenue streams, known channels of distribution and consumer acceptance.
Oryon will simultaneously develop the occupational safety and corporate identity markets that have a much shorter timeline to revenue.
|
|
·
|
In parallel, Oryon will create a highly adaptive licensing or strategic
relationship model for both manufacturing and selling Elastolite
®
.
|
|
·
|
Oryon will build the needed sales infrastructure, both internal and
external that will be responsible for working with sales prospects to develop specifications for product prototypes and co-develop
new product applications.
|
|
·
|
Oryon will build an infrastructure of supporting companies (approved
suppliers) with capabilities that will permit Oryon to become a solution provider to its strategic partners, customers and licensees
in each of the market segments it undertakes.
|
|
·
|
Oryon will continually evaluate and expand the intellectual property
and patent portfolio that will permit and enable its future growth and market opportunities.
|
As Oryon gains traction in its initial focus markets, it will
gradually begin expanding into new market segments it has identified, such as in-molded products, membrane switches, point-of-sale,
toys, automotive and military. Oryon will seek industry partners to either co-develop or license Elastolite
®
technology
in promising new high technology fields that require extended developmental time horizons. Such fields include biometric fingerprint
sensors in which Oryon holds two patents, high speed roll-to-roll printing that may permit Oryon to offer cost effective solutions
for such product as floor lighting and printed flexible batteries. These new technological developments may provide expansive future
growth opportunities for Oryon.
Revenues and Capital Requirements
Oryon’s historical revenues have been minimal as the focus
has been on product development. Past revenues were principally generated through the following:
|
·
|
Market tests with Lands’ End and Marmot Mountain Ltd.;
|
|
·
|
Running jacket with leading Fortune 500 sports apparel brand;
|
|
·
|
Royalty from Rogers Corporation generated by the backlighting of the
keypad of the Motorola RAZR cell phone
|
|
·
|
Prototypes created for prospective customers; and
|
|
·
|
Revenue generated by lighting the costumes for Disney’s movie
Tron Legacy
.
|
Oryon believes it will require additional capital in the future.
It is currently developing a specific multi-year fundraising plan based on the following considerations:
|
·
|
The identification of potential new markets for our products;
|
|
·
|
Projected short and long term revenues and profits;
|
|
·
|
Personnel required to properly service its projected future sales;
and
|
|
·
|
Future requirement for capital expenditures.
|
See “Management’s Discussion and Analysis of Financial
Condition and Results of Operations: Liquidity and Capital Resources”.
Technology
Oryon, utilizing polymer thick film technology, has created
a new generation EL lamp. Oryon’s technology has created an elastomeric lamp that is capable of being placed on and over
three dimensional shapes that require a high level of malleability in operation or performance. Traditional EL technologies require
the EL lamp to be manufactured, or printed, on an indium tin oxide sputtered polyester foundation, which creates a semi-rigid structure.
This structure is highly susceptible to both moisture and stress. Oryon’s patented innovation eliminates all rigid and semi-rigid
materials used in constructing a traditional EL lamp and replaces those materials with membranous films, creating an elastomeric
and membranous lamp that can be printed on many different surfaces. This breakthrough has opened multiple new and innovative opportunities
for EL lighting in textiles and related apparel, membrane switches, keypads, toys, safety products, point of sale displays, automotive
and household utilitarian and decorative applications and gear. Further, Oryon’s technology permits light to be printed only
where it is needed on a cost effective basis.
Management of the Registrant believes that Elastolite
®
,
Oryon’s trademarked electroluminescent lamp, is a disruptive platform lighting technology. Unlike reflective tapes, an electroluminescent
lamp emits light by the direct conversion of electrical energy into light through energized phosphors. Although electroluminescent
lamp technology is not new, Elastolite
®
broke through restrictive barriers previously existing that limited the
growth of electroluminescent technology:
|
·
|
Elastolite
®
is a unique form of electroluminescent
lamp
|
|
·
|
Elastolite
®
is 3-dimensional, elastomeric, membranous
Polymer Thick Film (PTF)
|
|
·
|
Elastolite
®
can be printed directly on almost any surface
|
|
·
|
Elastomeric is a polyurethane ink structure
|
Advantages of Elastolite
®
Oryon’s Elastolite
®
is advantageously positioned
alongside other lighting technologies such as traditional EL and light emitting diode (“LED”) technology. Oryon believes
Elastolite
®
offers multiple advantages over existing light technologies such as:
|
·
|
Water Resistant – Elastolite
®
, unlike LED’s
and traditional EL lamps, is an all-weather lamp. Although it is not, in its natural state, totally waterproof, it is highly water
resistant. It can be machine washed and dried. Unlike competitive lighting sources, it is a natural addition to any article of
clothing, gear, or safety related product that is used or worn in an outdoor environment or to most outdoor displays where resistance
to adverse weather is required.
|
|
·
|
Elastomeric and Moldable – Elastolite
®
is 3-Dimensional.
Unlike traditional EL lamps or LED’s, it can stretch, bend, fold or literally be united with almost any application where
flexibility and malleability are important. Elastolite
®
is extremely thin. The thinness and elastomeric malleable
characteristics permit Elastolite
®
to be applied or printed to clothing where movement and comfort are important
or it could, with some additional development, be placed directly under or in-molded into individual keys on keypads or push buttons
on membrane switches thereby maintaining a tactile feel while providing a uniform high quality light literally unobtainable by
competing light sources.
|
|
·
|
Durable – Distinct from traditional EL, due to its elastomeric,
membranous and homogenous polyurethane structure, Elastolite
®
will not crease or break when folded, bent or compression
molded. It can withstand both heat and cold, yet generates no heat of its own. In switch and keypad applications it has successfully
been tested to over 10,000,000 actuations. These characteristics permit Elastolite
®
to be molded, used directly
under laptop and membrane switch keypads, withstand the rigors clothing applications require and survive uses on outdoor applications
such as outdoor displays, equipment, and rainwear in addition to multiple military applications.
|
|
·
|
Economical– Elastolite
®
, although capable of
being created with thermally cured inks, is principally built based on Ultra Violet (“UV”) cured inks. This permits
Elastolite
®
to be printed on high speed roll-to-roll printing equipment and can eliminate costly elongated thermal
heating equipment required by traditional EL lamp systems. Additionally, as opposed to printing on an ITO PET substrate like traditional
EL, Elastolite
®
can be printed on most substrates and printed only where light is needed thereby eliminating wasted
materials and integration and assembly labor. Oryon’s membrane switch patents also eliminate most all hand assembly required
when building a membrane switch.
|
|
·
|
Moldable – Elastolite
®
can be in-molded or compression
molded into or onto plastics. Because of the durable and elastomeric advantages described above, Elastolite
®
can
withstand the pressure, heat and deformation required when in-molding it into plastic applications. This opens up multiple potential
applications such as lit cell phone cases, lit logos on company products, and lit decorative effects printed with graphics on multiple
plastic products. It permits light to take the shape of the product or application onto which it is placed.
|
|
·
|
Uniform Light – Elastolite
®
is a blanket uniform
light as opposed to a LED point light. Although not as bright as an LED; in poor visibility or at night, it can be seen more easily.
Since the light can be placed directly where light is needed, the resulting effort is a uniform high quality light thereby enhancing
the value of any product where quality of light and image is important.
|
Because of its unique characteristics and competitive advantages,
Oryon believes Elastolite
®
is an enabling technology that allows new and innovative uses of light in product applications
in which light, using any other lighting technology, previously was not practical or cost effective. Unlike other lighting technologies,
due to its elastomeric, durable and cost effective features and thereby its ability to be folded, crushed, molded, and washed,
Elastolite
®
opens up the possibility of multiple breakthrough innovative applications spanning numerous industries.
Intellectual Property
Oryon’s intellectual property (“IP”) position
has provided the company with a strong competitive position. As of December 31, 2013, Oryon had 57 patents considered by management
to be material, including 18 U.S. patents (all issued and none pending) and 39 international patents (32 issued and 7 pending).
Oryon’s core patents are not related directly to specific products, but instead relate to technical processes, manufacturing
methods, materials and other aspects of Oryon’s Elastolite
®
technology, including, for example, producing
a lamp in a membranous form, the use of UV cured inks in a membranous lamp, construction of a lit membrane switch through a continuous
printing methodology and others related to the manufacturing or construction of the lamps. Oryon has two biometric patents that
Oryon management believes, when they are developed, will permit the launch of multiple, high volume, cost effective biometric applications.
The following table lists Oryon’s patents, both issued and pending, the jurisdictions in which they were filed, the dates
issued and the expiration dates.
Name
|
|
Jurisdiction
|
|
Issue Date
or Pending
|
|
Expiration
Date
|
Addressable PTF Receptor for Irradiated Images (Biometrics)
|
|
US
|
|
08/30/2005
|
|
12/21/2021
|
Addressable PTF Receptor for Irradiated Images (Biometrics)
|
|
Germany
|
|
04/10/2013
|
|
12/21/2021
|
Alerting System Using Elastomeric EL Lamp Structure
|
|
US
|
|
08/07/2001
|
|
12/30/2016
|
Alerting System Using Elastomeric EL Lamp Structure
|
|
Taiwan
|
|
04/15/2002
|
|
01/11/2021
|
Deployment of EL Structures on Porous or Fibrous Substrates
|
|
US
|
|
04/22/2003
|
|
05/30/2016
|
Elastomeric EL Lamp on Apparel
|
|
US
|
|
10/30/2001
|
|
10/15/2018
|
Elastomeric Electroluminescent Lamp
|
|
US
|
|
01/05/1999
|
|
12/30/2016
|
Elastomeric Electroluminescent Lamp
|
|
South Korea
|
|
08/21/2001
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Australia
|
|
03/22/2001
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Belgium
|
|
06/02/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
France
|
|
06/02/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Great Britain
|
|
06/02/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Italy
|
|
06/02/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Netherlands
|
|
06/02/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Canada
|
|
03/29/2005
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Germany
|
|
06/02/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Spain
|
|
06/02/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Hong Kong
|
|
10/29/2010
|
|
12/22/2017
|
Elastomeric Electroluminescent Lamp
|
|
Mexico
|
|
10/8/2003
|
|
12/22/2017
|
Electroluminescent Lamp Membrane Switch (Continuation)
|
|
US
|
|
03/06/2007
|
|
06/09/2025
|
Electroluminescent Lamp Membrane Switch (Continuation)
|
|
China
|
|
05/26/2010
|
|
04/06/2026
|
Electroluminescent Lamp Membrane Switch
|
|
US
|
|
05/23/2006
|
|
06/09/2025
|
Electroluminescent Lamp Membrane Switch (CIP)
|
|
US
|
|
02/17/2012
|
|
06/14/2026
|
Electroluminescent Lamp Membrane Switch (CIP)
|
|
China
|
|
06/05/2012
|
|
06/06/2027
|
Electroluminescent Lamp Membrane Switch (CIP)
|
|
Hong Kong
|
|
01/25/2013
|
|
06/06/2027
|
Electroluminescent Lamp Membrane Switch (CIP)
|
|
Taiwan
|
|
04/03/2013
|
|
06/12/2027
|
Electroluminescent Lamp Membrane Switch (CIP)
|
|
EU
|
|
Pending
|
|
06/07/2027
|
Electroluminescent System in Monolithic Structure
|
|
US
|
|
01/05/1999
|
|
05/30/2016
|
Electroluminescent System in Monolithic Structure
|
|
Spain
|
|
07/14/2004
|
|
05/29/2017
|
Electroluminescent System in Monolithic Structure
|
|
Great Britain
|
|
07/14/2004
|
|
05/29/2017
|
Electroluminescent System in Monolithic Structure
|
|
Germany
|
|
07/14/2004
|
|
05/29/2017
|
Electroluminescent System in Monolithic Structure
|
|
Hong Kong
|
|
12/24/2004
|
|
05/29/2017
|
Irradiated Images Described by Electrical Contact
|
|
US
|
|
07/18/2000
|
|
06/08/2018
|
Irradiated Images Described by Electrical Contact
|
|
Singapore
|
|
11/28/2003
|
|
06/08/2019
|
Irradiated Images Described by Electrical Contact
|
|
Taiwan
|
|
05/01/2003
|
|
12/02/2019
|
Irradiated Images Described by Electrical Contact
|
|
Canada
|
|
05/19/2009
|
|
06/08/2019
|
Irradiated Images Described by Electrical Contact
|
|
Japan
|
|
05/14/2010
|
|
06/08/2019
|
Irradiated Images Described by Electrical Contact
|
|
South Korea
|
|
06/14/2006
|
|
06/08/2019
|
Membranous EL System in UV-Cured Urethane Envelope
|
|
US
|
|
04/06/2004
|
|
10/10/2021
|
Membranous EL System in UV-Cured Urethane Envelope
|
|
China
|
|
04/11/2007
|
|
10/10/2021
|
Membranous EL System in UV-Cured Urethane Envelope
|
|
EU
|
|
Pending
|
|
10/10/2021
|
Membranous EL System in UV-Cured Urethane Envelope
|
|
Taiwan
|
|
01/07/2004
|
|
10/11/2021
|
Membranous EL System in UV-Cured Urethane Envelope
|
|
Japan
|
|
04/15/2011
|
|
10/10/2021
|
Membranous Monolithic EL Structure with Urethane Carrier
|
|
US
|
|
02/24/2004
|
|
10/10/2021
|
Membranous Monolithic EL Structure with Urethane Carrier
|
|
Japan
|
|
09/26/2008
|
|
10/10/2021
|
Membranous Monolithic EL Structure with Urethane Carrier
|
|
Taiwan
|
|
01/13/2004
|
|
10/11/2021
|
Membranous Monolithic EL Structure with Urethane Carrier
|
|
China
|
|
05/23/2007
|
|
10/10/2021
|
Method of Construction of Elastomeric EL Lamp
|
|
US
|
|
08/07/2001
|
|
12/30/2016
|
Method of Construction of Elastomeric EL Lamp
|
|
China
|
|
04/09/2008
|
|
10/15/2019
|
Method and Apparatus for Illuminating a Key Pad
|
|
US
|
|
11/30/2004
|
|
06/08/2020
|
Method for Constructing EL System in Monolithic Structure
|
|
US
|
|
11/09/1999
|
|
05/30/2016
|
PTF Touch Enabled Image Generator
|
|
US
|
|
08/12/2003
|
|
06/08/2018
|
UV-Curable Inks for PTF Laminates (Including Flexible Circuitry)
|
|
China
|
|
11/08/2006
|
|
06/19/2022
|
Highly Transmissive Electroluminescent Lamp
|
|
US
|
|
01/31/2012
|
|
12/12/2026
|
Translucent Layer including Metal/Metal Oxide
|
|
US
|
|
07/17/2001
|
|
10/15/2018
|
Flexible Interconnect Circuitry System
|
|
US
|
|
Pending
|
|
|
Oryon keeps developing its technology and, with the support
of the funding provided by future financings, will continue to expand, maintain and enforce patent rights and protect its IP and
trade secrets.
Oryon’s technology comprises three basic components: the
core EL lamp, electronics to power the lamp, and the interconnect system between the lamp and the power system. Through outsourcing,
Oryon believes that it has established the infrastructure, principally through third parties, to scale the manufacturing of the
technology. Oryon continues to develop the technology to gain cost advantages, improve performance and functionality, and to support
new applications. The technologies, processes and designs described in Oryon’s patents are incorporated into many of Oryon’s
important products and expire at various times.
Oryon has developed significant processes and methodologies
for integrating Elastolite
®
systems into end-user applications and products in the textile and membrane switch markets,
successfully tested in molding Elastolite
®
into plastics and moving forward with the concept that Elastolite
®
can be printed on high speed roll-to-roll printers. Oryon also has successfully worked with many of its customers’ contract
manufacturers and assemblers to integrate Elastolite
®
into their manufacturing operations. In addition, Oryon has
setup and managed relationships with low cost, high quality contract manufacturers.
These patents that protect Oryon from certain potential competition
come at a high cost. The average cost to obtain a patent ranges anywhere from $25,000 to $100,000 per patent in addition to the
annual financial maintenance requirements Oryon must pay to maintain the patents. Failure to pay maintenance fees on each outstanding
patent will cause a loss of the patent in the individual country in which the patent’s renewal fee is not paid. Fees can
range as high as $5,000 per renewal.
Each country has its own rules and regulations for both obtaining
and maintaining patents although there is coordination and streamlining of processes between European Union countries. Patents
can be filed in one filing for multiple countries, and once approved, individual countries where the patent will be effective can
be selected. Cooperation also exists in filings between the European Union and the U.S.
Patents, even when approved and issued can still be challenged
by third parties as not being valid. The possibility always exists that there are competing patents or technologies existing at
the time the patent was issued that were overlooked when the patent was issued. Patents can be challenged and lost based on previously
existing prior art. There are also multiple rules and regulations one must follow when challenging a patent or making claims when
prosecuting a patent. Patent law is complex and expensive. Although Oryon feels secure with its patents, there always remains the
possibility that challenges to these patents may arise and Oryon’s patents invalidated.
Oryon will continue to evaluate the business benefits in pursuing
patents in the future. Oryon currently protects all of its development work with confidentiality agreements with its engineers,
employees and any outside contractors. However, third parties may, in an unauthorized manner, attempt to use, copy or otherwise
obtain and market or distribute Oryon’s intellectual property or technology or otherwise develop a product with the same
functionality as Oryon’s IP. Policing unauthorized use of intellectual property rights is difficult, and nearly impossible
on a worldwide basis. Therefore, Oryon cannot be certain that the steps it has taken or will take in the future will prevent misappropriation
of its technology or intellectual property, particularly in foreign countries where Oryon may do business, where the laws may not
protect proprietary rights as fully as do the laws of the United States or where the enforcement of such laws is not common or
effective.
Products and Distribution
Although Oryon has the potential to create multiple applications
and products in multiple industries, Oryon management has determined to attack these markets not with its own products that would
require unique design, development, marketing and manufacturing expertise and capability, but rather by targeting established brands,
retailers or companies with proven revenue streams, known channels of distribution and consumer acceptance and in cooperation with
these companies let Oryon’s technology become an integral part of these companies’ products. Oryon’s targeted
customers typically have design, development and marketing teams as well as factories capable of producing their products in mass.
Oryon will work with the designers and product developers from these companies to design Oryon’s Elastolite
®
and supporting technology into their own products and through technology transfer teach their factories how to integrate Elastolite
®
into their manufacturing process. To date, Oryon has worked with or provided Elastolite
®
, through license agreements,
to the following companies: a leading Fortune 100 company, a leading Fortune 500 sports apparel and shoe brand, Lands’ End,
a leading international sport and shoe brand, Marmot Mountain, Rogers Corporation, Motorola, Puma, Under Armour and suppliers to
Disney.
Oryon has and will distribute Elastolite
®
through
multiple brands and corporations seeking the ability to differentiate their products with Oryon’s Elastolite
®
.
Oryon’s customers have been and will principally be established leaders in their respective industries with defined channels
of distribution and product acceptance. As Oryon expands into new industries or product applications, it will seek to partner with
leading companies in each of its target markets.
Manufacturing
Oryon is not in the manufacturing business. Oryon has in the
past established and trained third party manufacturers capable of producing Elastolite
®
in volume. Management anticipates
continuing this policy and developing additional third party relationships in the future. These manufacturers typically will be
established through licenses granted to them by Oryon. Other than samples or small lots created for sales purposes, Oryon will
outsource the production of Elastolite
®
to these companies. Oryon does not have any exclusive manufacturing agreements
and at present, no outsourced manufacturer represents a significant portion of Oryon’s manufacturing business.
Oryon either designs the technology needed to operate Elastolite
®
(principally inverters that power the Elastolite
®
lamp) or contracts the creation of the technology with third party
design teams. All inverters must meet pre-established design and performance criteria established by Oryon. Once created and successfully
tested, the manufacture of the electronics is contracted to third party manufacturers and assemblers, both domestic and foreign.
Oryon itself does not manufacture, other than prototypes, any of the electronics needed to operate Elastolite
®
.
To ensure that Elastolite
®
and the products in
which Elastolite
®
is used is of the highest quality and standards, Oryon has established and continues to implement
quality control systems and procedures at all levels of product development, design and manufacturing regardless of the customer
or the factory in which it is produced. Some of the procedures pertain to the following:
|
·
|
Testing and understanding the specifications of all materials on which
Elastolite
®
is placed.
|
|
·
|
Working closely with Oryon’s customers’ design and product
development teams, at the earliest stages of product creation, to ensure that Elastolite
®
is properly designed into
their product and is capable of low cost mass production.
|
|
·
|
Manufacturing guidelines and procedures are established with Oryon
customers’ factories and Oryon technical transfer engineers to train the factories in low cost methods of integrating Elastolite
®
into the manufacturing process.
|
|
·
|
Continual audit of third party manufacturers.
|
|
·
|
Establishment of well-defined processes and standards that must be
met in manufacturing.
|
|
·
|
Quality control on all materials used in each stage of manufacture.
|
|
·
|
Continual monitoring and adherence to environmental rules and regulations
and the meeting of proper working conditions under which Elastolite
®
is produced.
|
Industry and Competition
Oryon positions itself alongside other lighting technologies
such as traditional EL and LED. In management’s opinion, Elastolite
®
is an enabling, innovative technology
allowing the use of light in products and applications that heretofore were not practical or cost effective.
As a result, Elastolite
®
is defining its own
application space. This is especially true in the textile market, where other lighting technologies have limited capabilities.
Among its primary competitive advantages, Elastolite
®
is positioned in applications demanding ruggedness, durability,
wearability and flexibility.
|
|
Elastolite
®
|
|
Traditional
EL
|
|
LED
|
Temperature
|
|
Cool
|
|
Cool
|
|
Warm
|
Lighting
|
|
Uniform
|
|
Uniform
|
|
Point
|
Thickness
|
|
Ink Layer
|
|
Ink Layer +
|
|
Surf. Mount
|
Flexibility
|
|
Rubber- Like
|
|
Semi-Rigid
|
|
Rigid
|
Water Resistant
|
|
Yes
|
|
No
|
|
No
|
Moldable
|
|
Yes
|
|
No
|
|
No
|
Traditional EL
. Traditional EL is typically used
as backlighting in conditions where high flexibility is not required, need for ruggedness is average and water resistance is not
an issue. Traditional EL is at a distinct disadvantage to Elastolite
®
in the switch segment since Elastolite
®
is capable of applying its light directly behind, or directly onto, a key. Traditional EL providers actually cut out the key placements
from a polyethylene terephthalate (PET) substrate containing EL. Through Oryon’s patented printing process for switches,
customers can save money, improve manufacturing, and improve the quality of lighting. Within the apparel space, conventional EL
products are very limited because traditional EL cannot be washed, without incurring additional costs to waterproof, and is rigid
or semi-rigid in nature.
LED
. LED is normally deployed as a point light
source where there is average need for ruggedness, little need for large areas of uniform light, and no need for flexibility or
water resistance. LEDs are typically used as indicator lights, in camera displays, and in cell phones. More recently LEDs have
advanced in brightness characteristics and are being positioned as a replacement to incandescent lighting technology. The pointed
nature of LEDs creates non-uniform light which cannot be channeled effectively onto the intended surface. This creates a low quality
appearance, especially in switch applications. In addition, as the trend toward miniaturization continues, LEDs are in many cases
not thin enough for membrane switch applications. Many switch applications require extensive flex at one or more connection points,
which LEDs cannot handle. In addition, the price-power-quality tradeoff is not optimal. LED prices in the switch segment increase
proportionately with the number of LEDs used in a particular application. Because Elastolite
®
is a blanket light,
it can achieve full coverage of uniform light that cannot be achieved by LEDs. The more LEDs required in a particular application
to achieve a given light effect, the higher the cost. In any given application, the cost advantages/disadvantages between LED’s
and Elastolite
®
are based on the quality of light demanded and the number of LEDs required to obtain that quality.
Management of Oryon believes that Elastolite
®
should be the light of choice where high-quality uniform lighting is required that needs to be thin, malleable, washable and durable
when exposed to multiple stresses. It is not the light of choice for all applications. Traditional EL and LEDs may be preferred
when used in non-stressed environments where brightness is needed. LEDs can be cheaper to use than Elastolite
®
where
quality of light is not paramount. In addition, traditional EL presently requires less power than Elastolite
®
to
achieve the same brightness, although Elastolite’s increased power demands permit applications with the same brightness,
but with increased malleability, which is one of Elastolite’s differentiating characteristics. One of Oryon’s research
objectives is the reduction in power demanded by Elastolite
®
while maintaining its increased malleability. LEDs
can be used in full color active displays whereas neither Elastolite
®
nor traditional EL can presently be used in
this manner. Nevertheless, the management of Oryon is not aware of any significant competitors utilizing LEDs or traditional EL
for stressed applications such as apparel where we are focusing our marketing efforts.
To the extent that Oryon pursues applications in non-stressed
uses such as keypad backlighting or similar uses, management views the Company’s competition to consist of other light sources
or technologies, such as traditional EL, LEDs, fiber optics or organic light-emitting diodes (OLED). Oryon has focused on target
markets where it has significant advantages relative to these other technologies. Oryon views competitors in many of its market
segments as potential customers because Elastolite
®
can offer solutions that are complementary to competitors’
existing applications. Traditional EL is a limited market, therefore no dominant player exists. There are many small companies
in the field. Some of the leading players in the field include Rogers Corporation, Hansung, Planar, EL Korea and DuPont. Newer
entrants include Lyttron (subsidiary of Bayer), Salux and others that may have pursued alternative EL technologies; however, Oryon
is not aware of any market traction related to a competitive technology.
Oryon is focused on continuing the development of its IP and
know-how, aligning itself with the strongest possible strategic partners and expanding its infrastructure to service customers
in its target markets. We believe these activities will increase barriers to potentially competitive technologies.
Markets
Because Oryon’s Elastolite
®
is a platform
lighting technology, management believes that lit applications heretofore untried, impractical or ineffective as a light solution
are now possible to achieve. Two examples are the Motorola Razr cell phone and lighting on clothing and gear.
|
·
|
Motorola, in building a state-of-the-art icon cell phone beginning
in 2002, wanted the phone to be both thin and provide uniform lighting in the keypad. Without adding a multiplicity of LED’s,
uniform light would be hard to achieve as the LED could not be placed directly under the keypad and even if it were, the tactile
feel of the keypad would be lost. Further, Elastolite
®
, being extremely thin, helped the overall objective of thinness
of the cell phone. Traditional EL was not practical to use. Although it was thin, and even flexible, it was neither malleable nor
durable. It would not wear satisfactorily and the tactile feel would be lost. The solution was Elastolite
®
. Through
the end of its product life in 2008, over 100,000,000 Razr cell phones were produced using Oryon’s Elastolite
®
technology.
|
|
|
|
|
·
|
Outdoor Apparel and Occupational Safety Clothing and Gear: Lighted
clothing in the past, although possible, was either impractical, difficult to wear, not cost effective or not suited for an outdoor
environment or for washing. Elastolite
®
eliminated these obstacles. Being washable, malleable, durable and friendly
to outdoor environments, it developed clothing applications that were market tested and validated. As a result of the information
learned from these tests, Oryon was able to refine Elastolite
®
and its electronic system to where a Fortune 500
company and a leading sports apparel company, integrated it into a product for retail introduction in late fall/winter 2009-10.
In addition, the world’s leading company in reflective materials and office products, a Fortune 100 company, licensed in
December 2008 the use of Elastolite
®
to integrate with their existing product mix. That license remains in effect,
although the licensee has made no sales under the license.
|
Elastolite
®
caters to multiple multi-billion
dollar companies and markets. The above are just a few examples of these markets. The premier markets for Elastolite
®
include:
·
Outdoor Apparel, Textiles and Gear
|
|
·
Gauges
|
|
|
|
·
Occupational Safety Apparel and Products
|
|
·
Lit bicycles and Motorbikes
|
|
|
|
·
Keypads and Membrane Switches
|
|
·
Carpet Runners
|
·
In-Molded and Compression Molded Products
|
|
·
Household Appliances
·
Microwaves
·
Air Conditioning Units, Etc.
|
·
Automotive and Marine
·
Dashboards and Controls
·
Decorative
·
Safety
|
|
·
Security Systems
|
|
|
|
·
Costumes
|
|
·
Outdoor Advertising and Displays
|
|
|
|
·
Point of Sale
|
|
·
Outdoor Equipment
|
|
|
|
·
Decorative Floorings
|
|
·
Military
|
|
|
|
·
Toys and Games
|
|
·
Multiple Miscellaneous Applications
|
Seasonality
Elastolite
®
is global in usage and its seasonality
is dependent on the applications to which it becomes attached. As an example, many outdoor utilitarian products, although used
year round, will achieve their highest outdoor utility during periods of the greatest and longest darkness; fall through spring.
Some products such as toys and decorations will reach their highest consumer consumption during the Christmas holiday season. Other
applications, such as military and automotive uses, have no seasonality.
Government Regulation
Being a new technology, there are few governmental regulations
that directly affect Elastolite
®
. Regardless, Oryon’s larger customers have established many environmental
and work place regulations that do affect their suppliers and contractors. Oryon, although typically a second tier supplier to
these customers, must meet the environmental and workplace standards established by each of its customers. Most of these standards
overlap from one company to the next although Oryon must be careful that it meets, at a minimum, all standards established by its
customers.
In addition, in the United States, Oryon is or may be required
to comply with certain federal health and safety laws, laws governing equal employment opportunity, customs and foreign trade laws
and regulations, laws regulating the sales of products in schools, and various other federal statutes and regulations. Oryon may
also be subject to various state and local statutes and regulations, including California Proposition 65 which requires that a
specific warning appear on any product that contains a component listed by the State of California as having been found to cause
cancer or birth defects. Many of our customers who sell products in California may be required to provide warning labels on their
products. Oryon relies on legal and operational compliance programs, as well as local counsel, to guide its businesses in complying
with applicable laws and regulations of the jurisdictions in which it does or plans to do business. Further, the conduct of Oryon’s
businesses, and the production, distribution, sale, advertising, labeling, safety, transportation and use of Elastolite
®
,
are and will be subject to various foreign laws and regulations administered by government entities and agencies in markets where
Oryon may operate and sell Elastolite
®
. It is Oryon’s policy to abide by the laws and regulations that apply
to its business.
Also, Oryon must be careful it understands and adheres to standards
established in the U.S., the European Union and multiple Asian countries where Elastolite
®
is produced and potentially
distributed in addition to Underwriters Laboratories Inc. (UL) and Conformance European (CE) standards established on the electronic
components used to power Elastolite
®
.
Oryon does not anticipate at this time that the cost of compliance
with U.S. and foreign laws will have a material financial impact on its operations, business or financial condition, but new regulatory
and tariff legislation or changes in existing regulations may have a material negative effect on Oryon’s business in the
future. Oryon is also committed to meeting all applicable environmental compliance requirements. Environmental compliance costs
are not expected to have a material impact on Oryon’s capital expenditures, earnings or competitive position.
Employees
Oryon has two full-time employees. Occasionally, Oryon engages
temporary part-time workers or consultants to assist in the completion of specific assignments or projects. All full-time employees
are offered the opportunity to receive healthcare benefits. No employees are covered by collective bargaining agreements. Certain
management employees of Oryon have employment agreements with individually customized terms. Oryon has an equity incentive plan
and all Oryon employees are eligible for grants under that plan.
ITEM 1A.—RISK FACTORS
The statements contained in this document that are not historic
facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially
from those set forth in or implied by forward-looking statements. If any of the following events described in these risk factors
actually occurs, our business, financial condition or results of operations could be harmed.
Risks Relating to Our Company and Our Industry
Oryon has limited revenues and has incurred losses.
Oryon has limited revenues and we anticipate that our existing
cash and cash equivalents will not be sufficient to fund our longer term business needs and we will need to generate additional
revenue or receive additional investment to continue operations. In 2013 and 2012, Oryon had losses of approximately $1.4 million
and $2.6 million, respectively. Based on our current internal forecast, we anticipate that we will continue to incur losses through
the year ending December 2014.
We operate a business that is highly speculative and may
not generate any profit.
There can be no assurance that our products will have commercial
viability and/or that our plan to develop and exploit our technology is feasible. Because of the numerous risks and uncertainties
associated with developing and marketing new technologies, we are unable to predict the extent of any future profits, if at all.
We have financed operations and internal growth primarily through funding provided by investors and funds generated from operations.
To date, we have devoted substantially all of our efforts to research and development, infrastructure building and initial marketing
activities. There is no guarantee the cost estimates used by us or the sales volumes projected are accurate and will be attained.
An inability to meet sales volumes as forecast or to achieve assumed cost figures could have a negative impact on our profitability,
cash flow and survival. Some of the initial sales volumes that we are projecting are expected to be in the apparel and gear areas.
These areas are highly volatile and sometimes affected by economic conditions beyond our control, which could impact planned sales
volumes and could negatively impact our finances.
Our auditors have expressed uncertainty as to our ability
to continue as a going concern.
Primarily as a result of our recurring losses and our lack of
liquidity, we received a report from our independent auditors that includes an explanatory paragraph describing the substantial
uncertainty as to our ability to continue as a going concern as of our fiscal year ended December 31, 2013.
If we fail to raise additional capital, our ability to
implement our business model and strategy could be compromised.
We have limited capital resources and operations. To date, our
operations have been funded entirely from the proceeds from limited revenues, equity and debt financings. We currently do not have
adequate capital or revenue to meet current or projected operating expenses. We anticipate needing substantial additional capital
in the near future to develop and market new products, services and technologies. We currently do not have commitments for financing
to meet our expected needs and we may not be able to obtain additional financing on terms acceptable to us, or at all. Even if
we obtain financing for our near term operations and product development, we expect that we will require additional capital beyond
the near term. If we are unable to raise capital when needed, our business, financial condition and results of operations would
be materially adversely affected, and we could be forced to reduce or discontinue our operations. Debt financing, if obtained,
may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional
debt and could increase our expenses, and would be required to be repaid regardless of our operating results. Moreover, we may
issue equity securities in connection with such debt financing. Equity financing, even if obtained, could result in ownership and
economic dilution to our existing stockholders and/or require us to grant certain rights and preferences to new investors. In addition,
we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient
funds for our current operations.
We do not currently have credit facilities or arrangements in
place as a source of funds and there can be no assurance that we will be able to raise sufficient additional capital or raise such
capital on acceptable terms or raise such capital when we need it. If such capital is not available on satisfactory terms, or is
not available at all, we may be required to delay, scale back or stop the development of our products and/or cease our operations.
If our products or technology do not gain market acceptance,
we may not be able to fund future operations.
There can be no assurance that our products or technology will
have commercial viability and/or that our plan to develop and exploit our technology is feasible. A number of factors may affect
the market acceptance of our products, including, among others, the perception by consumers of the effectiveness of our products,
our ability to fund our sales and marketing efforts, and the effectiveness of our sales and marketing efforts. If our products
do not gain acceptance by consumers, we may not be able to fund future operations, including the development of new products, and/or
our sales and marketing efforts for our current products, which inability would have a material adverse effect on our business,
financial condition and operating results.
If we underestimate our operating expenses, we may not
be able to fund future operations.
To date, we have devoted substantially all of our efforts to
research and development, infrastructure building and initial marketing activities. There is no guarantee that our cost estimates
or projected sales volumes are accurate and will be attained. An inability to meet sales volumes as forecast or to achieve assumed
cost figures could have a negative impact on our profitability, cash flow and survival.
We expect our operating expenses to increase in connection with
the continued development of our products and technology and expansion of our marketing activities. We may also incur costs and
expenses that are unexpected, in excess of amounts anticipated or are otherwise not contemplated or provided for in connection
with our business plan. If these or other costs or expenses are incurred, it could have a material adverse effect on our financial
performance.
Any failure to adequately establish outsourcing capabilities
and an internal and distributor sales force will impede our growth.
We require adequate arrangements with third party outsourcing
sources to manufacture our products. Any failure to enter into and maintain such arrangements would adversely affect our growth.
In addition, we expect to be substantially dependent on an internal and distributor sales force to attract new consumers of our
products and technology. We believe that there may be significant competition for qualified, productive sales personnel and distributors
who have the skills and technical knowledge necessary to promote and sell our products and technology. Our ability to achieve significant
growth in revenue in the future will depend, in large part, on our success in establishing our sales network. If we are unable
to develop an efficient sales network, it will make our growth more difficult and our business could suffer.
Our failure to accurately estimate demand for our products
and technology could adversely affect our business and financial results.
We may not accurately estimate demand for our products and technology.
Our ability to estimate the overall demand for our products and technology is imprecise and may be less precise in certain markets.
If we materially underestimate demand for our products and technology we might not be able to satisfy demand on a short-term basis.
Moreover, industry-wide shortages of certain electronic and lighting components, parts or raw materials have been, and could, from
time to time in the future, be experienced. Such shortages could interfere with and/or delay production of our products by our
customers and could have a material adverse effect on our business and financial results.
Changes in consumer preferences may reduce demand for
our products and technology.
Our future success will depend upon our ability to develop and
introduce different and innovative lighting solutions and applications for Elastolite
®
. In order to develop our
market share, the impact of our products must address a consumer need and then meet that need in the areas of quality and derived
benefits. There can be no assurance of our ability to meet that need and there is no assurance that consumers will purchase our
products. Additionally, our products are considered premium products and to maintain market share during recessionary periods we
may have to reduce profit margins which would adversely affect our results of operations. Product lifecycles for some consumer
electronic products in which our products may be used may be limited to a few years before consumers’ preferences change.
There can be no assurance that our products will become or remain profitable for us. Our industry is subject to changing consumer
preferences and shifts in consumer preferences may adversely affect us if we misjudge such preferences. We may be unable to achieve
volume growth through product initiatives. We also may be unable to penetrate new markets. If we are unable to address any or all
of these issues, it may affect our ability to produce revenues and our business, financial condition and results of operations
will be adversely affected.
If we are unable to develop and establish brand image
or product quality, or if we encounter product recalls, our business may suffer.
Our success depends on our ability to develop and establish
brand image for our products, lighting solutions and applications for Elastolite
®
. We have no assurance that our
advertising, marketing and promotional programs will have the desired impact on our products’ brand image or consumer preferences.
Product quality issues, real or imagined, or allegations of product defects, even if false or unfounded, could tarnish the image
of the affected brands and may cause consumers to choose other products. We may be required from time to time to recall products
entirely. Product recalls could adversely affect our profitability and our brand image. We do not maintain recall insurance. While
we do not expect to have any credible product liability litigation, there is no assurance that we will not experience such litigation
in the future. In the event we do experience product liability claims or a product recall, our financial condition and business
operations could be materially adversely affected.
We may acquire or make investments in companies or technologies
that could cause loss of value to our stockholders and disruption of our business.
Subject to our capital constraints, we intend to continue to
explore opportunities to acquire companies or technologies in the future. Entering into an acquisition entails many risks, any
of which could adversely affect our business, including:
|
·
|
Failure to integrate the acquired assets and/or companies with our
current business;
|
|
·
|
The price we pay may exceed the value we eventually realize;
|
|
·
|
Loss of share value to our existing stockholders as a result of issuing
equity securities as part or all of the purchase price;
|
|
·
|
Potential loss of key employees from either our current business or
the acquired business;
|
|
·
|
Entering into markets in which we have little or no prior experience;
|
|
·
|
Diversion of management’s attention from other business concerns;
|
|
·
|
Assumption of unanticipated liabilities related to the acquired assets;
and
|
|
·
|
The business or technologies we acquire or in which we invest may
have limited operating histories, may require substantial working capital, and may be subject to many of the same risks we are
subject to, as well as additional risks.
|
If we do not respond effectively and on a timely basis
to rapid technological change, our business could suffer.
Our industry is characterized by rapidly changing technologies,
industry standards, customer needs and competition, as well as by frequent new product and service introductions. We must respond
to technological changes affecting both our customers and suppliers. We may not be successful in developing and marketing, on a
timely and cost-effective basis, new services that respond to technological changes, evolving industry standards or changing customer
requirements. Our success will depend, in part, on our ability to accomplish all of the following in a timely and cost-effective
manner:
|
·
|
Effectively using and integrating new technologies;
|
|
·
|
Continuing to develop our technical expertise;
|
|
·
|
Enhancing our engineering and system design services;
|
|
·
|
Developing services that meet changing customer needs;
|
|
·
|
Advertising and marketing our services; and
|
|
·
|
Influencing and responding to emerging industry standards and other
changes.
|
An interruption in the supply of products and services
that we obtain from third parties could cause a decline in sales of our products.
In designing, developing and supporting our products, lighting
solutions and applications for Elastolite
®
, we rely on many third party providers. These suppliers may experience
difficulty in supplying us products or services sufficient to meet our needs or they may terminate or fail to renew contracts for
supplying us these products or services on terms we find acceptable. If our liquidity deteriorates, our vendors may tighten our
credit, making it more difficult for us to obtain suppliers on terms satisfactory to us. Any significant interruption in the supply
of any of these products or services could cause a decline in sales of our services, unless and until we are able to replace the
functionality provided by these products and services. We also depend on third parties to deliver and support reliable products,
enhance their current products, develop new products on a timely and cost-effective basis and respond to emerging industry standards
and other technological changes.
Growth of internal operations and business may strain
our financial resources.
We intend to significantly expand the scope of our operating
and financial systems in order to build and expand our business. Our growth rate may place a significant strain on our financial
resources for a number of reasons, including, but not limited to, the following:
|
·
|
The need for continued development of our financial and information
management systems;
|
|
·
|
The need to manage strategic relationships and agreements with manufacturers,
suppliers and distributors; and
|
|
·
|
Difficulties in hiring and retaining skilled management, technical
and other personnel necessary to support and manage our business.
|
We cannot give you any assurance that we will adequately address
these risks and, if we do not, our ability to successfully expand our business could be adversely affected.
Current global economic conditions may adversely affect
our industry, business and result of operations.
Historically, disruptions in the current global credit and financial
markets have included diminished liquidity and credit availability, a decline in consumer confidence, a decline in economic growth,
an increased unemployment rate, and uncertainty about economic stability. There can be no assurance that there will not be deterioration
in credit and financial markets and confidence in economic conditions. These economic uncertainties affect businesses such as ours
in a number of ways, making it difficult to accurately forecast and plan our future business activities. Adverse global economic
conditions and tightening of credit in financial markets may lead consumers to postpone spending, which may cause our customers
to cancel, decrease or delay their existing and future orders with us. In addition, financial difficulties experienced by our suppliers,
manufacturers, distributors or customers could result in product delays, increased accounts receivable defaults and inventory challenges.
We are unable to predict the likely duration and severity of the current disruptions in the credit and financial markets and adverse
global economic conditions. If uncertain economic conditions occur, our business and results of operations could be materially
and adversely affected.
Significant changes in government regulation may hinder
sales.
The production, distribution, sale and marketing of our products
and technology are subject to the rules and regulations of various federal, state, local and foreign agencies, various environmental
statutes, and various other federal, state, local and foreign statutes and regulations applicable to the production, transportation,
sale, safety, and advertising of or pertaining to our products and technology. New statutes and regulations may also be instituted
in the future. Compliance with applicable federal and state regulations is crucial to our success. Although we believe that we
are in compliance with applicable regulations, should the federal government or any jurisdiction in which we operate amend its
guidelines or impose more stringent interpretations of current laws or regulations, we may not be able to comply with these new
guidelines. Such regulations could require the reformulation of certain products to meet new standards, market withdrawal or discontinuation
of certain products we are unable to re-design or re-formulate, imposition of additional record keeping requirements and expanded
documentation regarding the properties of certain products. Failure to comply with applicable requirements could result in sanctions
being imposed on us or the manufacturers of any of our products, including but not limited to fines, injunctions, product recalls,
seizures and criminal prosecution. Further, if a regulatory authority finds that a current or future product or production run
is not in compliance with any of these regulations, we may be required to have the packaging of our products changed which may
adversely affecting our financial condition and operations. We are also unable to predict whether or to what extent a warning under
any of applicable statute would have an impact on costs or sales of our products.
If we are not able to adequately protect our intellectual
property, we may not be able to compete effectively.
Our ability to compete depends in part upon the strength of
our proprietary rights in our technologies, brands and content. Currently, and going forward, we expect to rely on a combination
of U.S. and foreign patents, trademarks, trade secret laws and license agreements to establish and protect our intellectual property
and proprietary rights. The efforts we have taken and expect to take to protect our intellectual property and proprietary rights
may not be sufficient or effective at stopping unauthorized use of our intellectual property and proprietary rights. In addition,
effective trademark, patent, copyright and trade secret protection may not be available or cost-effective in every country in which
our products or services are made available. There may be instances where we are not able to fully protect or utilize our intellectual
property in a manner that maximizes competitive advantage. If we are unable to protect our intellectual property and proprietary
rights from unauthorized use, the value of our products may be reduced, which could negatively impact our business. Our inability
to obtain appropriate protections for our intellectual property may also allow competitors to enter our markets and produce or
sell the same or similar products. In addition, protecting our intellectual property and other proprietary rights is expensive
and diverts critical managerial resources. We rely in part on our currently issued patents to support competitive position. There
can be no assurance that some of our patents will not be challenged at a later date. There can be no guarantee that we will be
successful in obtaining additional patents that we may need at a later date to support certain growth initiatives. Our ability
to defend our patents, if they are challenged, or the inability to obtain certain patents in the future, could have a material
adverse effect in future periods. If we are otherwise unable to protect our intellectual property and proprietary rights, our business
and financial results could be adversely affected.
If we are forced to resort to legal proceedings to enforce our
intellectual property rights, the proceedings could be burdensome and expensive. In addition, our proprietary rights could be at
risk if we are unsuccessful in, or cannot afford to pursue, those proceedings. In addition, the possibility of extensive delays
in the patent issuance process could effectively reduce the term during which a marketed product is protected by patents.
The intellectual property to support our intermediate and long-term
growth plans continues to be developed and there can be no assurance that we will complete such process. The addition of intellectual
property to support this growth is particularly dependent on the continued services of our technology team and its ability to develop
additional technologies to support such growth plans. If we do not have the financial resources to develop the intellectual property
to fully support these growth plans, our ability to develop future products and refinement of current products could be negatively
impacted.
We may also need to obtain licenses to patents or other proprietary
rights from third parties. We may not be able to obtain the licenses required under any patents or proprietary rights or they may
not be available on acceptable terms. If we do not obtain required licenses, we may encounter delays in product development or
find that the development, manufacture or sale of products requiring licenses could be foreclosed. We may, from time to time, support
and collaborate in research conducted by universities and governmental research organizations. We may not be able to acquire exclusive
rights to the inventions or technical information derived from these collaborations, and disputes may arise over rights in derivative
or related research programs conducted by us or our collaborators.
Assertions against us by third parties for infringement
of their intellectual property rights could result in significant costs and cause our operating results to suffer.
The electronic and alternative lighting industries are characterized
by vigorous protection and pursuit of intellectual property rights and positions, which results in protracted and expensive litigation
for many companies. Other companies with greater financial and other resources than us have gone out of business from costs related
to patent litigation and from losing a patent litigation. We may be exposed to future litigation by third parties based on claims
that our technologies or activities infringe the intellectual property rights of others. Although we try to avoid infringement,
there is the risk that we will use a patented technology owned or licensed by another person or entity and be sued for patent infringement
or infringement of another party’s intellectual property or proprietary rights. If we or our products are found to infringe
the intellectual property or proprietary rights of others, we may have to pay significant damages or be prevented from making,
using, selling, offering for sale, or importing such products or services or from practicing methods that employ such intellectual
property or proprietary rights.
Further, we may receive notices of infringement of third-party
intellectual property rights. Specifically, we may receive claims from various industry participants alleging infringement of their
patents, trade secrets or other intellectual property rights in the future. Any lawsuit resulting from such allegations could subject
us to significant liability for damages and invalidate our proprietary rights. These lawsuits, regardless of their success, would
likely be time-consuming and expensive to resolve and would divert management time and attention. Any potential intellectual property
litigation also could force us to do one or more of the following:
|
·
|
stop selling products or using technology or manufacturing processes
that contain the allegedly infringing intellectual property;
|
|
·
|
pay damages to the party claiming infringement;
|
|
·
|
attempt to obtain a license for the relevant intellectual property,
which may not be available on commercially reasonable terms or at all; and
|
|
·
|
attempt to redesign those products that contain the allegedly infringing
intellectual property with non-infringing intellectual property, which may not be possible.
|
The outcome of a dispute may result in our need to develop non-infringing
technology or enter into royalty or licensing agreements. We may agree to indemnify certain customers for certain claims of infringement
arising out of the sale of our products. Any intellectual property litigation could have a material adverse effect on our business,
operating results or financial condition.
Confidentiality agreements with employees and others may
not adequately prevent disclosure of our trade secrets and other proprietary information.
Our success depends upon the skills, knowledge and experience
of our technical personnel, our consultants and advisors as well as our licensors and contractors. Because we operate in a highly
competitive field, we rely almost wholly on trade secrets to protect our proprietary technology and processes. However, trade secrets
are difficult to protect. We enter into confidentiality and intellectual property assignment agreements with our corporate partners,
employees, consultants, outside scientific collaborators, developers and other advisors. These agreements generally require that
the receiving party keep confidential and not disclose to third parties confidential information developed by us during the course
of the receiving party’s relationship with us. These agreements also generally provide that inventions conceived by the receiving
party in the course of rendering services to us will be our exclusive property. However, these agreements may be breached and may
not effectively assign intellectual property rights to us. Our trade secrets also could be independently discovered by competitors,
in which case we would not be able to prevent use of such trade secrets by our competitors. The enforcement of a claim alleging
that a party illegally obtained and was using our trade secrets could be difficult, expensive and time consuming and the outcome
would be unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets. The failure
to obtain or maintain meaningful trade secret protection could adversely affect our competitive position.
We face intense competition and expect competition to
increase in the future, which could prohibit us from developing a customer base and generating revenue.
There are many companies who do or will compete directly with
our current and planned products, technology and services. These companies may already have an established market in our industry.
Most of these companies have significantly greater financial and other resources than us and have been developing their products
and services longer than we have been developing ours. Additionally, there are not significant barriers to entry in our industry
and new companies may be created that will compete with us and other, more established companies who do not now directly compete
with us, may choose to enter our markets and compete with us in the future. Our inability to compete effectively with larger companies
could have a material adverse effect on our business activities, financial condition and results of operations.
If we are unable to attract, train and retain marketing,
technical and financial personnel, our business may be materially and adversely affected.
Our future success depends, to a significant extent, on our
ability to attract, train and retain marketing, technical and financial personnel. Recruiting and retaining capable personnel,
particularly those with expertise in our chosen industries, are vital to our success. There is substantial competition for qualified
marketing, technical and financial personnel, and there can be no assurance that we will be able to attract or retain our marketing,
technical and financial personnel. If we are unable to attract and retain qualified employees, our business may be materially and
adversely affected.
Our business depends substantially on the continuing efforts
of our executive officers and our business may be severely disrupted if we lose their services.
Our future success depends substantially on the continued services
of our executive officers. In particular, our performance depends, in large part, upon our officers and their existing relationships
in the industry. We do not maintain key man life insurance on any of our executive officers and directors. If one or more of our
executive officers are unable or unwilling to continue in their present positions, we may not be able to replace them readily,
if at all. Therefore, our business may be severely disrupted, and we may incur additional expenses to recruit and retain new officers.
In addition, if any of our executives joins a competitor or forms a competing company, we may lose some of our customers.
We are subject to manufacturing risks.
We intend to use contract manufacturers for a majority of our
production volumes. There can be no assurance that contract arrangements will be finalized or maintained at cost levels that will
insure we achieve the necessary gross margin to attain profitability. Any interruption in the manufacturing capacity or production
of contract manufacturers would impact their ability to complete orders under contract terms or accept new orders and could have
a negative impact on our sales and financial viability.
We are subject to production risks.
Some of our products and technology have not undergone extensive
field and consumer testing. If failure of our products or technology should occur, we could be subject to warranty claims and other
liabilities which could have a negative effect on our financial stability and further negatively affect both current and future
sales. Certain of our important raw materials are available or obtained from a limited number of suppliers at the current time.
Should one of these suppliers discontinue its production or distribution of these materials, unless we have developed additional
suppliers in the interim, the result would have a materially adverse impact on us and could result in our production being suspended
until an acceptable substitute could be found.
We are subject to potential technological obsolescence.
Our success is based on our ability to capitalize on our core
patents and intellectual property in the marketplace and continue, through research and development, to develop improved technology.
Other companies may develop technology that leapfrogs our existing technology thereby making our technology obsolete. Advancements
could materially adversely affect our growth and future business.
We are subject to marketing risks.
The markets that we targeted as immediately viable are subject
to changing consumer trends and personal taste and could be impacted by factors outside our control. Any economic factors which
impact our markets could have a negative impact on us and our financial performance. Certain of the markets that we have targeted
are classified as “high tech” and as such are subject to rapid technological advancements as well as high barriers
such as cost, vendor status, criteria and time constraints. If any of these markets are subject to adverse economic conditions
or experience an economic downturn, we could be negatively impacted.
After we introduce some of our products to the market, it is
expected that we will attract an increased level of competition from companies that make products that are similar to our products.
Any increased level of competition from other companies in the areas that we have targeted could lead to lower margins than projected
and have a negative impact on us. We have made assumptions on the timing and cycles to market that, if in error, could adversely
impact future revenue and cash flow.
Our products are subject to government regulations and
customer requirements regarding safety matters that may require significant expenditures by us to ensure compliance.
Our products (and certain uses of our products) may be subject
to governmental regulations for compliance with applicable safety standards. Any failure to comply with such standards could subject
us to both governmental fines as well as possible claims by consumers.
Risks Relating to our Common Stock and our Status as a
Public Company
We are subject to new corporate governance and internal
control reporting requirements, and our costs related to compliance with, or our failure to comply with, existing and future requirements
could adversely affect our business.
We face new corporate governance requirements under the Sarbanes-Oxley
Act of 2002, as well as new rules and regulations subsequently adopted by the Securities and Exchange Commission (“SEC”)
and the Public Company Accounting Oversight Board. These laws, rules and regulations continue to evolve and may become increasingly
stringent in the future. The financial cost of compliance with these laws, rules and regulations is expected to be
substantial. We cannot assure you that we will be able to fully
comply with these laws, rules and regulations that address corporate governance, internal control reporting and similar matters.
Failure to comply with these laws, rules and regulations could materially and adversely affect our reputation, financial condition
and the value of our securities.
The relative lack of public company experience of our
management team may put us at a competitive disadvantage.
Our management team lacks public company experience, which could
impair our ability to comply with legal and regulatory requirements such as those imposed by Sarbanes-Oxley Act of 2002. Prior
to the Merger, the individuals who now constitute our senior management team had never had responsibility for managing a publicly
traded company. Such responsibilities include complying with federal securities laws and making required disclosures on a timely
basis. Our senior management may not be able to implement programs and policies in an effective and timely manner that adequately
responds to such increased legal and regulatory compliance and reporting requirements. Our failure to comply with all applicable
requirements could lead to the imposition of fines and penalties and distract our management from attending to the growth of our
business.
Our board of directors does not intend to declare or pay
any dividends to our stockholders in the foreseeable future.
The declaration, payment and amount of any future dividends
will be made at the discretion of our board of directors, and will depend upon, among other things, the results of our operations,
cash flows and financial condition, operating and capital requirements, and other factors the board of directors considers relevant.
There is no plan to pay dividends in the foreseeable future, and if dividends are paid, there can be no assurance with respect
to the amount of any such dividend.
Nevada law and our articles of incorporation authorize
us to issue shares of stock, which shares may cause substantial dilution to our existing stockholders and/or have rights and preferences
greater than our common stock.
Pursuant to our Articles of Incorporation, we currently have
600,000,000 shares of common stock authorized and 50,000,000 shares of preferred stock authorized. As of December 31, 2013, we
had 62,660,778 shares of common stock issued and outstanding and up to an additional 18,151,721 shares issuable upon exercise of
outstanding options and warrants. In January 2014, we issued an additional 104,538,789 shares in connection with a transaction,
bringing the total shares of common stock issued and outstanding to 167,199,567. The subscription agreement with EFL Tech requires
the Company to issue an additional 214,966,748 shares of common stock by March 31, 2014, resulting in 382,166,315 shares of common
stock issued and outstanding with a potential of 400,318,036 fully diluted shares issued. As a result, our board of directors has
the ability to issue a large number of additional shares of common stock without shareholder approval, which, if issued, could
cause substantial dilution to our existing stockholders. In addition, we may elect to issue preferred stock or other securities
in the future having rights and preferences greater to our common stock. Our Articles of Incorporation provide that the Board may
designate the rights and preferences of preferred stock without a vote by the shareholders.
A limited public trading market exists for our common
stock, which makes it more difficult for our stockholders to sell their common stock in the public markets.
Our common stock is not listed on any stock exchange, although
it is quoted on the OTCQB Tier of the U.S. OTC Markets. No trades of our common stock took place on the OTCQB prior to the Merger.
No assurance can be given that an active market will continue to develop or that a stockholder will ever be able to liquidate its
shares of common stock without considerable delay, if at all. Many brokerage firms may not be willing to effect transactions in
our securities. Even if a purchaser finds a broker willing to effect a transaction in these securities, the combination of brokerage
commissions, state transfer taxes, if any, and any other selling costs may exceed the selling price. Furthermore, our stock price
may be impacted by factors that are unrelated or disproportionate to our operating performance. These market fluctuations, as well
as general economic, political and market conditions, such as recessions, lack of available credit, interest rates or international
currency fluctuations may adversely affect the market price and liquidity of our common stock.
Shares of our common stock that have not been registered
under the Securities Act of 1933, as amended, regardless of whether such shares are restricted or unrestricted, are subject to
resale restrictions imposed by Rule 144. In addition, any shares of our common stock that are held by affiliates, including any
received in a registered offering, will be subject to the resale restrictions of Rule 144(i).
Pursuant to Rule 144 of the Securities Act of 1933, as amended
(“
Rule 144
”), any restricted securities we sell in the future or issue to consultants or employees, in consideration
for services rendered or for any other purpose will have no liquidity until and unless such securities are registered with the
SEC and we have otherwise complied with the other requirements of Rule 144. As a result, it may be harder for us to fund our operations
and pay our employees and consultants with our securities instead of cash. Furthermore, it will be harder for us to raise funding
through the sale of debt or equity securities unless we agree to register such securities with the SEC, which could cause us to
expend additional resources in the future. Lastly, any shares held by affiliates, including shares received in any registered offering,
will be subject to the resale restrictions of Rule 144(i).
Our stock is categorized as a penny stock. Trading of
our stock may be restricted by the SEC’s penny stock regulations which may limit a stockholder’s ability to buy and
sell our stock.
Our stock is categorized as a “penny stock”. The
SEC has adopted Rule 15g-9 which generally defines “penny stock” to be any equity security that has a market price
(as defined) less than $5.00 per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Our securities
are covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons
other than established customers and accredited investors. The penny stock rules require a broker-dealer, prior to a transaction
in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by
the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer
also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer
and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the
customer’s account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be
given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before
or with the customer’s confirmation. In addition, the penny stock rules require that prior to a transaction in a penny stock
not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable
investment for the purchaser and receive the purchaser’s written agreement to the transaction. These disclosure requirements
may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny
stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our securities. We believe
that the penny stock rules discourage investor interest in and limit the marketability of our common stock.
FINRA sales practice requirements may also limit a stockholder’s
ability to buy and sell our stock.
In addition to the “penny stock” rules described
above, the Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require that in recommending an
investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer.
Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable
efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information.
Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will
not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that
their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the
market for our shares.
We may not qualify to meet listing standards to list our
stock on an exchange.
The SEC approved listing standards for companies using reverse
mergers to list on an exchange may limit our ability to become listed on an exchange. We would be considered a reverse merger company
(i.e., an operating company that becomes an Exchange Act reporting company by combining with a shell Exchange Act reporting company)
that cannot apply to list on NYSE, NYSE MKT (formerly NYSE-Amex) or Nasdaq until our stock has traded for at least one year on
the U.S. OTC market, a regulated foreign exchange or another U.S. national securities market following the filing with the SEC
or other regulatory authority of all required information about the merger, including audited financials. We would be required
to maintain a minimum $4 share price ($2 or $3 for NYSE MKT) for at least thirty (30) of the sixty (60) trading days before our
application and the exchange’s decision to list. We would be required to have timely filed all required reports with the
SEC (or other regulatory authority), including at least one annual report with audited financials for a full fiscal year commencing
after filing of the above information. Although there is an exception for a firm underwritten IPO with proceeds of at least $40
million, we do not anticipate being in a position to conduct a public offering in the foreseeable future. In order for the minimum
stock price requirement to not apply, we must satisfy the one year trading requirement and file at least four (4) annual reports
with the SEC after the Merger. To the extent that we cannot qualify for a listing on an exchange, our ability to raise capital
will be diminished.
ITEM 1B.—UNRESOLVED STAFF COMMENTS
None.
ITEM 2.—PROPERTIES
The Registrant’s executive office and development facility
is located at 4251 Kellway Circle, Addison, Texas 75001. The rent for this property is $6,597 per month. The Registrant’s
main telephone number is: (214) 267-1321 and its fax number is (214) 267-1303. The Registrant’s website is located at http://elastolite.com.
ITEM 3.—LEGAL PROCEEDINGS
Marcus v. Oryon, et. al.
On February 6, 2014, M. Richard Marcus (the “Plaintiff”)
filed a lawsuit against Oryon Technologies, Inc. (“Oryon”) and certain of its subsidiaries and directors, and EFL
Tech B.V. (“EFL”) and an affiliate (collectively, the “Defendants”), in the District Court for Dallas
County, Texas (the “Court”), alleging a breach of fiduciary duty, inducement of breach of fiduciary duty, minority
shareholder oppression, breach of promissory note, and tortious interference with contract, in connection with the transaction
between Oryon and EFL that is described in Oryon’s Current Report on Form 8-K filed with the Securities and Exchange Commission
on January 27, 2014 (the “EFL Transaction”).
The Plaintiff is the former Chief Executive Officer,
President and Chairman of the Board of OryonTechnologies, LLC, having relinquished those positions upon the closing of the
Merger (as that term is defined in Part II, Item 5, Initial Public Offering) on May 4, 2012.
In the lawsuit, the Plaintiff seeks monetary damages, and a
temporary restraining order, temporary injunction and permanent injunction that would,
inter
alia
, restrain the Defendants
from: (i) closing the second and third tranches (as required by the Subscription Agreement between the parties) pursuant to which
EFL would contribute $500,000 to Oryon in exchange for shares of common stock that would increase EFL’s ownership stake in
Oryon to 75% of Oryon’s fully diluted common stock, and allow EFL to nominate three additional directors to Oryon’s
Board of Directors; (ii) acting under the Subscription Agreement, License Agreement, Equipment Lease Agreement, or the Business
Relationship Agreement that are part of the EFL Transaction; and (iii) dissipating the assets of Oryon.
The Plaintiff also alleges that Oryon breached a promissory
note held by Plaintiff which accelerates the full amount of principal and interest of due thereunder, in the amount of approximately
$68,000.
At a hearing held on February 6, 2014, the Court denied the
Plaintiff’s motion for a temporary restraining order.
After a hearing before the Court held on February 14 and 19,
2014, the Court entered an Order on February 20, 2014:
1. Denying Plaintiff’s request for
a Temporary Injunction; and
2. Ordering that Plaintiff shall not obstruct or interfere
with the Defendants’ continuing operations and transactions.
Oryon intends to vigorously defend against the foregoing action.
Myant v. Oryon, et. al.
On January 3, 2014, Myant Capital Partners filed a lawsuit against
Oryon Technologies, Inc. in the United States District Court for the Northern District of Texas, Dallas Division, alleging that
Oryon breached an exclusivity agreement and a non-disclosure/confidentiality agreement, and seeking $1.25 million in damages. On
January 28, 2014, Oryon filed its Answer to the Complaint denying the allegations and asserting affirmative defenses.
Oryon intends to vigorously defend against the foregoing action.
ITEM 4.—MINE SAFETY DISCLOSURES
Not applicable.
PART II
ITEM 5. – MARKET FOR REGISTRANT’S COMMON EQUITY,
RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Investment by EFL Tech B.V.
Issuance under Subscription Agreement
.
On January 21, 2014, Oryon Technologies, Inc., a Nevada corporation (the “Registrant,” “ORYN” or the “Company”)
entered into a Subscription Agreement (the “Subscription Agreement”) with EFL Tech B.V., a Netherlands corporation
(“EFL Tech”). At the closing of the first tranche of issuances of shares of the Company’s common stock, par value
$0.001 (the “Common Stock”) pursuant to the Subscription Agreement, on January 21, 2014 (the “First Closing”),
the Registrant issued to EFL Tech an aggregate of 85,271,779 shares of Common Stock, and EFL Tech delivered $1,000,000 (of the
net $1.5 million cash portion of the consideration for all share issuances under the Subscription Agreement) to the Company. Subsequent
to the First Closing, on January 21, 2014, EFL Tech held 51.0% of the Company’s issued and outstanding Common Stock (46.0%
on a fully diluted basis). Based upon information from EFL Tech, the source of such funds was the working capital of EFL Tech.
Other consideration provided to the Company
at the First Closing for the sale of shares of Common Stock to EFL Tech consists of the following agreements, each of which was
entered into and delivered by the Company and EFL Holdings Tech B.V., a Netherlands corporation (“EFL Holdings”), and
an affiliate of EFL Tech, on January 21, 2014: (a) License Agreement granting the Company an exclusive, worldwide, perpetual, sub-licensable,
royalty-free, paid-up license (the “License Agreement”) for all of EFL Holding’s EL-related patents, trademarks
and other intellectual property, both U.S. and international (the “EFL Holdings IP”); (b) Equipment Lease Agreement
for certain printing equipment used in the production of electroluminescent (“EL”) lamps, the Company’s principal
product, which EFL Holdings valued at $1.5 million, at no cost to the Company (the “Equipment Lease”); and (c) Business
Relationship Agreement pursuant to which EFL Holdings covenants that it will not, directly or indirectly, provide services to or
otherwise engage in the business of manufacturing, designing, marketing, selling or distributing EL, or any products incorporating
the EFL Holdings IP, other than through the ownership, management and control of the Company by EFL Tech. The License Agreement
has a term that continues until the expiration of the last of the patents licensed thereunder, unless sooner terminated by EFL
Holdings due to the Company’s bankruptcy or other specified, similar financial difficulties. The Business Relationship Agreement
has a term that continues until, and the Equipment Lease has a term of the earlier of 21 years or until, the License Agreement
expires or is terminated. The above-referenced agreements contemplate that the Company will license, and will manufacture and market
products incorporating, its own EL-related intellectual property, as well as the EFL Holdings IP, as a combined intellectual property
portfolio. The descriptions of the Subscription Agreement, the License Agreement, the Equipment Lease, and the Business Relationship
Agreement herein are qualified in their entirety by reference to the full text of such agreements, which are attached hereto as
Exhibits 10.1, 10.3, 10.4, and 10.5, respectively.
At the closing of the second tranche under
the Subscription Agreement, on or before February 28, 2014 (the “Second Closing”), EFL Tech is required to deliver
to the Company additional funds in the amount of $250,000 on or before February 28, 2014. At the Second Closing, the Company is
required to issue to EFL Tech an additional 85,133,871 shares of Common Stock, at which time EFL Tech’s cumulative ownership
will be 170,405,650 shares of Common Stock, constituting 63.0% of the Common Stock on a fully diluted basis. Additionally, at the
closing of the third and final tranche under the Subscription Agreement, on or before March 31, 2014 (the “Third Closing”),
EFL Tech is required to deliver to the Company additional funds in the amount of $250,000 (bringing the total amount of the cash
component paid by EFL Tech to the Company in consideration for the issuance by the Company of shares of Common Stock to EFL Tech
under the Subscription Agreement to $1,500,000). At the Third Closing, the Company is required to issue to EFL Tech an additional
129,832,877 shares of Common Stock, at which time EFL Tech’s cumulative ownership will be 300,238,527 shares of Common Stock,
constituting 75.0% of the Common Stock on a fully diluted basis.
The proceeds from the foregoing funding
of $1,500,000 ($1,000,000 at the First Closing, consisting of $689,330 in cash plus the forgiveness of the obligation to repay
the $310,670 in temporary unsecured advances that EFL Tech provided to the Company in periods prior to the First Closing, and the
additional $250,000 payments by EFL Tech at each of the Second Closing and the Third Closing)
will be used for general
corporate purposes and the repayment of debt, including, but not limited to, the payments required to be made under the Exchange
Agreements (as defined and described below). At the First Closing, the Company paid the sum of $122,125 in cash, and issued
an aggregate of 19,267,010 shares of Common Stock, to certain creditors, including directors and executive officers, for the
settlement and release of a total of $817,375 of the Company's debt, pursuant to the Exchange Agreements.
In connection with the foregoing issuance
of shares of Common Stock (and the Additional Shares (as defined below), if any) to EFL Tech under the Subscription Agreement,
the Company and EFL Tech entered into a Registration Rights Agreement - Subscription Securities, effective on the First Closing,
pursuant to which the Company agreed to provide EFL Tech with rights to request registration of such shares under the Securities
Act of 1933, as amended. The foregoing description of such Registration Rights Agreement is qualified in its entirety by reference
to the full text of such agreement, which is attached hereto as Exhibit 10.2.
No underwriter was involved in the above
sale of shares of Common Stock.
The foregoing shares were issued (and in
the case of any Additional Shares (as defined below), will be issued) in reliance upon an exemption from registration set forth
in Regulation D and/or Section 4(2) of the Securities Act, which exempts transactions by an issuer not involving a public offering.
Issuance under Exchange and Release Agreements
.
As
required by the Subscription Agreement, on January 21, 2014, the Company entered into exchange and release agreements (each an
“Exchange Agreement” and collectively, the “Exchange Agreements”) by and between the Company and each member
of a group of unsecured creditors of the Company (including current directors and Executive Officers). At the First Closing, pursuant
to the Exchange Agreements the Company issued an aggregate of 19,267,010 shares of Common Stock, constituting 10.39% of the Common
Stock on a fully diluted basis, in exchange for the settlement and release of $695,250 in unpaid and accrued debt to such creditors.
Under the Exchange Agreements, the per-share exchange price for such debt was determined by the average of the closing prices of
the Common Stock on the trading days commencing on December 1, 2013, and ending on January 20, 2014 (the day prior to the First
Closing), which resulted in an exchange price of $0.036085 per share of Common Stock. The Company also paid the sum of $122,125
in cash to such creditors under the Exchange Agreement for the settlement and release of such amount of debt (for the settlement
and release of a total of $817,375 of debt pursuant to the Exchange and Release Agreements).
Under the Subscription Agreement, the Company
has the option of entering into additional Exchange Agreements with other holders of outstanding debt of the Company for the purpose
of exchanging shares of Common Stock for the settlement and release of additional amounts of unpaid and accrued debt of the Company.
The Company has not made a decision regarding whether to enter into any such additional Exchange Agreements. If the Company were
to enter into one or more Exchange Agreements in the future, the Company would issue to EFL Tech that number of additional shares
of Common Stock such that, after issuing shares of Common Stock in exchange for Company debt under such Exchange Agreements, EFL
Tech would continue to hold 75% of the fully diluted shares of Common Stock (the “Additional Shares”). Under the Subscription
Agreement, the cash and non-cash consideration described above for the issuance to EFL Tech of shares of Common Stock at the First
Closing, the Second Closing and the Third Closing will apply to and suffice in all respects for the issuance by the Company of
all Additional Shares, and EFL Tech will not provide the Company will any additional consideration in connection with the issuance
by the Company of any such Additional Shares to EFL Tech.
In connection with the foregoing issuance
of shares of Common Stock to such creditors under the Exchange Agreements, the Company and such creditors entered into a Registration
Rights Agreement – Exchange Shares, effective on the First Closing, pursuant to which the Company agreed to provide such
creditors with rights to request registration of such shares under the Securities Act of 1933, as amended. The foregoing description
of such Registration Rights Agreement is qualified in its entirety by reference to the full text of the form of such agreement,
which is attached hereto as Exhibit 10.7.
The foregoing shares were issued (and in
the case of any shares issued to Oryon creditors subsequent to the First Closing, will be issued) in reliance upon an exemption
from registration set forth in Regulation D and/or Section 4(2) of the Securities Act, which exempts transactions by an issuer
not involving a public offering.
No underwriter was involved in the sale
of the above shares of Common Stock.
Change in Control
.
Effective at the First Closing,
on January 21, 2014, EFL Tech became the holder of 51.0% of the Company’s issued and outstanding shares Common Stock under
the terms of the Subscription Agreement, and on March 31, 2014, will become the holder of 75.0% of the Company’s shares of
Common Stock on a fully diluted basis (upon the occurrence of the Second Closing and the Third Closing).
Departure and Election of Directors
. On January 21, 2014,
effective at the First Closing, the following events occurred:
1. Jon S. Ross, an independent director and Chairman
of the Compensation Committee of the Board, and Mark E. Pape, a director and the Company’s Chief Financial Officer and Secretary,
resigned from the Board, as provided in the Subscription Agreement.
2. Richard K. Hoesterey, an existing
independent director, a Member of the Compensation Committee of the Board, and the Chairman of the Nominating and Governance Committee
of the Board, was appointed Chairman of the Compensation Committee of the Board, replacing Mr. Ross as Chairman of such committee.
3. The Board appointed Larry
L. Sears, an existing independent director and the Chairman of the Audit Committee of the Board, as a member of the Compensation
Committee of the Board.
4. The Board appointed Dr. Clifton Kwang-Fu Shen,
the Chief Scientific Officer of EFL Tech International Group N.V, a Netherlands corporation and an affiliate of EFL Tech, to fill
one of the foregoing vacancies, in accordance with the provisions of the Company’s Bylaws. Dr. Shen was appointed to serve
until the Company’s next annual meeting of shareholders.
5. The Board increased the number of directors that
may serve on the Board from five (5) to seven (7), pursuant to the authority granted to the Board in the Company’s Bylaws.
With the resignations of Messrs. Pape and Ross as directors, and the appointment of Dr. Shen as a director, effective at the Closing,
there were four (4) directors on the Board, leaving three (3) directorships unfilled.
Under the Subscription Agreement, EFL Tech has the right to
nominate a total of four (4) directors to the Company’s Board, one (1) of whom is Dr. Shen, who was appointed a director
effective at the Closing, as described above. EFL Tech has the right to nominate one (1) director at the Second Closing, and two
(2) directors at the Third Closing; however, EFL Tech has made no decision regarding whom it will nominate with respect to such
right to nominate. Accordingly, when the Second Closing and the Third Closing occur, and the EFL Tech-nominated directors have
been appointed as directors by the Board, EFL Tech will have four (4) of its director-nominees on the Company’s seven (7)
member Board. The description of the Subscription Agreement herein is qualified in its entirety by reference to the full text of
such agreement.
Effective at the First Closing, Thomas P. Schaeffer, retained
his position as Chief Executive Officer of the Company, but he resigned the office of President. That office has not been filled.
The Board may appoint a replacement to the office of President, which may be a member of EFL Tech’s management team, but
no decision has been made, as of the date hereof, if or when such appointment will be made, or who will be appointed.
Amendments to Bylaws
.
Prior to the First Closing,
Section 3.3 of the Company’s Bylaws provided that the Board may not fill more than two (2) newly created directorships during
the period between any two successive annual meetings of stockholders. On January 21, 2014, effective at the First Closing, the
Board amended Section 3.3 of the Bylaws to delete the foregoing restriction on the Board’s authority to fill newly created
directorships.
Initial Public Offering
On May 4, 2012 (the “Closing Date”), the Company
closed a merger transaction with Oryon Merger Sub, LLC, a Texas limited liability company and wholly-owned subsidiary of the Company
(“Merger Sub”), and OryonTechnologies, LLC, a Texas limited liability company (“Oryon”) pursuant to an
Agreement and Plan of Merger dated March 9, 2012 (the “Merger Agreement”). In accordance with the terms of Merger Agreement,
on the Closing Date, Oryon merged into Merger Sub in exchange for the issuance to the members of Oryon (“Oryon Members”)
of eight (8) shares of the Company’s common stock for each outstanding membership unit of Oryon (the “Merger”).
In addition, Oryon had outstanding equity equivalents, consisting of convertible notes payable, accrued interest on the notes payable,
warrants and unit options, that by their terms required the Company to be prepared to issue common stock in an amount equal to
the number of shares (at the 8 to 1 ratio) that would have been issuable at the Closing Date to holders of all of the equity equivalents
if they had been converted to membership units before the Closing Date.
A financing agreement (the “Financing Agreement”)
was signed on November 2, 2011, with Maxum Overseas Fund (“Maxum”) under which Maxum agreed to: (1) invest $100,000
in the common equity of the Company and (ii) either invest an additional amount up to $1,900,000 in the common equity of the Company
or assist the Company in securing all or a portion of such $1,900,000 investment from alternate sources. Prior to entering into
this funding relationship, there were no relationships between Maxum and the directors, officers or other affiliates of Oryon.
To the best of our knowledge, prior to entering into this funding relationship there were no existing relationships between Maxum
and the Registrant’s then-existing directors, officers or other affiliates.
Under the terms of the Financing Agreement, for each dollar
invested, the investor(s) making such investment were issued two (2) shares of common stock of the Company and a warrant to purchase
two (2) shares of common stock of the Company with a current exercise price of $0.50 per share and a term of five (5) years. Between
November 2, 2011, and August 31, 2012, the Company received a total of $2,000,000 from subscriptions pursuant to the Financing
Agreement resulting in the obligation to issue 4,000,000 shares (the “Subscription Shares”) and warrants having the
right to purchase an additional 4,000,000 shares, each with a current exercise price of $0.50. Warrants having the right to purchase
an additional 133,335 shares, each with a current exercise price of $0.50 per share, were issued to a consultant in connection
with this transaction. The Subscription Shares were issued in reliance upon Regulation S under the Securities Act of 1933, as amended
and the rules and regulations promulgated thereunder (the “Securities Act”), to investors in offshore transactions
(as defined in Rule 902 under Regulation S under the Securities Act), based upon representations made by such investors.
In anticipation of the Merger (as defined below), on October
31, 2011, certain shareholders, including our two former executive officers and directors, Ms. Crystal Coranes and Ms. Rizalyn
Cabrillas, surrendered in aggregate 30,000,000 shares of our common stock for cancellation, and on November 17, 2011, an additional
1,000,000 shares were surrendered for cancellation. Further, on April 19, 2012, an additional 12,000,000 shares were surrendered
for cancellation by Ms. Coranes, and on April 30, 2012, an additional 2,000,000 shares were surrendered for cancellation. In total,
of the 60,000,000 shares outstanding prior to October 31, 2011, an aggregate of 45,000,000 shares were surrendered for cancellation
prior to the Merger. On March 12, 2012, the Company fulfilled some of the subscriptions pursuant to the Financing Agreement in
the aggregate amount of $400,000 resulting in the issuance of 800,000 shares of common stock (along with warrants to purchase an
additional 800,000 shares at $0.75 per share). As a result of the cancellations and the subscription fulfillment, our total number
of issued and outstanding shares of common stock was 15,800,000 as of May 4, 2012. In addition, as of May 4, 2012, as a result
of the fulfillment in March 2012 of $400,000 in subscriptions out of the aggregate of $725,000 in subscriptions received prior
to the Closing Date, there remained unfulfilled subscriptions pursuant to the Financing Agreement for $325,000 resulting in an
obligation to issue an additional 650,000 shares of Company common stock (subsequently issued on or about June 3, 2012) along with
warrants for the purchase of an additional 650,000 shares of common stock at $0.50 per share.
Between November 2, 2011 and the Closing Date, the Company advanced
the total of $725,000 that was derived from the sale of the Subscriptions Shares to Oryon in return for a series of promissory
notes from Oryon in the cumulative amount of $725,000. The purpose of the advances was to provide Oryon with sufficient capital
to sustain its operations until the Closing Date. The promissory notes did not have maturity dates and did not provide for interest
if the Merger was completed. The promissory notes also provided that, at closing, as explained below, when Oryon became a wholly-owned
subsidiary of the Company and, the amounts due under the promissory notes between the Company and Oryon became intercompany obligations
within the corporate group, the promissory notes would be cancelled. In the event that the Merger was not completed, the promissory
notes would accrue interest at 5% and become payable when the Company experienced one of several events as defined in the promissory
notes. Subsequent to the Closing Date, the Company received $775,000 in aggregate from two additional subscriptions dated May 10,
2012, and May 15, 2012, pursuant to the Financing Agreement, resulting in the issuance upon fulfillment of the subscriptions, on
or about June 3, 2012, of 1,550,000 shares and warrants having the right to purchase an additional 1,550,000 shares, each with
a current exercise price of $0.50. The Company received $250,000 from each of two additional subscriptions ($500,000 in aggregate)
dated July 24, 2012, and August 31, 2012, respectively, pursuant to the Financing Agreement, resulting in the issuance upon fulfillment
of the subscriptions, during September 2012, of 1,000,000 shares and warrants having the right to purchase an additional 1,000,000
shares, each with an exercise price of $0.50.
In accordance with the terms of Merger Agreement, on the Closing
Date, Oryon merged into Merger Sub in exchange for the issuance to the members of Oryon (“Oryon Members”) of 16,502,121
shares of Company common stock (the “Merger”).
As a result of the Merger, the Oryon Members acquired 50.1%
of our issued and outstanding common stock, Oryon became our wholly-owned subsidiary, and the Registrant acquired the business
and operations of Oryon. Oryon is a technology company with certain valuable products and intellectual property rights related
to a three-dimensional, elastomeric, membranous, flexible electroluminescent lamp.
Prior to the Merger, we were a public reporting “shell
company,” as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended and the rules and regulations promulgated
thereunder (“Exchange Act”).
The following description of the terms and conditions of the
Merger Agreement and the transactions contemplated thereunder that are material to the Registrant does not purport to be complete
and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which was filed as Exhibit 2.1
to our Current Report on Form 8-K filed with the SEC on March 14, 2012, and is incorporated by reference thereto.
Issuance of Common Stock
. At the closing of the Merger
(the “Closing”), each issued and outstanding membership unit of Oryon (each an “Oryon Unit”) immediately
prior to the Closing was converted automatically into the right to receive eight (8) shares of Company common stock and a Contingent
Share Right (as defined below) upon surrender of the Oryon Units (the “Merger Consideration”).
Convertible Debt of Oryon
. Prior to Closing, Oryon solicited
its Series C convertible promissory note holders (each a “Series C Holder”) to amend Oryon’s Series C convertible
promissory notes (“Series C Notes”) such that each Series C Holder may elect to convert the amount of outstanding principal
and accrued unpaid interest under its Series C Notes into shares of Company common stock on or after the Closing and that upon
receipt by Oryon of the full $2 million of proceeds from a financing as contemplated in the Merger Agreement within nine (9) months
of the Closing, all of the Series C Notes will automatically be converted into shares of Company common stock. Such amendment was
approved by the Series C Holders on March 26, 2012. On August 31, 2012, the Company received the last installment of the $2.0 million
in proceeds required to cause the automatic conversion of the Series C Notes, resulting in the issuance of 27,158,657 shares.
Warrants and Options
. In connection with the Merger,
Oryon solicited the consent of the holders of outstanding warrants issued by Oryon to exchange such warrants effective as of the
Closing, whereby each outstanding warrant to purchase an Oryon Unit shall be exchanged for a warrant to purchase eight (8) shares
of Company common stock. Each warrant has a Contingent Share Right. Each outstanding option to purchase an Oryon Unit was exchanged
for an option to purchase eight (8) shares of Company common stock under the Company’s 2012 Equity Incentive Plan. The options
also have Contingent Share Rights in that each option, when exercised, will be exercisable for the number of Company shares for
which it would have been exercisable had it been exercised prior to the Closing.
Change in Management
. As a condition to closing the Merger,
Ms. Crystal Coranes and Ms. Rizalyn Cabrillas resigned as members of the Registrant’s Board of Directors. In addition, at
Closing, Ms. Coranes resigned as the Registrant’s President and Chief Executive Officer and Ms. Cabrillas resigned as the
Registrant’s Chief Financial Officer and Secretary. At Closing, Messrs. Thomas Patrick Schaeffer, Mark E. Pape, Larry L.
Sears, Jon S. Ross and Brendon W. Mills were appointed to the Registrant’s Board of Directors. Mr. Mills subsequently resigned
and was replaced by Richard K. Hoesterey. In addition, effective at Closing, Mr. Schaeffer was appointed as the Registrant’s
new President and Chief Executive Officer, and Mr. Pape was appointed as the Registrant’s new Chief Financial Officer, Treasurer
and Secretary.
Additional information regarding the above-mentioned current
directors and/or executive officers is set forth below under the section titled “Directors, Executive Officers and Corporate
Governance.”
From and after the Closing Date, our primary operations consist
of the business and operations of Oryon. In the Merger, or reverse acquisition, the Registrant is the accounting acquiree and Oryon
is the accounting acquirer. Accordingly, we are presenting herein the financial statements of Oryon. Further, we disclose information
about the business, financial condition, and management of Oryon herein.
Market Information
Our common stock is not listed on any stock exchange. Although
our common stock is currently quoted on the OTCQB under the symbol “ORYN,” there has been a limited public market and
history of trading in shares of our common stock. Any market for our common stock should be considered sporadic, illiquid and highly
volatile. Since the common stock began trading on the OTCQB on May 7, 2012, the historical highest and lowest closing prices for
the periods indicated were as follows:
|
|
HIGH
|
|
|
LOW
|
|
2012
|
|
|
|
|
|
|
|
|
2nd Quarter (May 7 through June 30)
|
|
$
|
1.24
|
|
|
$
|
0.55
|
|
3rd Quarter
|
|
$
|
0.94
|
|
|
$
|
0.46
|
|
4th Quarter
|
|
$
|
0.85
|
|
|
$
|
0.16
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
|
|
|
|
|
|
1st Quarter
|
|
$
|
0.40
|
|
|
$
|
0.18
|
|
2nd Quarter
|
|
$
|
0.34
|
|
|
$
|
0.14
|
|
3rd Quarter
|
|
$
|
0.15
|
|
|
$
|
0.08
|
|
4th Quarter
|
|
$
|
0.07
|
|
|
$
|
0.03
|
|
|
|
|
|
|
|
|
|
|
Holders
As of March 7, 2014, there were approximately 90 shareholders
of record of our common stock based upon the shareholders listing provided by our transfer agent. Our transfer agent is Securities
Transfer Corporation. The transfer agent’s address is 2591 Dallas Parkway, Suite 102, Frisco, Texas 75034, its phone number
is (469) 633-0101 and its fax number is (469) 633-0088.
Dividends
We have never paid cash dividends on our common stock. We intend
to keep future earnings, if any, to finance the expansion of our business, and we do not anticipate that any cash dividends will
be paid in the foreseeable future. Our future payment of dividends will depend on our earnings, capital requirements, expansion
plans, financial condition and other relevant factors that our board of directors may deem relevant. Our retained earnings deficit
currently limits our ability to pay dividends.
Registration of Common Stock
In October 2012, we filed with the SEC a registration statement
on Form S-1 under the Securities Act that registered the sale of 4,043,200 shares of common stock currently outstanding and 4,133,335
shares of common stock issuable upon exercise of the Series A Warrants.
Securities Authorized for Issuance Under Equity Compensation
Plans
During the fiscal year ended January 31, 2012, we did not have
any form of stock option plan for the benefit of our directors, officers or future employees and we did not have a long-term incentive
plan nor did we have a defined benefit, pension plan, profit sharing or other retirement plan. Subsequent to our fiscal year ended
January 31, 2012, on February 24, 2012, our Board adopted the 2012 Equity Incentive Plan (the “Plan”) and reserved
7,500,000 shares of the Company’s common stock for issuance thereunder to officers, directors, employees, consultants and
other service providers of the Company. The Plan was approved by the Company’s shareholders on March 19, 2012.
Description of Securities
The following information describes our capital stock as in
effect as of the date hereof. This description is only a summary. You should also refer to our articles of incorporation and bylaws,
which are incorporated by reference herein.
General
Our authorized capital stock consists of 600,000,000 shares
of common stock at a par value of $0.001 per share, of which 15,800,000 shares were issued and outstanding immediately prior to
the Closing of the Merger after giving effect to the cancellation of an aggregate of 45,000,000 shares held by former shareholders,
including 13,000,000 shares held by Mr. Coranes and Ms. Cabrillas, our former officers and directors. At December 31, 2013, there
were 62,660,778 shares outstanding, consisting of the 15,000,000 shares of the Registrant that were outstanding (net of the above
mentioned cancellations) prior to the Merger, the 16,502,121 shares that were issued to the former holders of the units of Oryon
in connection with the Closing, the 4,000,000 shares that were issued in connection with the $2.0 million in financing received
through August 31, 2012, and the 27,158,657 shares that were issued in connection with the conversion of the Series C Notes effective
August 31,2012. In January 2014, we issued 104,538,789 shares of common stock in connection with the EFL Tech transaction, making
total issued and outstanding shares equal to 167,199,567.
We are also authorized to issue 50,000,000 shares of preferred
stock at a par value of $0.001 per share, of which zero shares were issued and outstanding as of December 31, 2013.
The issuance of the common stock, warrants, and options to the
Oryon Members and Oryon Note Holders pursuant to the Merger Agreement, and the issuance of Series A Warrants, was exempt from registration
in reliance upon Regulation D and/or Regulation S of the Securities Act as the investors are “accredited investors,”
as such term is defined in Rule 501(a) under the Securities Act and in offshore transactions (as defined in Rule 902 under Regulation
S of the Securities Act), such determination based upon representations made by such investors.
The issuance of the common stock in connection with the EFL
Tech transaction was exempt from registration in reliance upon an exemption from registration set forth in Regulation D and/or
Section 4(2) of the Securities Act, which exempts transactions by an issuer not involving a public offering.
Common Stock
The holders of Common Stock are entitled to one
vote per share. They are not entitled to cumulative voting rights or preemptive rights. The holders of Common Stock are entitled
to receive ratably such dividends, if any, as may be declared by the Board of Directors out of legally available funds. However,
the current policy of the Board of Directors is to retain earnings, if any, for operations and growth. Upon liquidation, dissolution
or winding-up, the holders of Common Stock are entitled to share ratably in all assets that are legally available for distribution
after payment in full of any preferential amounts. The holders of Common Stock have no subscription, redemption or conversion rights.
The rights, preferences and privileges of holders of Common Stock are subject to, and may be adversely affected by, the rights
of the holders of any series of preferred stock, which may be designated solely by action of the Board of Directors and issued
in the future. All outstanding shares of common stock are duly authorized, validly issued, fully paid and non-assessable.
Preferred Stock
In accordance with our Articles of Incorporation,
the Board of Directors may fix and determine the designations, rights, preferences or other variations of each class or series
within each class of preferred stock. To date, the Company has not issued any shares of preferred stock or designated any class
of preferred stock. No shares of preferred stock are outstanding.
Outstanding Options, Warrants and Convertible Securities
Warrants for 8,121,112 shares of common stock, with an exercise
price of $0.3125 per share were issued as of the Closing in exchange for all of the Oryon warrants outstanding immediately prior
to the Closing. In addition, as of the date hereof, there are outstanding Series A Warrants with the right to purchase 4,133,335
shares of Company common stock, each with a current exercise price of $0.50 per share, related to the $2,000,000 of the financing
as contemplated in the Merger Agreement that was completed as of August 31, 2012.
In connection with the Merger, each outstanding equity option
to purchase an Oryon membership unit was exchanged for an option to purchase eight (8) shares of the Company’s common stock
under the Company’s 2012 Equity Incentive Plan. As a result of the Merger, certain of the Oryon equity options are immediately
vested. Immediately prior to Closing, there were 345,388 options to purchase Oryon units outstanding, of which 295,388 were fully
vested as of Closing. This resulted in the issuance of options to purchase 2,763,104 shares of the Company’s common stock
(2,363,104 fully vested at issuance) at prices ranging from $0.125 per share to $0.625 per share.
As of the Closing, the Company had outstanding convertible securities
with the issued face amount (excluding accrued and unpaid interest) of $2.6 million, consisting of: (a) $972.1 thousand Series
C-1 Notes, (b) $1,044.6 thousand Series C-2 Notes, and (c) $569.2 thousand Series C-3 Notes (collectively, the Series C Notes).
Immediately after the Closing, the Series C Notes and all accrued but unpaid interest became convertible to Company common stock
at the rate of $0.0625 (Series C-1 Notes), $0.1875 (Series C-2 Notes) or $0.15 (Series C-3 Notes) under certain conditions, as
specified in the Notes. The Series C Notes were convertible into common stock in the event that Oryon received a qualified financing
of at least $2 million. As of August 31, 2012, the Company received an aggregate amount of $2.0 million from the issuance of common
stock pursuant to the Financing Agreement. As a result, all of the Company’s Series C Notes were automatically converted
into shares of common stock of the Company on August 31, 2012. The Series C Notes, with aggregate outstanding principal of $2,585.8
thousand and aggregate accrued and unpaid interest of $231.0 thousand, were converted into an aggregate of 27,158,657 shares of
common stock.
Change in Fiscal Year
In connection with the Merger, the Company’s Board of
Directors changed the Company’s fiscal year end from January 31 to December 31, effective as of the Closing. Accordingly,
the Company was required to file an Annual Report on Form 10-K for the fiscal year ended December 31, 2012 with the SEC on or before
March 31, 2013. As the transition period covers one month or less, in accordance with the SEC’s transition report rules as
set forth in Rule 13a-10, the Company did not need to file a separate transition report and the Company’s Quarterly Report
on Form 10-Q for the period ended June 30, 2012 contained the necessary financial information for the transition period.
ITEM 6.—SUMMARY SELECTED CONSOLIDATED FINANCIAL
DATA
The following tables summarize selected consolidated financial
data regarding the business of the Company and should be read together with “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” and the consolidated financial statements of the Company and the related notes
included with those financial statements. The summary consolidated financial information has been derived from the audited consolidated
financial statements for Oryon and its subsidiaries for the years ended December 31, 2013 and 2012. All monetary amounts are expressed
in U.S. dollars.
|
|
December 31,
|
|
|
|
2013
|
|
|
2012
|
|
Consolidated Balance Sheet Data:
|
|
($)
|
|
|
($)
|
|
Cash and cash equivalents
|
|
|
44,741
|
|
|
|
169,678
|
|
Total current assets
|
|
|
175,570
|
|
|
|
286,562
|
|
Total assets
|
|
|
320,655
|
|
|
|
469,805
|
|
Total current liabilities
|
|
|
1,944,426
|
|
|
|
802,906
|
|
Notes payable, net
|
|
|
114,156
|
|
|
|
164,187
|
|
Total equity (deficit)
|
|
|
(1,737,927
|
)
|
|
|
(497,288
|
)
|
Net working capital
|
|
|
(1,768,856
|
)
|
|
|
(516,344
|
)
|
Combined short and long term debt
|
|
|
1,263,677
|
|
|
|
565,842
|
|
|
|
Year Ended December 31,
|
|
|
|
2013
|
|
|
2012
|
|
|
|
($)
|
|
|
($)
|
|
Consolidated Income Statement Data:
|
|
|
|
|
|
|
|
|
Product sales
|
|
$
|
124,573
|
|
|
$
|
68,428
|
|
Cost of goods sold
|
|
|
(56,684
|
)
|
|
|
(40,184
|
)
|
Gross profit
|
|
|
67,889
|
|
|
|
28,244
|
|
Other revenues
|
|
|
-
|
|
|
|
-
|
|
Total revenues
|
|
|
67,889
|
|
|
|
28,244
|
|
Operating expenses
|
|
|
(1,422,093
|
)
|
|
|
(1,819,258
|
)
|
Income from operations
|
|
|
(1,354,204
|
)
|
|
|
(1,791,014
|
)
|
Interest income
|
|
|
-
|
|
|
|
522
|
|
Interest expense
|
|
|
(38,684
|
)
|
|
|
(271,992
|
)
|
Other income (expense)
|
|
|
568
|
|
|
|
(545,377
|
)
|
Net loss before tax
|
|
|
(1,392,320
|
)
|
|
|
(2,607,861
|
)
|
Income tax expense
|
|
|
-
|
|
|
|
-
|
|
Net loss after tax
|
|
|
(1,392,320
|
)
|
|
|
(2,607,861
|
)
|
Non-controlling interest
|
|
|
-
|
|
|
|
1,054
|
|
Net loss attributable to shareholders
|
|
$
|
(1,392,320
|
)
|
|
$
|
(2,606,807
|
)
|
|
|
|
|
|
|
|
|
|
Basic and diluted loss per share
|
|
$
|
(0.02
|
)
|
|
$
|
(0.07
|
)
|
Weighted average shares outstanding
|
|
|
62,660,778
|
|
|
|
37,754,324
|
|
|
|
Year Ended December 31,
|
|
|
|
2013
|
|
|
2012
|
|
|
|
|
($)
|
|
|
|
($)
|
|
Consolidated Cash Flow Data:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,392,320
|
)
|
|
$
|
(2,606,807
|
)
|
Adjustments to net loss for non-cash items
|
|
|
211,445
|
|
|
|
1,042,468
|
|
Net loss after non-cash adjustments
|
|
|
(1,180,875
|
)
|
|
|
(1,564,339
|
)
|
Changes in operating assets and liabilities:
|
|
|
386,811
|
|
|
|
(164,500
|
)
|
Net cash used in operating activities
|
|
|
(794,064
|
)
|
|
|
(1,728,839
|
)
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
-
|
|
|
|
(18,528
|
)
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
669,127
|
|
|
|
1,830,219
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rates on changes in cash
|
|
|
-
|
|
|
|
141
|
|
Net (decrease) increase in cash and cash equivalents
|
|
$
|
(124,937
|
)
|
|
$
|
82,993
|
|
ITEM 7.—MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of the results of operations
and financial condition of Oryon Technologies, Inc. and its subsidiaries for the fiscal years ended December 31, 2013 and 2012
should be read in conjunction with the Summary Selected Consolidated Financial Data and the consolidated financial statements and
the notes to those financial statements that are included elsewhere in this Annual Report on Form 10-K. Our discussion includes
forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives,
expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking
statements as a result of a number of factors, including those set forth under the Risk Factors, Cautionary Notice Regarding Forward-Looking
Statements and Business sections in this Annual Report. We use words such as “anticipate,” “estimate,”
“plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,”
“intend,” “may,” “will,” “should,” “could,” and similar expressions
to identify forward-looking statements.
Recent Transactions
EFL Tech Transaction
On January 21, 2014, the Company entered
into a Subscription Agreement (the “Subscription Agreement”) with EFL Tech B.V., a Netherlands corporation (“EFL
Tech”). At the closing of the first tranche of issuances of shares of the Company’s common stock, par value $0.001
(the “Common Stock”) pursuant to the Subscription Agreement, on January 21, 2014 (the “First Closing”),
the Registrant issued to EFL Tech an aggregate of 85,271,779 shares of Common Stock, and EFL Tech delivered $1,000,000 (of the
net $1.5 million cash portion of the consideration for all share issuances under the Subscription Agreement) to the Company. Subsequent
to the First Closing, on January 21, 2014, EFL Tech held 51.0% of the Company’s issued and outstanding Common Stock (46.0%
on a fully diluted basis). Based upon information from EFL Tech, the source of such funds was the working capital of EFL Tech.
Other consideration provided to the Company
at the First Closing for the sale of shares of Common Stock to EFL Tech consists of the following agreements, each of which was
entered into and delivered by the Company and EFL Holdings Tech B.V., a Netherlands corporation (“EFL Holdings”), and
an affiliate of EFL Tech, on January 21, 2014: (a) License Agreement granting the Company an exclusive, worldwide, perpetual, sub-licensable,
royalty-free, paid-up license (the “License Agreement”) for all of EFL Holding’s EL-related patents, trademarks
and other intellectual property, both U.S. and international (the “EFL Holdings IP”); (b) Equipment Lease Agreement
for certain printing equipment used in the production of electroluminescent (“EL”) lamps, the Company’s principal
product, which EFL Holdings valued at $1.5 million, at no cost to the Company (the “Equipment Lease”); and (c) Business
Relationship Agreement pursuant to which EFL Holdings covenants that it will not, directly or indirectly, provide services to or
otherwise engage in the business of manufacturing, designing, marketing, selling or distributing EL, or any products incorporating
the EFL Holdings IP, other than through the ownership, management and control of the Company by EFL Tech. The License Agreement
has a term that continues until the expiration of the last of the patents licensed thereunder, unless sooner terminated by EFL
Holdings due to the Company’s bankruptcy or other specified, similar financial difficulties. The Business Relationship Agreement
has a term that continues until, and the Equipment Lease has a term of the earlier of 21 years or until, the License Agreement
expires or is terminated. The above-referenced agreements contemplate that the Company will license, and will manufacture and market
products incorporating, its EL-related intellectual property and the EFL Holdings IP as a combined intellectual property portfolio.
The descriptions of the Subscription Agreement, the License Agreement, the Equipment Lease, and the Business Relationship Agreement
herein are qualified in their entirety by reference to the full text of such agreements, which are attached hereto as Exhibits
10.1, 10.3, 10.4, and 10.5, respectively.
At the closing of the second tranche under
the Subscription Agreement, on or before February 28, 2014 (the “Second Closing”), EFL Tech is required to deliver
to the Company additional funds in the amount of $250,000 on or before February 28, 2014. At the Second Closing, the Company is
required to issue to EFL Tech an additional 85,133,871 shares of Common Stock, at which time EFL Tech’s cumulative ownership
will be 170,405,650 shares of Common Stock, constituting 63.0% of the Common Stock on a fully diluted basis. Additionally, at the
closing of the third and final tranche under the Subscription Agreement, on or before March 31, 2014 (the “Third Closing”),
EFL Tech is required to deliver to the Company additional funds in the amount of $250,000 (bringing the total amount of the cash
component paid by EFL Tech to the Company in consideration for the issuance by the Company of shares of Common Stock to EFL Tech
under the Subscription Agreement to $1,500,000). At the Third Closing, the Company is required to issue to EFL Tech an additional
129,832,877 shares of Common Stock, at which time EFL Tech’s cumulative ownership will be 300,238,527 shares of Common Stock,
constituting 75.0% of the Common Stock on a fully diluted basis.
The proceeds from the foregoing funding
of $1,500,000 ($1,000,000 at the First Closing, consisting of $689,330 in cash plus the forgiveness of the obligation to repay
the $310,670 in temporary unsecured advances that EFL Tech provided to the Company in periods prior to the First Closing, and the
additional $250,000 payments by EFL Tech at each of the Second Closing and the Third Closing)
will be used for general
corporate purposes and the repayment of debt, including, but not limited to, the payments required to be made under the Exchange
Agreements (as defined and described below). At the First Closing, the Company paid the sum of $122,125 in cash, and issued
an aggregate of 19,267,010 shares of Common Stock, to certain creditors, including directors and executive officers, for the
settlement and release of a total of $817,375 of the Company's debt, pursuant to the Exchange Agreements.
As required by the Subscription Agreement,
on January 21, 2014, the Company entered into certain exchange and release agreements (each an “Exchange Agreement”
and collectively, the “Exchange Agreements”) by and between the Company and each member of a group of unsecured creditors
of the Company (including current directors and Executive Officers). At the First Closing, pursuant to the Exchange Agreements
the Company issued an aggregate of 19,267,010 shares of Common Stock, constituting 10.39% of the Common Stock on a fully diluted
basis, in exchange for the settlement and release of $695,250 in unpaid and accrued debt to such creditors. Under the Exchange
Agreements, the per-share exchange price for such debt was determined by the average of the closing prices of the Common Stock
on the trading days commencing on December 1, 2013, and ending on January 20, 2014 (the day prior to the First Closing), which
resulted in an exchange price of $0.036085 per share of Common Stock. The Company also paid the sum of $122,125 in cash to such
creditors under the Exchange Agreement for the settlement and release of such amount of debt (for the settlement and release of
a total of $817,375 of debt pursuant to the Exchange and Release Agreements).
Under the Subscription Agreement, the Company has the option
of entering into additional Exchange Agreements with other holders of outstanding debt of the Company for the purpose of exchanging
shares of Common Stock for the settlement and release of additional amounts of unpaid and accrued debt of the Company. The Company
has not made a decision regarding whether to enter into any such additional Exchange Agreements. If the Company were to enter into
one or more Exchange Agreements in the future, the Company would issue to EFL Tech that number of additional shares of Common Stock
such that, after issuing shares of Common Stock in exchange for Company debt under such Exchange Agreements, EFL Tech would continue
to hold 75% of the fully diluted shares of Common Stock (the “Additional Shares”). Under the Subscription Agreement,
the cash and non-cash consideration described above for the issuance to EFL Tech of shares of Common Stock at the First Closing,
the Second Closing and the Third Closing will apply to and suffice in all respects for the issuance by the Company of all Additional
Shares, and EFL Tech will not provide the Company will any additional consideration in connection with the issuance by the Company
of any such Additional Shares to EFL Tech.
Initial Public Offering
On May 4, 2012 (the “Closing Date”), the Company
closed a merger transaction with Oryon Merger Sub, LLC, a Texas limited liability company and wholly-owned subsidiary of the Company
(“Merger Sub”), and OryonTechnologies, LLC, a Texas limited liability company (“Oryon”) pursuant to an
Agreement and Plan of Merger dated March 9, 2012 (the “Merger Agreement”). In accordance with the terms of Merger Agreement,
on the Closing Date, Oryon merged into Merger Sub in exchange for the issuance to the members of Oryon (“Oryon Members”)
of eight (8) shares of the Company’s common stock for each outstanding membership unit of Oryon (the “Merger”).
In addition, Oryon had outstanding equity equivalents, consisting of convertible notes payable, accrued interest on the notes payable,
warrants and unit options, that by their terms required the Company to be prepared to issue common stock in an amount equal to
the number of shares (at the 8 to 1 ratio) that would have been issuable at the Closing Date to holders of all of the equity equivalents
if they had been converted to membership units before the Closing Date.
From and after the Closing Date, our primary operations consist
of the business and operations of Oryon. In conjunction with the Merger, Oryon assumed no liabilities from the Company and all
members of the Company’s executive management are from Oryon. Accordingly, the Merger was accounted for as a reverse-merger
and recapitalization in accordance with GAAP, whereby the Registrant is the accounting acquiree and Oryon is the accounting acquirer.
Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to
the Merger are those of Oryon and are recorded at the historical cost basis of Oryon, and the consolidated financial statements
after completion of the Merger include the assets and liabilities of the Company and Oryon, historical operations of Oryon and
operations of the Company from the Closing Date. Membership units and the corresponding capital amounts of Oryon pre-Merger have
been retroactively restated as shares of common stock reflecting the eight (8) to one exchange ratio in the Merger. All references
in this document to equity securities and all equity related historical financial measurements, including weighted average shares
outstanding, earnings per share, par value of common stock, additional paid in capital, option exercise prices and warrant exercise
prices, have been retroactively restated to reflect the Merger exchange ratio.
Oryon is a research and development and applications engineering
company that developed multiple patents relating to electroluminescent (“EL”) lighting (trademarked as “Elastolite
®
”).
Elastolite
®
enables thin, flexible, crushable, water-resistant lighting systems to be incorporated into multiple
applications such as safety apparel, sporting goods, consumer goods and membrane switches, among others.
For the year ended December 31, 2013, Oryon had a net loss of
$1.392 million as compared to a net loss of $2.607 million for the year ended December 31, 2012, a decreased loss of 46.6%. There
was no change in Oryon’s business plan and operations were comparable in both years. However, in 2012, Oryon was more negatively
impacted by the effects of capital transactions that had a negative but non-cash impact on the net loss. In July 2011, due to lack
of capital, Oryon eliminated most of its work force, including all of its sales personnel, and began making only minimal payments
on accounts payable in order to preserve capital.
In October 2011, Oryon signed the letter of intent (the “LOI”)
with the Company in connection with the Merger. In connection with the LOI, Oryon received funding of $325.0 thousand in exchange
for promissory notes as of December 31, 2011 ($725.0 thousand as of the Closing) as advances against the proceeds to be received
by Oryon from the sale of Company common stock at the Closing of the Merger. At Closing, Oryon became a wholly-owned subsidiary
of the Company and, as a result, the amounts due under the promissory notes between the Company and Oryon became intercompany obligations
within the corporate group that have been cancelled. These advances provided Oryon with working capital to continue its operations
and to make some repayments on outstanding liabilities.
Overview
The accompanying consolidated balance sheets, statements of
operations, statements of cash flows and statement of changes in stockholders’ equity (deficit) have been prepared by the
Company’s management in conformity with accounting principles generally accepted in the United States of America (“GAAP”).
In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations, financial
position and cash flows have been included and all such adjustments are of a normal recurring nature.
Key factors affecting our results of operations include revenues,
cost of revenues, operating expenses and income and taxation.
Comparison of the Year Ended December 31, 2013 to the Year
Ended December 31, 2012
Gross Profit and Other Revenues
|
|
For the Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
2012
|
|
|
Change from 2012 to 2013
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
%
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales
|
|
|
124,573
|
|
|
|
68,428
|
|
|
|
56,145
|
|
|
|
82.0
|
%
|
Cost of goods sold
|
|
|
(56,684
|
)
|
|
|
(40,184
|
)
|
|
|
(16,500
|
)
|
|
|
41.1
|
%
|
Gross profit
|
|
|
67,889
|
|
|
|
28,244
|
|
|
|
39,645
|
|
|
|
140.4
|
%
|
Royalty and license fees
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
Other
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
Total revenues
|
|
|
67,889
|
|
|
|
28,244
|
|
|
|
39,645
|
|
|
|
140.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit margin
|
|
|
54.5
|
%
|
|
|
41.3
|
%
|
|
|
|
|
|
|
|
|
Gross profit and other revenues for the year ended
December 31, 2013 increased $39.6 thousand, or 140.4%, to $67.9 thousand from $28.2 thousand for the year ended December 31, 2012,
primarily due to a 82.0% increase in product sales, but increased by an improvement in the cost of goods sold as a percentage of
product sales revenues. Cost of goods sold represented 45.5% of product sales revenues in 2013 as compared to 58.7% in 2012.
Operating Expense—Overview
Total operating expense for the year ended December 31, 2013,
decreased $397.2 thousand, or 21.8%, to $1,422.1 thousand in 2012 from $1,819.3 thousand in 2012, as shown in the table below:
|
|
For the year ended
|
|
|
For the year ended
|
|
|
|
|
|
|
December 31, 2013
|
|
|
December 31, 2012
|
|
|
Change
|
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
Total applications development exp.
|
|
|
294,150
|
|
|
|
20.7
|
%
|
|
|
324,575
|
|
|
|
17.8
|
%
|
|
|
(30,425
|
)
|
|
|
-9.4
|
%
|
Total sales and marketing exp.
|
|
|
96,313
|
|
|
|
6.8
|
%
|
|
|
152,091
|
|
|
|
8.4
|
%
|
|
|
(55,778
|
)
|
|
|
-36.7
|
%
|
Total general and administrative exp.
|
|
|
1,000,573
|
|
|
|
70.4
|
%
|
|
|
1,302,429
|
|
|
|
71.6
|
%
|
|
|
(301,856
|
)
|
|
|
-23.2
|
%
|
Depreciation and amortization
|
|
|
31,057
|
|
|
|
2.2
|
%
|
|
|
40,163
|
|
|
|
2.2
|
%
|
|
|
(9,106
|
)
|
|
|
-22.7
|
%
|
Total operating expenses
|
|
|
1,422,093
|
|
|
|
100.0
|
%
|
|
|
1,819,258
|
|
|
|
100.0
|
%
|
|
|
(397,165
|
)
|
|
|
-21.8
|
%
|
The primary reason for the decrease in total operating expenses
is the $301.9 thousand decrease in total general and administrative expense, as discussed below.
Applications Development Expense
|
|
For the Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
2012
|
|
|
Change from 2012 to 2013
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
%
|
|
Applications Development Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wages
|
|
|
93,556
|
|
|
|
173,888
|
|
|
|
(80,332
|
)
|
|
|
-46.2
|
%
|
Payroll taxes and benefits
|
|
|
20,508
|
|
|
|
26,455
|
|
|
|
(5,947
|
)
|
|
|
-22.5
|
%
|
Materials, equipment, services
|
|
|
164,986
|
|
|
|
117,008
|
|
|
|
47,978
|
|
|
|
41.0
|
%
|
Office and overhead
|
|
|
15,100
|
|
|
|
7,224
|
|
|
|
7,876
|
|
|
|
109.0
|
%
|
Travel and entertainment
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
Total applications development exp.
|
|
|
294,150
|
|
|
|
324,575
|
|
|
|
(30,425
|
)
|
|
|
-9.4
|
%
|
Total applications development expense decreased
by $30.4 thousand, or 9.4%, primarily due to the $80.3 thousand, or 46.2%, decrease in wages. A secondary but related reason for
the decrease is the $5.9 thousand, or 22.5% decrease in payroll taxes and employee benefits in 2013 as compared to 2012. In 2013,
due to capital constraints, the Company reduced its applications development workforce and, in addition, reduced the overall level
of employee benefits.
Sales and Marketing Expense
|
|
For the Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
2012
|
|
|
Change from 2012 to 2013
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
%
|
|
Sales and Marketing Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wages
|
|
|
40,500
|
|
|
|
66,000
|
|
|
|
(25,500
|
)
|
|
|
-38.6
|
%
|
Payroll taxes and benefits
|
|
|
3,125
|
|
|
|
6,925
|
|
|
|
(3,800
|
)
|
|
|
-54.9
|
%
|
Overhead
|
|
|
16,391
|
|
|
|
14,357
|
|
|
|
2,034
|
|
|
|
14.2
|
%
|
Outside services
|
|
|
16,200
|
|
|
|
32,400
|
|
|
|
(16,200
|
)
|
|
|
-50.0
|
%
|
Travel and entertainment
|
|
|
20,097
|
|
|
|
32,409
|
|
|
|
(12,312
|
)
|
|
|
-38.0
|
%
|
Total sales and marketing exp.
|
|
|
96,313
|
|
|
|
152,091
|
|
|
|
(55,778
|
)
|
|
|
-36.7
|
%
|
Total sales and marketing expense decreased $55.8 thousand,
or 36.7%, in 2013 as compared to 2012 due to the reduction of marketing staff in September 2013 (wages down $25.5 thousand, or
38.6%) and the related reduction in costs during 2013 such as travel expenses (down $12.3 thousand, or 38.0%).
General and Administrative Expense
|
|
For the Years Ended December 31,
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
2012
|
|
|
Change from 2012 to 2013
|
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
%
|
|
General and Administrative Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
Wages
|
|
|
242,098
|
|
|
|
339,378
|
|
|
|
(97,280
|
)
|
|
|
-28.7
|
%
|
Payroll taxes and benefits
|
|
|
152,769
|
|
|
|
163,292
|
|
|
|
(10,523
|
)
|
|
|
-6.4
|
%
|
Overhead
|
|
|
142,453
|
|
|
|
160,099
|
|
|
|
(17,646
|
)
|
|
|
-11.0
|
%
|
Outside services
|
|
|
453,257
|
|
|
|
633,244
|
|
|
|
(179,987
|
)
|
|
|
-28.4
|
%
|
Travel and entertainment
|
|
|
9,996
|
|
|
|
6,416
|
|
|
|
3,580
|
|
|
|
55.8
|
%
|
Total general and administrative exp.
|
|
|
1,000,573
|
|
|
|
1,302,429
|
|
|
|
(301,856
|
)
|
|
|
-23.2
|
%
|
General and administrative expense decreased $301.9 thousand,
or 23.2%, to $1,000.6 thousand from $1,302.4 thousand, primarily due to (i) the decrease in outside services of $180.0 thousand,
or 28.4%, to $453.3 thousand in 2013 from $633.2 thousand in 2012, as detailed in the table below and (ii) the decrease in employee
wages of $97.3 thousand, or 28.7%, to $242.1 thousand in 2013 from $339.4 thousand in 2012.
The primary reason for the decrease in outside services expense
was the absence of a major funding transaction in 2013. The closing of the Merger in May 2012, which made Oryon a public company
for the first time, required the one-time services of legal counsel and auditors. In 2013, the cost of such outside services was
more appropriate for a normal year without unusual transactions. For example, legal expenses declined $96.7 thousand, or 44.1%,
and accounting and audit expenses declined $41.0, or 40.5%. In 2013, as a public company with outside directors for a full year,
the Company incurred increased directors’ fees and expenses (an increase to $96.0 thousand in 2013 from $78.8 thousand in
2012), including $23.3 thousand in directors’ stock-based compensation expense in 2013 as compared to $33.8 thousand in 2012.
Accounting and auditing fees decreased by $41.0 thousand, or 40.5%, because in 2012 the outside auditors were required to audit
the Company for the first time for two previously unaudited years (2012 and 2011). In 2013, the outside auditors audited only the
latest year, 2013.
Consulting expense decreased $65.6 thousand in 2013 as compared
to 2012 because in 2012 the Company incurred $82.6 thousand in non-recurring consulting fees for a financial advisor in connection
with the Merger. This was partially offset by the action of management in outsourcing certain secretarial and administrative services
during part of 2012 and most of 2013 to reduce the fixed payroll overhead.
|
|
For the year ended
|
|
|
For the year ended
|
|
|
|
|
|
|
|
|
|
December 31, 2013
|
|
|
December 31, 2012
|
|
|
Change
|
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal expenses
|
|
|
122,768
|
|
|
|
27.1
|
%
|
|
|
219,514
|
|
|
|
34.7
|
%
|
|
|
(96,746
|
)
|
|
|
-44.1
|
%
|
Accounting and audit expenses
|
|
|
60,232
|
|
|
|
13.3
|
%
|
|
|
101,217
|
|
|
|
16.0
|
%
|
|
|
(40,985
|
)
|
|
|
-40.5
|
%
|
Directors' fees and expenses
|
|
|
95,987
|
|
|
|
21.2
|
%
|
|
|
78,800
|
|
|
|
12.4
|
%
|
|
|
17,187
|
|
|
|
21.8
|
%
|
Public relations expenses
|
|
|
3,115
|
|
|
|
0.7
|
%
|
|
|
5,000
|
|
|
|
0.8
|
%
|
|
|
(1,885
|
)
|
|
|
-37.7
|
%
|
Consulting
|
|
|
113,963
|
|
|
|
25.1
|
%
|
|
|
179,554
|
|
|
|
28.4
|
%
|
|
|
(65,591
|
)
|
|
|
-36.5
|
%
|
Payroll processing expenses
|
|
|
2,088
|
|
|
|
0.5
|
%
|
|
|
2,565
|
|
|
|
0.4
|
%
|
|
|
(477
|
)
|
|
|
-18.6
|
%
|
Banking Fees
|
|
|
998
|
|
|
|
0.2
|
%
|
|
|
2,491
|
|
|
|
0.4
|
%
|
|
|
(1,493
|
)
|
|
|
-59.9
|
%
|
Stock transfer agent and filing fees
|
|
|
54,106
|
|
|
|
11.9
|
%
|
|
|
44,103
|
|
|
|
7.0
|
%
|
|
|
10,003
|
|
|
|
22.7
|
%
|
Total G&A outside services
|
|
|
453,257
|
|
|
|
100.0
|
%
|
|
|
633,244
|
|
|
|
100.0
|
%
|
|
|
(179,987
|
)
|
|
|
-28.4
|
%
|
The stock-based compensation expense included in general and
administrative payroll taxes and benefits decreased to $128.4 thousand in 2013, as compared to $159.0 thousand in 2012, primarily
due to the lower fair market value of grants in 2013. In addition, the acceleration of the vesting of the options outstanding as
a result of the Merger on May 4, 2012, created additional expense in the second quarter of 2012 that otherwise would have been
spread over the remaining vesting period of such options.
Other Income (Expense)
Other income (expense) consists of: interest income, interest
expense (discussed below and net other income/expense (discussed below). The largest single component of Other Income (Expense)
in the year ended December 31, 2012, was the non-recurring expense for the change in the fair market value of the Series A warrants.
In September 2012, the board of directors authorized the re-pricing of the Series A warrants’ exercise price from the original
$0.75 per share to the current $0.50 per share. This resulted in an increase of $535,367 in allocation of the proceeds to paid-in
capital and a matching expense on the income statement. Interest income is negligible.
Interest Expense:
Interest expense decreased $233.3 thousand,
or 85.8%, to $38.7 thousand from $272.0 thousand due to the elimination of (a) the interest on Oryon’s Series C convertible
notes payable, (b) the amortization of the debt discount for the beneficial conversion feature on the series C-1 convertible note
payable and (c) the amortization of the debt discount on the related warrants, as shown in the table below, when the Series C convertible
notes payable were all converted to common stock, effective August 31, 2012.
|
|
For the year ended
|
|
|
For the year ended
|
|
|
|
|
|
|
|
|
|
December 31, 2013
|
|
|
December 31, 2012
|
|
|
Change
|
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
|
$
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense on convertible notes payable
|
|
|
-
|
|
|
|
|
|
|
|
91,284
|
|
|
|
33.6
|
%
|
|
|
(91,284
|
)
|
|
|
NM
|
|
Interest expense on promissory notes and short-term debt
|
|
|
38,684
|
|
|
|
100.0
|
%
|
|
|
31,741
|
|
|
|
11.7
|
%
|
|
|
6,943
|
|
|
|
21.9
|
%
|
Amortization of debt discount related to warrants
|
|
|
-
|
|
|
|
|
|
|
|
12,893
|
|
|
|
4.7
|
%
|
|
|
(12,893
|
)
|
|
|
NM
|
|
Amortization of debt
discount-beneficial conversion feature on the Series C-1 convertible notes payable
|
|
|
-
|
|
|
|
|
|
|
|
136,074
|
|
|
|
50.0
|
%
|
|
|
(136,074
|
)
|
|
|
NM
|
|
Total interest expense
|
|
|
38,684
|
|
|
|
100.0
|
%
|
|
|
271,992
|
|
|
|
100.0
|
%
|
|
|
(233,308
|
)
|
|
|
-85.8
|
%
|
NM = Not Meaningful
Net other income (expense):
For the year ended December
31, 2012, the other expense of $10.0 thousand consisted primarily of local personal property taxes.
Taxes
The Company has incurred operating losses through the date of
the financial statements. As a result, no provision for tax liability has been deemed necessary.
Liquidity and Capital Resources
The Company does not have sufficient cash on hand and working
capital to be able to meet its anticipated cash requirements through 2014. See Note 16 “Going Concern” and Note 17
“Subsequent Events” of the Notes to the Consolidated Financial Statements. Not including capital expenditures and costs
directly related to revenues, monthly operating expenditures are expected to range between $125,000 and $150,000 per month. Management
anticipates that an additional $1,000,000 to $3,000,000 will be necessary to fund operations over the next twelve to twenty-four
month period subsequent to December 31, 2013. We do not currently have any material commitments for capital expenditures.
To meet our future objectives, we will need to meet our revenue
objectives and sell additional equity and debt securities, which could result in dilution to current shareholders, or seek additional
loans. The incurrence of indebtedness would result in increased debt service obligations and could require us to agree to operating
and financial covenants that would restrict our operations. We do not have any lending arrangements in place with banking or financial
institutions and we do not anticipate that we will be able to secure these funding arrangements in the near future. Financing may
not be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable
to us, or at all, could limit our ability to expand our business operations, could harm our overall business prospects and could
adversely affect our ability to continue as a going concern.
Our current cash requirements are significant due to planned
development and marketing of our current products, and we anticipate generating additional operating monthly losses at least through
the end of 2014. In order to execute on our business strategy, we will require additional working capital, commensurate with the
operational needs of our planned marketing, development and production efforts. Our management anticipates that we should be able
to raise sufficient amounts of working capital through debt or equity offerings, as may be required to meet our short-term obligations,
although there is no assurance that we will be able to do so. However, changes in our operating plans, increased expenses, acquisitions,
or other events, may cause us to seek additional equity or debt financing in the future. We anticipate continued and additional
marketing, development and production expenses. Accordingly, we expect to continue to use debt and equity financing to fund operations
for the next twelve months, as we look to expand our asset base and fund marketing, development and production of our products.
There are no assurances that we will be able to raise the required
working capital on terms favorable to us, or that such working capital will be available on any terms when needed. Any failure
to secure additional financing may force us to modify our business plan and adversely affect our ability to continue as a going
concern. In addition, we cannot be assured of profitability in the future.
We are not aware of any unusual or infrequent events or transactions
or any significant economic changes that materially affected or could materially affect the amount of our reported income from
operations.
Sources and uses of funds
As of December 31, 2013, the Company had cash and equivalents
on hand of $44.7 thousand, and negative working capital of $1,768.9 thousand. Management of the Company recognizes that its cash
on hand and working capital will not be sufficient to meet its anticipated cash requirements through 2014.
Oryon’s sales cycle timing varies depending on the type
of customer being served. It can range from three months for certain specialty promotions to 12-18 months for certain branded products
from first contact with a prospective customer until product sales revenues can be reported. During that period, Oryon works with
the customer’s designs and engineers an application of its patented technology into the customer’s final product. This
requires substantial co-development with the customer’s personnel to meet the needs of the customer. Accordingly, Oryon must
have sufficient capital to fund administrative overhead, sales and marketing efforts and staffing expenses for an extended period
of time before cash is received from customers.
In 2010, Oryon completed an exchange of the then existing Series
A and Series B convertible notes payable for the newly issued Series C-1 and Series C-2 convertible notes payable, respectively.
Each holder of a Series A or Series B note also received detachable warrants in connection with the exchange. This exchange was
necessary to obtain a modification of the terms of the notes payable to enable Oryon to secure additional funding. In 2010, after
the completion of the exchange, Oryon began issuing Series C-3 convertible notes payable, with detachable warrants, obtaining additional
funding of $418.0 thousand in 2010 and $75.0 thousand in 2011. In addition, during the second half of 2011, Oryon issued $69.6
thousand in Series C-3 convertible notes payable, but without attached warrants, to the lessor of Oryon’s office space in
lieu of cash rent payments for the period of July 1 through December 31. In January 2012, Oryon issued an additional $6.6 thousand
in Series C-3 convertible notes payable, without attached warrants, to the same lessor in lieu of cash rent for the month of January
2012.
In October 2011, Oryon began discussions with an investment
firm concerning a merger with a publicly-traded company and a financing plan that would raise $2 million in new equity capital
for Oryon. A letter of intent was signed that same month and Oryon began working on a definitive merger agreement and on meeting
the related requirements, including the completion of audited financial statements. The investment firm arranged for the Company
to advance $725.0 thousand (prior to the Closing Date) to Oryon in exchange for promissory notes. The funding for the advances
to Oryon was generated by the equity financing. Without this advance, Oryon would not have been able to complete the Merger. Between
the Closing Date and June 30, 2012, the Company received an additional $775.0 thousand in exchange for the issuance of equity (consisting
of 1,550,000 shares of common stock along with warrants having the right to purchase an additional 1,550,000 shares currently at
$0.50 per share and a term of five years). On July 24, 2012, the Company received an additional $250.0 thousand in subscriptions
for the issuance of equity (consisting of 500,000 shares of common stock along with warrants having the right to purchase an additional
500,000 shares currently at $0.50 per share and a term of five years). ). On August 31, 2012, the Company received an additional
$250.0 thousand in subscriptions for the issuance of equity (consisting of 500,000 shares of common stock along with warrants having
the right to purchase an additional 500,000 shares currently at $0.50 per share and a term of five years). In total, the Company
received $2.0 million in subscriptions in connection with the Merger.
Net cash used in operating activities
Net cash used in operating activities for the year ended December
31, 2013 was $794.1 thousand, as compared to $1,696.3 thousand for the year ended December 31, 2012, a decreased use of cash of
$902.2 thousand. The primary reason for the significant decrease in cash used was the decreased net loss (net loss in 2013 was
$1,392.3 thousand as compared to the net loss of $2,606.8 thousand in 2012) partially offset by the decrease in non-cash expenses
in 2013 that were included in the 2012 net loss but that did not recur in 2013 such as the $535.4 thousand charge for the change
in the fair market value of the Series A warrants due to re-pricing.
Additionally, the net aggregate change in operating assets and
liabilities provided cash of $386.8 thousand as compared to using cash of $150.0 thousand in 2012, providing an increase in cash
of $536.8 thousand. The Company increased accounts payable in 2013 by $191.1 thousand whereas it used $137.0 thousand in operating
cash to pay down the accounts payable in 2012, a total difference of $328.1 thousand. The funding provided by the issuance of equity
in connection with the Merger, as discussed above, permitted the Company to reduce its outstanding accounts payable in 2012, whereas
financial constraints in 2013 required the Company to extend its payment terms with vendors, reduce current assets and increase
other current liabilities, all of which reduced the need for cash to be used in operating activities. Also in 2013, the Company
was able to reduce the use of operating cash through deferring $220.3 thousand in compensation to employees, as compared to a net
negligible amount in 2012.
Net cash provided by (used in) investing activities
There was no net cash provided by (used in) investing activities
in 2013. Net cash used in investing activities for the year ended December 31, 2012 was $18.5 thousand. In 2012, the Company acquired
property and equipment for $6.8 thousand to be used in the production of samples for prospective customers and used $4.2 thousand
to update the telephone system. In addition, the Company incurred expenses of $7.6 thousand in the process of liquidating the inactive
OTI and OAPS affiliates.
Net cash provided by financing activities
Net cash provided by financing activities was $669.1 thousand
for the year ended December 31, 2013, as compared to $1,797.7 thousand for the year ended December 31, 2012. In 2013, the principal
source of capital was the receipt of short term advances in the total amount of $728.8 thousand (including personal advances from
the Company’s senior officers of $28.2 thousand, of which $6.0 thousand remained unpaid at December 31, 2013) as compared
to 2012, when the Company recorded $2.0 million from the issuance of equity (consisting of 4,000,000 shares of common stock along
with warrants having the right to purchase an additional 4,000,000 shares at $0.50 per share and a term of five years), pursuant
to the terms of subscriptions for $2.0 million that consisted of $325.0 thousand received in 2011 (advanced to Oryon before December
31, 2011), $400.0 thousand received in 2012 prior to the Closing (advanced to Oryon when received) and $1,275.0 thousand received
after the Closing. Since amounts were advanced to Oryon prior to the Closing, they were reported as notes receivable on the Registrant’s
records and as notes payable on Oryon’s records. At Closing, when Oryon became a wholly owned subsidiary of the Registrant,
the notes in an aggregate amount of $725.0 thousand (including $325.0 thousand recorded at December 31, 2011 as notes payable at
OTLLC) became an intercompany receivable/payable and were cancelled.
In 2013, the Company paid debt in the total amount of $59.5
thousand, including (a) the repayment of $22.2 thousand in short term advances from the Company’s senior officers, (b) $33.8
thousand in principal on promissory notes payable and (c) $3.8 thousand on other short term debt.
Contractual Obligations and Off-Balance Sheet Arrangements
Contractual Obligations
The following table outlines payments due under our significant
contractual obligations over the periods shown, exclusive of interest, as of December 31, 2013:
|
|
Payments Due by Period
|
|
Contractual Obligations at September 30, 2013
|
|
Less than One Year
|
|
|
One to Three years
|
|
|
Three to Five Years
|
|
|
More Than Five Years
|
|
|
Total
|
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
|
($)
|
|
Operating lease obligations
|
|
|
79,164
|
|
|
|
98,955
|
|
|
|
-
|
|
|
|
-
|
|
|
|
178,119
|
|
Long-term debt obligations
|
|
|
-
|
|
|
|
114,156
|
|
|
|
-
|
|
|
|
-
|
|
|
|
114,156
|
|
Capital expenditure obligations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Purchase obligations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Other long-term obligations
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
The above table outlines our obligations as of December 31,
2013 and does not reflect any changes in our obligations that have occurred after that date.
Off-Balance Sheet Arrangements
We have not entered into any other financial guarantees or other
commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are
indexed to our shares and classified as shareholder’s equity or that are not reflected in our consolidated financial statements.
Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as
credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that
provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services
with us.
Critical Accounting Estimates
The preparation of the consolidated financial statements in
conformity with accounting principles generally accepted in the United States requires management to make estimates that affect
the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions
are those that management considers to be the most critical to an understanding of the consolidated financial statements because
they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s judgment about
current economic and market conditions and their effects based on information available as of the date of these consolidated financial
statements. If such conditions persist longer or deteriorate further than expected, it is reasonably possible that the judgments
and estimates could change, which may result in future impairments of assets, among other effects.
Significant estimates include the carrying value of intangible
assets and the value of equity instruments, including convertible notes, stock options, warrants, and membership units issued in
lieu of cash.
Recently Issued Accounting Pronouncements
There have been no new accounting rules or pronouncements introduced
in 2012 or 2011 that have had an effect of our financial conditions or results of operations.
ITEM 7A.—QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
The Company does not have any market risk sensitive instruments.
ITEM 8 – FINANCIAL STATEMENTS AND SUPPLEMENTARY
DATA
The Report of Independent Accountants, Financial Statements
and any supplementary financial data required by this Item are set forth beginning on pages F-1, and are incorporated herein by
reference.
ITEM 9.—CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ON ACCOUNTING AND FINANCIAL DISCLOSURE
Effective May 4, 2012, Madsen & Associates CPA’s Inc.
(“Madsen”) was dismissed as the Company’s independent registered public accounting firm. Madsen’s report
for the fiscal year ended January 31, 2012 was on the Company’s financial statements for the Company’s former operations
prior to the reverse acquisition. On May 4, 2012, the Company completed a reverse acquisition with Oryon, which became the operations
of the Company and the accounting acquirer on a going forward basis.
The dismissal of Madsen as the independent registered public
accounting firm was approved by the Company’s Audit Committee.
The reports of Madsen regarding the Company’s financial
statements for the fiscal years ended January 31, 2012 and 2011 did not contain any adverse opinion or disclaimer of opinion and
were not qualified or modified as to uncertainty, audit scope or accounting principles, except that the audit report of Madsen
on the Company’s financial statements for fiscal years ended January 31, 2012 and 2011 contained an explanatory paragraph
which noted that there was substantial doubt about the Company’s ability to continue as a going concern.
During the years ended January 31, 2012 and 2011, and during
the period from January 31, 2012 to May 4, 2012, the date of dismissal, (i) there were no disagreements with Madsen on any matter
of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreements, if
not resolved to the satisfaction of Madsen would have caused it to make reference to such disagreement in its reports; and (ii)
there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K.
The Company has provided Madsen with a copy of the foregoing
disclosures and requested that Madsen furnish the Company with a letter addressed to the SEC stating whether or not it agrees with
the above statements. A copy of such letter was filed as Exhibit 16.1 to our Current Report on Form 8-K, as amended, dated May
4, 2012.
Effective May 4, 2012, the Board of Directors of the Company
engaged Montgomery, Coscia, Greilich LLP (“MCG”) as its independent registered public accounting firm to audit the
Company’s financial statements for the fiscal year ending December 31, 2012.
ITEM 9A.—CONTROLS AND PROCEDURES
Our management, on behalf of the Company, has considered certain
internal control procedures as required by the Sarbanes-Oxley Act of 2002 (“SOX”) Section 404(a). Internal controls
are a mechanism to ensure objectives are achieved and are under the supervision of the Company’s management. Good controls
encourage efficiency, compliance with laws and regulations, sound information, and seek to eliminate fraud and abuse. These control
procedures provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Company’s
financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Internal control is
“everything that helps one achieve one’s goals—or better still, to deal with the risks that stop one from achieving
one’s goals.” Internal controls are mechanisms that are there to help the Company manage risks to success.
In other words, control activities are the policies and procedures
that help ensure the Company’s management directives are carried out. They help ensure that necessary actions are taken to
address risks that might prevent the achievement of the Company’s objectives. Control activities occur throughout the Company,
at all levels and in all functions. They include a range of activities as diverse as approvals, authorizations, verifications,
reconciliations, reviews of operating performance, security of assets and segregation of duties.
As of December 31, 2013 (the “Evaluation Date”),
the Company’s management assessed the effectiveness of the Company’s internal control over financial reporting based
on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting
such assessments. Management concluded that, during the two year period ended December 31, 2013, internal controls and procedures
were not effective to detect the inappropriate application of US GAAP rules. Management determined that there are deficiencies
in the design or operation of the Company’s internal control that adversely affected the Company’s internal controls
that management considers being material weaknesses.
This annual report does not include an attestation report by
the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s assessment
was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the SEC that permit
smaller reporting companies such as the Company to provide only management’s assessment in this annual report.
In the light of management’s review of internal control
procedures as they relate to COSO and the SEC the following were identified:
|
•
|
Through the Closing of the Merger on May 4, 2012, the Company’s Audit Committee did not function as an Audit Committee
should, since there was a lack of independent directors on the Audit Committee and the Board of Directors had not identified an
“expert”, one who is knowledgeable about reporting and financial statements requirements, to serve on the Audit Committee.
|
|
•
|
The Company has limited segregation of duties, which is not consistent with good internal control procedures.
|
|
•
|
The Company does not have a written internal control procedures manual that outlines the duties and reporting requirements
of the Directors and any staff to be hired in the future. This lack of a written internal control procedures manual does not meet
the requirements of the SEC or for good internal control.
|
|
•
|
There are no effective controls instituted over financial disclosure and the reporting processes.
|
Management determined that the weaknesses identified above have
not affected the financial results of the Company due to the Company’s operational and financial inactivity since inception.
Effective as of the closing of the Merger on May 4, 2012, five new directors were elected to the Board of Directors as disclosed
in the Company’s Current Report on Form 8-K, as amended, dated May 4, 2012. At the new Board’s first meeting on May
18, 2012, the three independent board members were elected to serve on the Audit Committee, including an identified “expert”
on the Audit Committee to advise other members as to correct accounting and reporting procedures. Appointing independent members
to the Audit Committee and using the services of an expert on the Audit Committee have greatly improved the overall performance
of the Audit Committee.
The Company will endeavor to correct the other above noted weaknesses
in internal control once it has adequate funds to do so. The Audit Committee directed management to initiate developmentof a written
policy manual outlining the duties of each of the officers and staff of the Company to facilitate better internal control procedures.
Management will develop the policy manual in connection with hiring additional accounting personnel to rectify the internal control
weakness caused by the Company’s inability to properly segregate duties.
Management will continue to monitor and evaluate the effectiveness
of the Company’s internal controls and procedures and its internal controls over financial reporting on an ongoing basis
and is committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.
There were no adverse changes in the Company’s internal
controls or in other factors that could affect its disclosure controls and procedures subsequent to the Evaluation Date, nor any
significant deficiencies or material weaknesses in such disclosure controls and procedures requiring corrective actions, except
as noted above.
ITEM 9B. – OTHER INFORMATION
Not applicable.
PART III
ITEM 10.—DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE
GOVERNANCE
Name
|
|
Age
|
|
Position
|
|
Since
|
Thomas P. Schaeffer
|
|
62
|
|
Director, Chief Executive Officer
|
|
2012
|
Mark E. Pape
|
|
63
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
2012
|
Larry L. Sears
|
|
59
|
|
Director
|
|
2012
|
Clifton K-F.Shen
|
|
42
|
|
Director
|
|
2014
|
Richard K. Hoesterey
|
|
71
|
|
Director
|
|
2012
|
Thomas P. Schaeffer
, Director, President and Chief Executive
Officer
Mr. Schaeffer has over 30 years of experience in sales and marketing,
specializing in new product introductions to mature industries and sourcing niches for existing products in emerging categories.
Mr. Schaeffer became President, Chief Executive Officer and a Director of the Company on May 4, 2012 and has served as President
(until January 21, 2014) and Chief Executive Officer of Oryon since October 2011. From 1983 until present, Mr. Schaeffer has been
the owner of Active Concepts, a sales and marketing company in the sportswear industry. From 2002 until 2008, Mr. Schaeffer served
as National Sales Manager of Dallas Cowboys Merchandising, a sales and marketing company for Dallas Cowboys merchandise. Mr. Schaeffer
began his career at Blue Ribbon Sports, which later became Nike Inc. In 1982, he formed Active Concepts, a sales and marketing
company, that is still active. He co-founded Vino Family Vineyards, a winery in Napa Valley, California, and has consulted for
major retailers in the United States. Mr. Schaeffer was the first National Sales Manager for the Dallas Cowboys, hiring and training
the national sales force, and implementing the business plan to build the Dallas Cowboys merchandising department into a $100 million
business. Mr. Schaeffer attended the University of California, San Diego. The Company believes that Mr. Schaeffer’s experience
in sourcing, marketing, building sales teams and implementing new product introduction will be a valuable resource as the Company
seeks to expand its business.
Mark E. Pape
, Chief Financial Officer, Secretary and
Treasurer
Mr. Pape is a financial executive with over 30 years of experience
in senior financial management, investment banking and auditing. Mr. Pape became Chief Financial Officer and a Director of the
Company on May 4, 2012 and has served as the Chief Financial Officer of Oryon since October 2010. He resigned as a Director effective
January 21, 2014. Mr. Pape has served as the Chairman of the Board of Directors of H2Options, Inc., a start-up water conservation
design/installation firm, since September 2009. Mr. Pape served as a partner at Tatum LLC, an executive services firm, from August
2008 through November 2009. From November 2005 to December 2007, Mr. Pape served as Executive Vice President and Chief Financial
Officer at Affirmative Insurance Holdings, Inc., a publicly-traded property and casualty insurance company specializing in non-standard
automobile insurance, and served on its board of directors and audit committee from July 2004 to November 2005. Mr. Pape has served
on the boards of directors of Wilhelmina International, Inc., a publicly-traded fashion model management company, since January
2011, YWire Technologies Inc., a start-up in the electrical energy conservation industry, from November 2009 through September
2013 and J.W. Resources Exploration & Development, Inc., a privately-held energy company, since June 2011. Mr. Pape was a member
of the board of directors of Specialty Underwriters’ Alliance, Inc., a publicly-traded specialty property and casualty insurance
company, from July 2009 through November 2009. From 1979 through 1991, Mr. Pape worked as an investment banker at several firms,
including Bear, Stearns & Co., Inc., The First Boston Corporation and Merrill Lynch Capital Markets. Mr. Pape has been a Certified
Public Accountant since 1975. He holds an MBA from Harvard Business School, a Masters in Hotel and Food Service Management from
Florida International University and an AB degree from Harvard College. We believe that with Mr. Pape’s extensive experience
as a business executive, Mr. Pape brings significant leadership, operational skills and public company director and executive experience
to the Board. In addition, Mr. Pape’s background in finance and financial services, including his significant transactional
experience, will be helpful to the Company as it grows.
Larry L. Sears
, Director
Mr. Sears has served as a Director of the Company since May
4, 2012. He has over 25 years of experience in banking, finance and advisory services. Since October 2012, Mr. Sears has served
as a Senior Vice President, Energy Banking for Amegy Bank, N.A. From August 2008 through September 2012, he served as a Vice President
of RB International Finance (USA) LLC, the U.S. subsidiary of Raiffeisen Bank International (“RBI”), a Vienna, Austria
based banking and financial group with presence throughout Austria, Central and Eastern Europe, Russia, China, Singapore and the
U.K. Mr. Sears was a Co-Founder and Principal of Venn Capital, LLC, a financial consulting firm where he held the position of President
from June 2005 until February 2008. From April 2002 through April 2004, Mr. Sears held business development and underwriting positions
for CSG Investments, Inc., providing financing to financially distressed companies. Mr. Sears also served as National Bank of Canada’s
Group Vice President and Representative for the Southwestern U.S. Region from April 1985 until February 2001. Mr. Sears holds a
Bachelor of Science in Business Administration degree from Kansas State University and conducted extensive post-graduate work at
Oklahoma State University. He has served on the Finance Advisory Board for the Department of Finance at Kansas State University
since 1994, holding various leadership positions. Mr. Sears’ brings to the Board his expertise and successful background
in domestic and international banking, finance and capital advisory services for companies in a wide variety of industries and
ranging in size from entrepreneurial startups to multinational corporations. His varied background and expertise in these areas
brings financial and strategic acumen to management and the Board.
Dr. Clifton Kwang-Fu Shen
, Director
Dr. Shen was appointed to the Board on January
21, 2014 in connection with the EFL Tech transaction. He is a highly qualified scientist with expertise in, among other subjects,
the development of novel organic/inorganic materials used in printed electronics. Since May 2012, he has served as the Chief Scientific
Officer and a director of EFL Tech International Group N.V., an affiliate of EFL Tech. From November 2007 to April 2012, he was
an assistant professor with the Crump Institute for Molecular Imaging and the Department of Molecular and Medicinal Pharmacology
in the David Geffen School of Medicine at the University of California, Los Angeles (“UCLA”). He is an organic/polymer
chemist who received a PhD from the Department of Chemistry and Biochemistry at UCLA. The Board of Oryon believes that Dr. Shen’s
extensive scientific expertise in materials and printed electronics brings significant competitive technology acumen to Oryon’s
Board.
Richard K. Hoesterey
, Director
Richard K. Hoesterey has served as a Director of the Company
since July 20, 2012. He is an experienced executive with over 35 years in general management and manufacturing operations management
in a variety of industries including high tech electronics, industrial products, and power regulation. Mr. Hoesterey served as
the President and Chief Executive Officer and as a Director of Components Corporation of America from January 2000 to August 2009.
In September 2009, he began serving as the President and Chief Executive Officer of R.K. Hoesterey & Associates to continue
applying his expertise enhancing business performance and mentoring senior executives. He is a past member of the National Association
of Corporate Directors (NACD). Mr. Hoesterey earned a B.B.A. in Industrial Management from Clarkson University and also achieved
lifetime certification (CPIM) from the American Production & Inventory Control Society. He has served on the board of directors
of Micropac Industries, Inc. (member of the audit committee) since October 2010 and on the board of directors of Trulite, Inc.
(chairman of the compensation committee and member of the audit committee) since May 2006. The Board of Oryon believes that Mr.
Hoesterey’s extensive business experience, both as a senior executive and as a mentor to senior executives, brings significant
leadership, operational skill and strategic acumen to Oryon’s management team and Board.
Terms of Office
The Company’s directors are appointed for a one-year term
to hold office until the next annual general meeting of the Company’s shareholders or until removed from office in accordance
with the Company’s Bylaws (“Bylaws”) and the provisions of the Nevada Revised Statutes. The Company’s directors
hold office after the expiration of his or her term until his or her successor is elected and qualified, or until he or she resigns
or are removed in accordance with the Company’s Bylaws and the provisions of the Nevada Revised Statutes.
The Company’s officers are appointed by the Company’s
Board of Directors and hold office until removed by the Board of Directors in accordance with the Company’s Bylaws and the
provisions of the Nevada Revised Statutes.
Involvement in Certain Legal Proceedings
To the best of our knowledge, no director, executive officer,
significant employee or control person of the Company, or any current officer or director has been involved in any legal proceeding
listed in Item 401(f) of Regulation S-K in the past 10 years.
Committees of the Board
Prior to the Closing, the Board of Directors held no formal
meetings during the fiscal year ended January 31, 2012. All proceedings of the Board of Directors were conducted by resolutions
consented to in writing by the directors and filed with the minutes of the proceedings of the directors. Such resolutions consented
to in writing by the directors entitled to vote on that resolution at a meeting of the directors are, according to the Nevada Revised
Statutes and the Bylaws of our Company, as valid and effective as if they had been passed at a meeting of the directors duly called
and held. We do not presently have a policy regarding director attendance at meetings.
Prior to the Closing, we did not have standing nominating or
compensation committees, or committees performing similar functions. Due to the size of our Board, our Board of Directors believed
that it was not necessary to have standing nominating or compensation committees at that time because the functions of such committees
were adequately performed by our Board of Directors. Prior to the Closing, we did not have a nominating or compensation committee
charter as we did not have such committees.
After the change in the Board of Directors in connection with
the Merger, the new Board of Directors appointed members to a Nominating and Corporate Governance Committee and a Compensation
Committee. The current members of the Compensation Committee are Messrs. Hoesterey and Mr. Sears, with Mr. Hoesterey serving as
Chairman. The members of the Nominating and Corporate Governance Committee are Messrs. Hoesterey and Sears, with Mr. Hoesterey
serving as Chairman. Mr. Jon Ross served as: (a) a member of the Nominating and Governance Committee, and (b) a member and the
Chairman of the Compensation Committee from May 2012 until he resigned from the Board effective January 21, 2014. The charters
of the Nominating and Corporate Governance Committee and the Compensation Committee are available on our website at
http://elastolite.com
.
Audit Committee
The Charter of the Audit Committee of the Board of Directors
sets forth the responsibilities of the Audit Committee. The primary function of the Audit Committee is to oversee and monitor the
Company’s accounting and reporting processes and the audits of the Company’s financial statements.
Prior to the Closing of the Merger, our audit committee was
comprised of Crystal Coranes, our former President, and Rizalyn Cabrillas, our former Chief Financial Officer and Secretary. Neither
Ms. Coranes nor Ms. Cabrillas was considered an “audit committee financial expert” within the meaning of Item 407(d)(5)
of Regulation S-K. From inception through the Closing, the Audit Committee conducted business entirely by consent resolutions and
did not meet, as such. Prior to Closing, we believed that our audit committee was capable of analyzing and evaluating our financial
statements and understanding internal controls and procedures for financial reporting and that retaining an independent director
who would qualify as an “audit committee financial expert” would be overly costly and burdensome and was not warranted
in the circumstances given the stage of development and the fact that no positive cash flow had been generated from operations.
However, following the Merger, the Board appointed new members
to our Audit Committee. The members of the Audit Committee are Messrs. Sears and Hoesterey, with Mr. Sears serving as chairman.
Mr. Jon Ross served as a member of the Audit Committee from May 2012 until he resigned from the Board effective January 21, 2014.
The Board has determined that each member of the Audit Committee is independent and that Mr. Sears qualifies as the “audit
committee financial expert” as that term is defined in Item 407(d)(5)(ii) of Regulation S-K promulgated under the Exchange
Act by the SEC. The charter of the Audit Committee is available on our website at http://elastolite.com.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires our directors, executive
officers, and shareholders beneficially holding more than 10% of our Common Stock to file with the SEC initial reports of ownership
and reports of changes in beneficial ownership of our Common Stock. Executive officers, directors, and persons who beneficially
own more than 10% of our Common Stock are required by SEC regulations to furnish us with copies of all Section 16(a) reports they
file.
Based solely upon a review of the copies of the Forms 3, 4,
and 5 delivered to us as filed with the SEC during our most recent fiscal year or written representations that no Forms 5 were
required, management of the Company believes that all current executive officers and directors have made their required Section
16(a) filings for 2013 on a timely basis, with the following exceptions: (i) three filings of Form 4 for Mr. Hoesterey, Mr. Ross
and Mr. Sears were filed on January 6, 2014, for stock option grants of 100,000 shares each that were granted on November 2, 2013,
(ii) a Form 4 for Mr. Schaeffer was filed on January 14, 2014, for a stock option grant of 500,000 shares that was granted on September
6, 2013, and (iii) four filings of Form 4 for Mr. Schaeffer, Mr. Pape, Mr. Hoesterey and Mr. Ross were filed on January 24, 2014
for the shares issued to them on January 21, 2014, under the Exchange Agreements in settlement of deferred compensation liabilities
of the Company to such officers and directors.
Family Relationships
There are no family relationships between or among the directors,
executive officers or persons nominated or chosen by us to become directors or executive officers. See “Certain Relationships
and Related Transactions” for a description of transactions between the Company and its directors, executive officers or
their affiliates.
Nominations to the Board of Directors
Our directors take a critical role in guiding our strategic
direction and oversee the management of the Company. Board of Director candidates are considered based upon various criteria, such
as their broad-based business and professional skills and experiences, a global business and social perspective, concern for the
long-term interests of the shareholders, diversity, and personal integrity and judgment.
In addition, directors must have time available to devote to
Board activities and to enhance their knowledge in the growing business. Accordingly, we seek to attract and retain highly qualified
directors who have sufficient time to attend to their substantial duties and responsibilities to the Company.
In carrying out its responsibilities, the Board of Directors
will consider candidates suggested by shareholders. If a shareholder wishes to formally place a candidate’s name in nomination,
however, such shareholder must do so in accordance with the provisions of the Company’s Bylaws. Suggestions for candidates
to be evaluated by the proposed directors must be sent to the Board of Directors, c/o Oryon Technologies, Inc., 4251 Kellway Circle,
Addison, Texas, 75001.
Board Leadership Structure and Role on Risk Oversight
Prior to the Closing of the Merger, Ms. Coranes served as the
Company’s Chief Executive Officer, President and a Director. We determined this leadership structure was appropriate for
the Company due to our small size and limited operations and resources. After the Closing, the Board of Directors evaluated the
Company’s leadership structure and elected the current executive officers.
Subsequent to the closing of the Merger, the Board of Directors
has established procedures regarding the appropriate role for the Board of Directors in the Company’s risk oversight function.
Code of Business Conduct and Ethics
The Company has adopted a Code of Business Conduct and Ethics
that applies to its directors, officers and employees. A copy of the Code of Business Conduct and Ethics is available in the “Governance”
section on the Company’s Web site at
http://elastolite.com
.
ITEM 11.—EXECUTIVE COMPENSATION
Board Compensation
In November 2012, the Compensation Committee of the Board of
Directors and the Board of Directors both approved a program of compensation for independent directors to compensate non-management
directors for their services. Management directors receive no compensation for board service. Compensation for independent director
services was established as $5,000 per calendar quarter, due at the end of each calendar quarter for services rendered during such
period. In addition, the chairman of the Audit Committee receives extra compensation of $1,875 per calendar quarter and the chairman
of the Compensation Committee receives extra compensation of $1,250 per calendar quarter. However, payment of all compensation
for director services through December 31, 2013, was deferred until January 21, 2014, when Mr. Hoesterey and Mr. Sears exchanged
their deferred compensation for common stock and cash under the Exchange Agreements. Directors are not paid for meetings attended.
In addition, the Compensation Committee and Board approvals
provided that each independent director will be granted stock options for 100,000 common shares, semi-annually for prior service,
pro-rated if service is less than the full six months, on every May 2
nd
and November 2
nd
. Such stock options
are fully vested on the date of grant, have an expiration date of ten years from the date of grant, specifically provide that there
are no termination provisions prior to expiration regardless of the individual director’s term of service as a board member,
and are to be granted at fair market value, determined as the average of the opening and closing common stock price as quoted on
the date of the option grant.
For the 2013 calendar year, under the director compensation
plan as described above, the Company’s independent directors earned directors’ compensation as reported in the table
below:
Director Compensation Table - 2013
|
|
|
|
|
|
|
|
|
|
|
Director's Name
|
|
Fees Earned or Paid
in Cash
|
|
|
Option Awards
|
|
|
Total
|
|
|
|
(d)
|
|
|
(e)
|
|
|
|
|
Richard K. Hoesterey (a)
|
|
$
|
20,000
|
|
|
$
|
7,759
|
|
|
$
|
27,759
|
|
Jon S. Ross (b)
|
|
|
25,000
|
|
|
|
7,759
|
|
|
|
32,759
|
|
Larry L. Sears (c )
|
|
|
27,500
|
|
|
|
7,759
|
|
|
|
35,259
|
|
Total
|
|
$
|
72,500
|
|
|
$
|
23,277
|
|
|
$
|
95,777
|
|
|
(a)
|
Mr. Hoesterey joined the Board effective July 10, 2012. Effective
January 21, 2014, he was appointed Chairman of the Compensation Committee. On May 2, 2013, he received an option for 100,000 shares,
with an exercise price of $0.21 per share, fully vested on the date of grant and a remaining term of approximately 9.2 years. On
November 2, 2013, he received an option for 100,000 shares, with an exercise price of $0.0418 per share, fully vested on the date
of grant and a remaining term of approximately 9.7 years.
|
|
(b)
|
Mr. Ross joined the Board effective as of the Closing of the Merger
on May 4, 2012, and resigned effective January 21, 2014. He served as the Chairman of the Compensation Committee. On May 2, 2013,
he received an option for 100,000 shares, with an exercise price of $0.21 per share, fully vested on the date of grant and a remaining
term of approximately 9.2 years. On November 2, 2013, he received an option for 100,000 shares, with an exercise price of $0.0418
per share, fully vested on the date of grant and a remaining term of approximately 9.7 years.
|
|
(c)
|
Mr. Sears joined the Board effective as of the Closing of the Merger
on May 4, 2012. Mr. Sears is Chairman of the Audit Committee. On May 2, 2013,he received an option for 100,000 shares, with an
exercise price of $0.21 per share, fully vested on the date of grant and a remaining term of approximately 9.2 years. On November
2, 2013, he received an option for 100,000 shares, with an exercise price of $0.0418 per share, fully vested on the date of grant
and a remaining term of approximately 9.7 years.
|
|
(d)
|
All board and committee fees earned in 2013 were deferred. No fees
were paid in cash. In January 2014, in connection with the EFL Tech transaction, a total of $75,833 in deferred directors' compensation
(representing all 2012 and 2013 deferred board fees due Mr. Sears and Mr. Hoesterey) were exchanged for 1,681,217 shares of common
stock with a fair market value of $0.036085 per share and $15,167 in cash. All deferred director's compensation payable to Mr.
Ross, amounting to $41,666, was written off as he voluntarily waived payment of any deferred compensation at the time of his resignation
from the Board on January 21, 2014.
|
|
(e)
|
All stock option grants were granted with an exercise price equal
to the average opening and the closing common stock price as quoted on the date of the option grant. The fair market value of each
stock option grant was based on the closing stock price on the grant date and computed using the Black-Scholes model with the assumptions
described in Note 14 to the Consolidated Financial Statements incorporated by reference herein.
|
All travel and lodging expenses associated with corporate matters
are reimbursed by the Company, if and when incurred. The total of all Board meeting expenses in 2013 and 2012 were $-0- and $35,
respectively.
Executive Compensation—Former Executive Officers
No director, officer or employee performing services for the
Registrant prior to the Merger received compensation during the Registrant’s last fiscal year.
Executive Compensation – Current Executive Officers
Summary Compensation Table
The following summary compensation table indicates the cash
and non-cash compensation earned from Oryon during the fiscal years ended December 31, 2013, 2012, 2011 and 2010, by the chief
executive and chief financial officers of Oryon. No other executive officers received total compensation that exceeded $100,000
during those periods.
Summary Compensation Table-Year Ended
December 31, 2013
Name and
Principal
Position
|
|
Year
|
|
|
Salary
|
|
|
Bonus
|
|
|
Option
Awards (k)
|
|
|
Non-Equity
Incentive Plan
Compensation
|
|
|
All Other
Compensation
(p)
|
|
|
Total
|
|
Thomas P. Schaeffer (a)
|
|
|
2013
|
|
|
$
|
150,000
|
(c)
|
|
|
-
|
|
|
$
|
8,170
|
(l)
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
Chief Executive Officer
|
|
|
2012
|
|
|
$
|
150,000
|
(d)
|
|
$
|
25,000
|
(j)
|
|
$
|
132,422
|
(m)
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
2011
|
|
|
$
|
68,750
|
(e)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
2010
|
|
|
|
na
|
|
|
|
na
|
|
|
|
na
|
|
|
|
na
|
|
|
|
|
|
|
|
na
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark E. Pape (b)
|
|
|
2013
|
|
|
$
|
93,972
|
(f)
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
|
|
|
|
|
$
|
6,573
|
|
Chief Financial Officer
|
|
|
2012
|
|
|
$
|
130,000
|
(g)
|
|
|
-
|
|
|
$
|
18,227
|
(n)
|
|
|
-
|
|
|
|
|
|
|
$
|
5,966
|
|
|
|
|
2011
|
|
|
$
|
118,623
|
(h)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
$
|
3,482
|
|
|
|
|
|
|
|
|
2010
|
|
|
$
|
28,656
|
(i)
|
|
|
-
|
|
|
$
|
22,243
|
(o)
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
(a)
|
Mr. Schaeffer began working for Oryon on July 15, 2011 and was appointed
to the positions of Chief Executive Officer and President of Oryon effective October 24, 2011. He was appointed to the positions
of Chief Executive Officer and President of the Company effective May 4, 2012 in connection with the Closing of the Merger. He
resigned as President of the Company effective January 21, 2014,
|
|
(b)
|
Mr. Pape was appointed to the position of Chief Financial Officer
of Oryon effective October 11, 2010. He was appointed to the position of Chief Financial Officer of the Company effective May 4,
2012, in connection with the Closing of the Merger.
|
|
(c)
|
Mr. Schaeffer's 2013 compensation included (a) $68,750 that was accrued
in 2013 as deferred compensation liability and (b) $18,750 in payroll that was accrued in 2013, both of which remained unpaid as
of December 31, 2013.
|
|
(d)
|
Mr. Schaeffer's 2012 compensation included $1,563 that was accrued
in 2012 as deferred compensation liability and that remained unpaid as of December 31, 2013.
|
|
(e)
|
Mr. Schaeffer's 2011 compensation included $53,750 that was accrued
in 2011 as deferred compensation liability, all of which remained unpaid as of December 31, 2013.
|
|
(f)
|
Mr. Pape's 2013 compensation included $24,375 that was accrued in
2013 as deferred compensation liability, all of which remained unpaid as of December 31, 2013.
|
|
(g)
|
Mr. Pape's 2012 compensation included $19,333 that was accrued in
2012 as deferred compensation liability, all of which remained unpaid as of December 31, 2013.
|
|
(h)
|
Mr. Pape's 2011 compensation included $70,323 for which he received
562,584 shares of the Company's common stock valued at $0.125 per share in lieu of cash compensation. It also included $31,333
that was accrued in 2011 as deferred compensation liability and remained unpaid as of December 31, 2013.
|
|
(i)
|
Mr. Pape's entire 2010 compensation was deferred until January 2011
when he received 229,248 shares of the Company's common stock valued at $0.125 per share in lieu of the deferred compensation.
|
|
(j)
|
Mr. Schaeffer's employment agreement provides that he receive a bonus
of $25,000 in 2013 for his services provided in 2012. However, in recognition of the Company's limited resources, Mr. Schaeffer
agreed to defer payment of the bonus until a future date, in exchange for a grant of stock options. The $25,000 bonus was accrued
in 2013 as deferred compensation liability and that remained unpaid at December 31, 2013. See note (m)
|
|
(k)
|
Amounts in this column reflect the dollar amount recognized for financial
reporting purposes in accordance with FASB ASC Topic 718, except that we excluded the effect of estimated forfeitures related to
service-based conditions pursuant to SEC rules. See Note 14 to Oryon’s Audited Consolidated Financial Statements for the
years ended December 31, 2013 and 2012, which are incorporated herein, for a discussion of Oryon’s valuation methodology
and assumptions.
|
|
(l)
|
On September 6, 2013, Mr. Schaeffer was granted an option to purchase
500,000 shares of the Company's common stock at $0.1096 per share. The option has a ten-year term. The option will vest for all
500,000 shares on the first anniversary of the grant.
|
|
(m)
|
On September 6, 2012, Mr. Schaeffer was granted an option to purchase
500,000 shares of the Company's common stock at $0.745 per share. The option has a ten-year term. One-half of the shares underlying
the option (250,000) vested on the date of grant and 250,000 shares will vest on the first anniversary of the grant. In January
2013, Mr. Schaeffer was granted an option to purchase 75,000 shares of the Company's common stock at $0.3425 per share in return
for agreeing to temporarily defer the payment of the $25,000 bonus provided by his employment agreement. The option has a ten-year
term and was fully vested on the date of grant.
|
|
(n)
|
In January 2013, Mr. Pape was granted an option to purchase 125,000
shares of the Company's common stock at $0.3425 per share in recognition of his services provided to the Company in prior periods.
The option has a ten-year term and was fully vested on the date of grant.
|
|
(o)
|
On November 1, 2010, Mr. Pape was granted an option to purchase 480,000
shares of the Company's common stock at $0.125 per share. The option has a ten-year term and became fully vested on May 4, 2012,
in connection with the Closing of the Merger, as provided under the terms of the option.
|
|
(p)
|
All Other Compensation consists solely of the cost of group health
insurance for the executive. Prior to June 1, 2012, the Company paid for the individual's personal healthcare insurance when the
executive participated in the Company's group health insurance plan. Subsequent to that date the Company has paid the greater of
$500 per month or the executive's monthly coverage. Mr. Pape did not elect to participate in the Company's group health insurance
plan until June 1, 2011.
|
None of our executive officers received, nor do we have any
arrangements to pay, any bonus, stock awards, option awards, non-equity incentive plan compensation, or non-qualified deferred
compensation other than as noted in the table above.
Outstanding Equity Awards at Fiscal Year-End
The following table sets forth certain information, as of December
31, 2013, regarding stock option grants by the Company:
Outstanding Equity Awards at Fiscal Year-end
- December 31, 2013
|
|
Number of securities
underlying unexercised
|
|
|
|
|
|
|
Name and Principal Position
|
|
Exercisable
(#)
|
|
|
Unexercisable
(#)
|
|
|
Option
Exercise Price
|
|
|
Option
Expiration Date
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas P. Schaeffer (a)
|
|
|
500,000
|
|
|
|
-
|
|
|
$
|
0.7450
|
|
|
September 6, 2022
|
Chief Executive Officer
|
|
|
75,000
|
|
|
|
-
|
|
|
$
|
0.3425
|
|
|
January 16, 2023
|
|
|
|
-
|
|
|
|
500,000
|
|
|
$
|
0.1096
|
|
|
September 6, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark E. Pape
|
|
|
480,000
|
|
|
|
-
|
|
|
$
|
0.1250
|
|
|
November 1, 2020
|
Chief Financial Officer
|
|
|
125,000
|
|
|
|
-
|
|
|
$
|
0.3425
|
|
|
January 16, 2023
|
|
(a)
|
On September 6, 2012, pursuant to his employment agreement, Mr. Schaeffer
was granted an option to purchase 500,000 shares of the Company's common stock at $0.745 per share. The option has a ten-year term.
One-half of the shares underlying the option (250,000) vested on the date of grant and the remaining 250,000 shares vested on the
first anniversary of the grant. On September 6, 2013, also pursuant to his employment agreement, Mr. Schaeffer was granted an option
to purchase 500,000 shares of common stock at $0.1096 per share to be vested on the first anniversary of the grant. The option
has a ten-year term. In addition, on January 16, 2013, Mr. Schaeffer was granted an option to purchase 75,000 shares of the Company's
common stock at $0.3425 per share in return for agreeing to temporarily defer the payment of the $25,000 bonus provided by this
employment agreement. This option has a ten-year term and was fully vested on the date of grant.
|
Executive Employment Agreements
On September 6, 2012, we entered into an employment agreement
with Mr. Schaeffer, our President and Chief Executive Officer. The agreement provides for an initial term of employment of two
years from September 6, 2012 (the “Effective Date”), with automatic one-year renewal periods. The agreement establishes
a base salary of $223,750 for the first year (including $73,750 in previously earned but unpaid and deferred compensation) and
$150,000 for subsequent years, and a minimum bonus of $25,000 for the year ending December 31, 2012. Mr. Schaeffer is also entitled
to any other bonus that may be awarded by the Compensation Committee. The agreement also provides for the grant of options to purchase
500,000 shares of common stock on the Effective Date, and an additional 500,000 shares on each of the first two anniversaries of
the Effective Date, to the extent that Mr. Schaeffer’s employment is continuing at that time. If Mr. Schaeffer’s employment
is terminated prior to the end of the term by (a) the Company without Cause (other than due to Mr. Schaeffer’s death or Disability),
(b) Mr. Schaeffer for Good Reason or (c) the Company for any reason within 12 months after a Change in Control, then the Company
is required to pay a lump sum amount equal to 200% of Mr. Schaeffer’s annual base salary in effect as of his termination,
a prorated bonus, and certain other amounts as provided in the agreement depending on the termination date. Effective January 21,
2014, Mr. Schaeffer waived these provisions.The foregoing capitalized terms have the meanings given to them in the agreement.
Mr. Pape is employed on an “at will” basis and does
not have employment, severance or change of control agreements with the Company.
Compensation Discussion and Analysis
Our Board of Directors established the Compensation Committee
with the authority to set all forms of compensation of our executive officers and the directors. The Compensation Committee has
overall responsibility for our compensation policies as provided in the written charter adopted by the Compensation Committee.
The Compensation Committee is empowered to review and approve the annual compensation and compensation procedures for our executives
and does not delegate any of its functions to others in setting compensation. During 2013, the Compensation Committee was comprised
of Mr. Ross (Chairman) and Mr. Hoesterey, who were both independent non-employee directors. Effective January 21, 2014, Mr. Ross
resigned from the Board, Mr. Sears was appointed to the Compensation Committee and Mr. Hoesterey was appointed Chairman of the
Compensation Committee.
When establishing base salaries, cash bonuses and equity grants
for each of the executives, the Compensation Committee considers the recommendations of the Chief Executive Officer, the specific
executive’s role and contribution to the management team, responsibilities and performance during the past year and future
anticipated contributions, corporate performance, and the amount of total compensation paid to executives in similar positions,
and performing similar functions, at other companies for which data is available, as provided by such third parties.
The Compensation Committee relies upon its judgment in making
compensation decisions, after reviewing the Company’s performance and evaluating each executive’s performance during
the year. The Compensation Committee generally does not adhere to formulas or necessarily react to short-term changes in business
performance in determining the amount and mix of compensation elements, incorporating flexibility into our compensation programs
and into the assessment process to respond to and adjust for the evolving business environment.
As Chairman of the Compensation Committee, Mr. Ross undertook
an examination of comparable compensation packages for companies situated similarly to the Company, as to market capitalization,
revenue, product type and/or performance history. Mr. Ross also took into account the experience and qualifications of the executive
officers of the Company.
Potential Payments Upon Termination or Change-in-Control
Other than as discussed above, we have no employment agreements
with any of our executive officers, nor any compensatory plans or arrangements resulting from the resignation, retirement or any
other termination of any of our executive officers, from a change-in-control, or from a change in any executive officer’s
responsibilities following a change-in-control. In the event of a termination of employment as a result of Mr. Schaeffer’s
death or disability, the Company is required to pay the costs of Mr. Schaeffer and his dependents under the Company’s medical
plans for one year.
Compensation Committee Interlocks and Insider Participation
No interlocking relationship exists between our Board of Directors
and the Board of Directors or compensation committee of any other company, nor has any interlocking relationship existed in the
past.
ITEM 12.—SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The following table sets forth certain information as of March
6, 2014, with respect to the beneficial ownership of our common stock for (i) each director and executive officer, (ii) all of
our directors and executive officers as a group, and (iii) each person known to us to own beneficially five percent (5%) or more
of the outstanding shares of our common stock. As of such date, there were 167,199,567 shares of common stock outstanding. No shares
of our preferred stock were outstanding as of such date.
To our knowledge, except as indicated in the footnotes to this
table or pursuant to applicable community property laws, the persons named in the table have sole voting and investment power with
respect to the shares of common stock indicated.
Name and Address of Beneficial Owner(1)
|
|
Shares Beneficially
Owned
|
|
|
Percentage
Beneficially
Owned
|
|
|
|
|
|
|
|
|
Directors and Executive Officers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thomas P. Schaeffer
|
|
|
5,948,978
|
|
|
|
2.35
|
%
|
Chief Executive Officer and Director (2)(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mark E. Pape
|
|
|
3,060,497
|
|
|
|
1.21
|
%
|
Chief Financial Officer, Director (2)(4)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Larry L. Sears
|
|
|
1,376,120
|
|
|
|
0.54
|
%
|
Director (2)(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clifton K-F. Shen
|
|
|
0
|
|
|
|
0.00
|
%
|
Director (2)(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Richard K. Hoesterey
|
|
|
931,764
|
|
|
|
0.37
|
%
|
Director (2)(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Officers and Directors as a Group (5 persons)
|
|
|
11,317,359
|
|
|
|
4.45
|
%
|
|
|
|
|
|
|
|
|
|
5% Shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EFL Tech B.V. (8)
|
|
|
170,405,650
|
|
|
|
67.53
|
%
|
Venture Capital First LLP (9)
|
|
|
10,807,815
|
|
|
|
4.28
|
%
|
MRM Acquisitions, LLC (10)
|
|
|
20,136,524
|
|
|
|
7.92
|
%
|
Oryon Capital, LLC (11)
|
|
|
27,312,479
|
|
|
|
10.70
|
%
|
M. Richard Marcus (12)
|
|
|
29,647,893
|
|
|
|
11.57
|
%
|
|
(1)
|
Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Pursuant to the rules of the
SEC, shares of common stock that an individual or group has a right to acquire within 60 days pursuant to the exercise of options
or warrants are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group, but
are not deemed to be beneficially owned and outstanding for the purpose of computing the percentage ownership of any other person
shown in the table.
|
|
(2)
|
The address for this individual or entity is: 4251 Kellway Circle, Addison, Texas 75001.
|
|
(3)
|
Mr. Schaeffer owns: (i) 2,000,000 restricted shares of Company common stock, (ii) 3,373,978 shares issued in January 2014 by
the Company in settlement of $121,750 in liabilities to Mr. Schaeffer, (iii) 500,000 shares underlying vested equity options with
an exercise price of $0.745 per share and a remaining term of approximately 8.5 years, and (iv) 75,000 shares underlying a vested
equity option granted to Mr. Schaeffer in January 2013 with an exercise price of $0.3425 per share and a remaining term of approximately
9.0 years.
|
|
(4)
|
Consists of: (i) 791,832 shares of Company common stock owned directly (received during 2011 in lieu of cash compensation),
(ii) 1,663,665 shares issued in January 2014 in settlement of $60,033 in liabilities to Mr. Pape, (iii) 480,000 shares underlying
vested equity options with a weighted average exercise price of $0.125 per share and a remaining term of approximately 6.5 years,
and (iv) 125,000 shares underlying a vested equity option granted to Mr. Pape in January 2013 with a weighted average exercise
price of $0.3425 per share and a remaining term of approximately 9.0 years.
|
|
(5)
|
Consists of: (i) 60,000 shares underlying vested equity options with a weighted average exercise price of $0.125 per share
and a remaining term of approximately 0.5 years, (ii) 1,016,120 shares issued in January 2014 by the Company in settlement of $36,669
in liabilities to Mr. Sears, (iii) 100,000 shares underlying vested equity options with a weighted average exercise price of $0.21
per share and a remaining term of approximately 9.2 years, (iv) 100,000 shares underlying vested equity options with a weighted
average exercise price of $0.0418 per share and a remaining term of approximately 9.7 years and (v) 100,000 shares underlying vested
equity options with a weighted average exercise price of $0.395 per share and a remaining term of approximately 8.7 years.
|
|
(6)
|
Dr. Shen was appointed to the Board of Directors on January 21, 2014.
|
|
(7)
|
Mr. Hoesterey holds: (i) 66,667 shares underlying vested equity options with a weighted average exercise price of $0.395 per
share and a remaining term of approximately 8.7 years, (ii) 665,097 shares issued in January 2014 by the Company in settlement
of $24,000 in liabilities to Mr. Hoesterey, (iii) 100,000 shares underlying vested equity options with a weighted average exercise
price of $0.21 per share and a remaining term of approximately 9.2 years, and (iv) 100,000 shares underlying vested equity options
with a weighted average exercise price of $0.0418 per share and a remaining term of approximately 9.7 years.
|
|
(8)
|
Consists of 85,271,779 shares issued in connection with the First Closing of the EFL Tech transaction and 85,133,871 shares
issued pursuant to the Second Closing. The address for this entity is: Andrews Kurth LLP, Attention: Mike Lockwood, 1717 Main Street,
Suite 3700, Dallas, Texas 75201.
|
|
(9)
|
Consists of 10,807,815 shares issued by the Company in January 2014 in settlement of $390,000 in liabilities (short-term advances)
to this entity. The address for this entity is: Greenberg, Taurig, LLP, Attention: Mark Lee, 1201 K St., Eleventh Floor, Sacramento,
California 95814.
|
|
(10)
|
Includes 18,289,700 shares of common stock owned directly and 1,846,824 shares underlying Series C Warrants to purchase common
stock at $0.3125 per share. Oryon Capital, LLC owns 66.19% of the membership units of MRM Acquisitions, LLC and consequently has
voting control and investment discretion over the securities held by MRM Acquisitions, LLC. As a result, Oryon Capital, LLC may
be deemed to have beneficial ownership (as defined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of the
shares of common stock owned by MRM Acquisitions, LLC. The address for this individual or entity is: 6335 W. Northwest Highway,
Suite 212, Dallas TX 75225.
|
|
(11)
|
Includes 6,205,227 shares of common stock owned directly by Oryon Capital, LLC, 970,728 shares underlying Series C Warrants
to purchase common stock at $0.3125 per share held by Oryon Capital, LLC and 20,136,524 shares beneficially owned by MRM Acquisitions,
LLC. See note (8) above. Mr. M. Richard Marcus, former Chief Executive Officer and Chairman of Oryon, is Chairman of the Board
of Managers of Oryon Capital, LLC and owns 43.43% of the membership interests of Oryon Capital, LLC. Mr. Marcus disclaims voting
control and investment discretion over the membership interests of MRM Acquisitions, LLC and the equity securities of Oryon held
by Oryon Capital, LLC. The address for this individual or entity is: 6335 W. Northwest Highway, Suite 212, Dallas TX 75225.
|
|
(12)
|
Includes (i) 1,300,310 shares of common stock owned directly, (ii) 983,104 shares underlying vested equity options with a weighted
average exercise price of $0.17 per share and a weighted average remaining term of 6.3 years, (iii) 52,000 shares underlying Series
C Warrants to purchase common stock at $0.3125 per share and (iv) 27,312,479 shares beneficially owned by Oryon Capital, LLC –
see note (9) above. Mr. Marcus is the former Chief Executive Officer and Chairman of Oryon and is currently the Chairman of the
Boards of Managers of Oryon Capital, LLC and MRM Acquisitions, LLC. He owns 43.43% of the membership interests of Oryon Capital,
LLC. He owns no membership units of MRM Acquisitions, LLC. Oryon Capital, LLC owns 66.19% of the membership units of MRM Acquisitions,
LLC. See notes (8) and (9) above. Mr. Marcus disclaims voting control and investment discretion over Oryon Capital, LLC’s
membership interests of MRM Acquisition, LLC and the equity securities of Oryon held by Oryon Capital, LLC. The address for this
individual or entity is: 6335 W. Northwest Highway, Suite 212, Dallas TX 75225.
|
Securities Authorized for Issuance Under Equity Compensation
Plans
On February 24, 2012, our Board adopted the 2012 Equity Incentive
Plan (the “Plan”) and reserved 7,500,000 shares of the Company’s common stock for issuance thereunder to officers,
directors, employees, consultants and other service providers of the Company. The Plan was approved by the Company’s shareholders
on March 19, 2012.
As of the date hereof, options for 5,897,274 shares have been
granted pursuant to the Plan.
The following table provides information regarding shares subject
to the Plan:
Equity Compensation Plan Information
Plan Category
|
|
Number of
securities to be
issued upon
exercise of
outstanding
options, warrants
and rights
|
|
|
Weighted-
average
exercise price
of outstanding
options,
warrants and
rights
|
|
|
Number of securities
remaining available
for future issuance
under equity
compensation plans
(excluding securities
reflected in column
(a) )
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
Equity compensation plans approved by security holders
|
|
|
5,897,274
|
|
|
$
|
0.207
|
|
|
|
1,602,726
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity compensation plans not approved by security holders
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
5,897,274
|
|
|
|
|
|
|
|
1,602,726
|
|
On August 27, 2012, we filed with the SEC a registration statement
on Form S-8 under the Securities Act that registered the 7,500,000 shares that could be issued to employees, directors or consultants
pursuant to the Plan.
ITEM 13.—CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
AND DIRECTOR INDEPENDENCE
Certain Relationships and Related Transactions
There are no family relationships between any of our former
directors or executive officers and the current directors and officers. Prior to the Closing of the Merger, during our fiscal year
ended January 31, 2012, and the previous fiscal year, there were no transactions with related parties other than as noted below.
To our knowledge, the officers and directors of the Company elected in conjunction with the Merger were not directors of the Company
prior to the Merger, did not hold any position with the Company prior to the Merger, other than Mr. Schaeffer who was a Company
shareholder, and have not been involved in any material proceeding adverse to the Company or its subsidiaries or have a material
interest adverse to the Company or its subsidiaries, or any transactions with the Company or any of its directors, executive officers,
affiliates, or associates that are required to be disclosed pursuant to the rules and regulations of the SEC.
In accordance with the Merger Agreement, upon the effectiveness
of the Merger, the Oryon Members received approximately 50% of the issued and outstanding common stock of the Company. Mr. Pape,
one of our new directors and chief financial officer, was a member of Oryon. Accordingly, Mr. Pape was issued certain shares of
our Common Stock in connection with the Merger Agreement in exchange for his membership units of Oryon.
Other than the transactions, including the EFL Tech transaction
and the Merger Agreement, both noted above, there are no transactions, since the beginning of the Company’s last fiscal year,
or any currently proposed transaction, in which the Company was or is to be a participant and the amount involved exceeds the lesser
of $120,000 or one percent of the average of the Company’s total assets at year-end for the last three completed fiscal years,
and in which any of the former directors or officers or the current directors and officers had or will have a direct or indirect
material interest. There is no material plan, contract or arrangement (whether or not written) to which any of the former directors
or officers or the current directors and officers is a party or in which they participate that is entered into or material amendment
in connection with our appointment of any of the former directors or officers or the current directors and officers, or any grant
or award to any of the former directors or officers or the current directors or officers or modification thereto, under any such
plan, contract or arrangement in connection with our appointment of any of the former directors or officers or the current directors
and officers.
Review, Approval or Ratification of Transactions with Related
Persons
Although we have adopted a Code of Business Ethics and Control,
we still rely on our Board to review related party transactions on an ongoing basis to prevent conflicts of interest. Our Board
reviews a transaction in light of the affiliations of the director, officer or employee and the affiliations of such person’s
immediate family. Transactions are presented to our Board for approval before they are entered into or, if this is not possible,
for ratification after the transaction has occurred. If our Board finds that a conflict of interest exists, then it will determine
the appropriate remedial action, if any. Our Board approves or ratifies a transaction if it determines that the transaction is
consistent with the best interests of the Company.
Director Independence
Until the Closing Date of the Merger, we did not have any independent
directors on our Board of Directors. Our Board currently has one member from management (Mr. Schaeffer, Chief Executive Officer),
two non-management directors (Mr. Hoesterey and Mr. Sears) and one non-management member nominated by EFL (Dr. Shen). The Board
has determined that Mr. Hoesterey and Mr. Sears meet the criteria for independence. Due to his management role, Mr. Schaeffer is
not considered to be an independent director and does not sit on any committees of the Board. Due to his employment by EFL, a “parent”
of the Company, Dr. Shen is not considered to be an independent director and does not sit on any committees of the Board. We evaluate
independence by the standards for director independence established by applicable laws, rules, and listing standards, including,
without limitation, the standards for independent directors established by the New York Stock Exchange, Inc., the NASDAQ National
Market, and the SEC.
Subject to some exceptions, these standards generally provide
that a director will not be independent if (a) the director is, or in the past three years has been, an employee of the Company
or of any parent or subsidiary of the Company; (b) a member of the director’s immediate family is, or in the past three years
has been, an executive officer of ours; (c) the director or a member of the director’s immediate family has received more
than $120,000 per year in direct compensation from us other than for service as a director (or for a family member, as a non-executive
employee); (d) the director or a member of the director’s immediate family is, or in the past three years has been, employed
in a professional capacity by our independent public accountants, or has worked for such firm in any capacity on our audit; (e)
the director or a member of the director’s immediate family is, or in the past three years has been, employed as an executive
officer of a company where one of our executive officers serves on the compensation committee; or (f) the director or a member
of the director’s immediate family is an executive officer of a company that makes payments to, or receives payments from,
us in an amount which, in any twelve-month period during the past three years, exceeds the greater of $1,000,000 or two percent
of that other company’s consolidated gross revenues.
ITEM 14.—PRINCIPAL ACCOUNTING FEES AND SERVICES
Audit Fees
For the years ended December 31, 2013 and 2012, the Company
paid or accrued $46,440 and $66,479, respectively, for the independent registered public accounting firm for professional services
rendered in connection with the audit of the Company’s annual financial statements, their quarterly review of the financial
statements included in the Company’s Quarterly Reports on Form 10-Q and audit services provided in connection with other
statutory and regulatory filings, including the Registration Statement on Form S-1 filed in October 2012. The independent registered
public accounting firm prepared and filed the Company’s tax return for 2012 at a cost of $4,790 and the Company has accrued
$5,000 as of December 31, 2013, for preparation of the 2013 tax return.
Policy on Audit Committee Pre-Approval of Audit and Non-Audit
Services Performed by the Independent Registered Public Accounting Firm
The Company maintains an auditor independence policy that bans
its auditors from performing non-financial consulting services, such as information technology consulting and internal audit services.
This policy mandates that the Audit Committee approve the audit and non-audit services and related budget in advance, and that
the Audit Committee be provided with quarterly reporting on actual spending. This policy also mandates that the Company may not
enter into auditor engagements for non-audit services without the express approval of the Audit Committee. In accordance with this
policy, the Audit Committee pre-approved all services to be performed by the Company’s independent registered public accounting
firm.
ITEM 15.—EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a)(1) and (2) Financial Statements and Financial Statement
Schedules
See “Index to Financial Statements”.
(a)(3) Exhibits
The exhibits listed in the accompanying “Index to Exhibits”
are filed or furnished as part of this Form 10-K.
Index to Financial Statements
ORYON TECHNOLOGIES, INC. AND SUBSIDIARIES
|
|
Report of Independent Registered Public Accounting Firm
|
F-2
|
|
|
Financial Statements:
|
|
|
|
Consolidated Balance Sheets at December 31, 2013 and 2012
|
F-3
|
|
|
Consolidated Statements of Operations for the years ended December 31, 2013 and 2012
|
F-4
|
|
|
Consolidated Statements of Changes in Shareholders’ Equity (Deficit) for the years ended December 31, 2013 and 2012
|
F-5
|
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2013 and 2012
|
F-6
|
|
|
Notes to Consolidated Financial Statements for the years ended December 31, 2013 and 2012
|
F-8
|
Montgomery Coscia
Greilich LLP
Certified Public
Accountants
2500 Dallas Parkway, Suite 300
Plano, Texas 75093
972.748.0300 p
972.748.0700 f
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Board of Directors and Shareholders
of Oryon Technologies, Inc. and Subsidiaries
We have audited the accompanying consolidated balance sheets
of Oryon Technologies, Inc. and Subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of operations,
changes in shareholders’ equity (deficit), and cash flows for the years then ended. These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the auditing standards
of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to
obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required
to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration
of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances,
but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.
Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management,
as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our
opinion.
In our opinion, the financial statements referred to above present
fairly, in all material respects, the financial position of Oryon Technologies, Inc. and Subsidiaries as of December 31, 2013 and
2012, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally
accepted in the United States of America.
The accompanying financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in Note 16 to the financial statements, the Company has accumulated
losses from inception through December 31, 2013 of $12,078,453, has minimal assets, and has negative working capital. These conditions
raise substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters also
are described in Note 16. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
/s/ MONTGOMERY COSCIA GREILICH LLP
Montgomery Coscia Greilich LLP
Plano, Texas
March 7, 2014
ORYON TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
December 31, 2013 and 2012
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2013
|
|
|
2012
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
44,741
|
|
|
$
|
169,678
|
|
Accounts Receivable, net of allowance for
|
|
|
|
|
|
|
|
|
doubtful accounts of $0 and $0, respectively
|
|
|
21,182
|
|
|
|
10,721
|
|
Inventory (see note 2)
|
|
|
100,931
|
|
|
|
97,456
|
|
Other current assets
|
|
|
8,716
|
|
|
|
8,707
|
|
Total current assets
|
|
|
175,570
|
|
|
|
286,562
|
|
|
|
|
|
|
|
|
|
|
PROPERTY AND EQUIPMENT, NET (see note 3)
|
|
|
13,736
|
|
|
|
21,708
|
|
|
|
|
|
|
|
|
|
|
INTANGIBLE ASSETS, NET (see note 4)
|
|
|
114,652
|
|
|
|
137,736
|
|
|
|
|
|
|
|
|
|
|
OTHER LONG-TERM ASSETS (see note 5)
|
|
|
16,697
|
|
|
|
23,799
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS
|
|
$
|
320,655
|
|
|
$
|
469,805
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
378,184
|
|
|
$
|
187,047
|
|
Deferred revenue
|
|
|
-
|
|
|
|
6,000
|
|
Deferred compensation (see note 6)
|
|
|
386,973
|
|
|
|
166,667
|
|
Current portion of promissory notes and other short-term debt (see note 7)
|
|
|
1,149,521
|
|
|
|
401,655
|
|
Other current liabilities (see note 8)
|
|
|
29,748
|
|
|
|
41,537
|
|
Total current liabilities
|
|
|
1,944,426
|
|
|
|
802,906
|
|
|
|
|
|
|
|
|
|
|
NOTES PAYABLE, NET (see note 9)
|
|
|
114,156
|
|
|
|
164,187
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
2,058,582
|
|
|
|
967,093
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par value, 50,000,000 shares authorized, none
|
|
|
|
|
|
|
|
|
issued and outstanding (see note 13)
|
|
|
-
|
|
|
|
-
|
|
Common stock, $0.001 par value, 600,000,000 shares authorized, 62,660,778
|
|
|
|
|
|
|
|
|
shares issued and outstanding (see note 13)
|
|
|
62,661
|
|
|
|
62,661
|
|
Paid in capital
|
|
|
10,277,865
|
|
|
|
10,126,184
|
|
Accumulated deficit
|
|
|
(12,078,453
|
)
|
|
|
(10,686,133
|
)
|
Total equity (deficit)
|
|
|
(1,737,927
|
)
|
|
|
(497,288
|
)
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
$
|
320,655
|
|
|
$
|
469,805
|
|
The accompanying notes are an integral part
of these financial statements.
ORYON TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Statements of Operations
For the Years Ended December 31,
2013 and 2012
|
|
For the Year Ended December 31,
|
|
|
|
2013
|
|
|
2012
|
|
REVENUES
|
|
|
|
|
|
|
|
|
Product sales
|
|
$
|
124,573
|
|
|
$
|
68,428
|
|
Cost of goods sold
|
|
|
(56,684
|
)
|
|
|
(40,184
|
)
|
Gross profit
|
|
|
67,889
|
|
|
|
28,244
|
|
Royalty and license fees
|
|
|
-
|
|
|
|
-
|
|
Other
|
|
|
-
|
|
|
|
-
|
|
Total revenues
|
|
|
67,889
|
|
|
|
28,244
|
|
OPERATING EXPENSES
|
|
|
|
|
|
|
|
|
Applications development
|
|
|
|
|
|
|
|
|
Wages
|
|
|
93,556
|
|
|
|
173,888
|
|
Payroll taxes and benefits
|
|
|
20,508
|
|
|
|
26,455
|
|
Materials, equipment, services
|
|
|
164,986
|
|
|
|
117,008
|
|
Office and overhead
|
|
|
15,100
|
|
|
|
7,224
|
|
Travel and entertainment
|
|
|
-
|
|
|
|
-
|
|
Total applications development expense
|
|
|
294,150
|
|
|
|
324,575
|
|
Sales and Marketing
|
|
|
|
|
|
|
|
|
Wages
|
|
|
40,500
|
|
|
|
66,000
|
|
Payroll taxes and benefits
|
|
|
3,125
|
|
|
|
6,925
|
|
Overhead
|
|
|
16,391
|
|
|
|
14,357
|
|
Outside services
|
|
|
16,200
|
|
|
|
32,400
|
|
Travel and entertainment
|
|
|
20,097
|
|
|
|
32,409
|
|
Total sales and marketing expense
|
|
|
96,313
|
|
|
|
152,091
|
|
General and Administrative
|
|
|
|
|
|
|
|
|
Wages
|
|
|
242,098
|
|
|
|
339,378
|
|
Payroll taxes and benefits
|
|
|
152,769
|
|
|
|
163,292
|
|
Overhead
|
|
|
142,453
|
|
|
|
160,099
|
|
Outside services
|
|
|
453,257
|
|
|
|
633,244
|
|
Travel and entertainment
|
|
|
9,996
|
|
|
|
6,416
|
|
Total general and administrative expense
|
|
|
1,000,573
|
|
|
|
1,302,429
|
|
Depreciation and Amortization
|
|
|
31,057
|
|
|
|
40,163
|
|
Total loss from operations
|
|
|
(1,354,204
|
)
|
|
|
(1,791,014
|
)
|
|
|
|
|
|
|
|
|
|
OTHER INCOME (EXPENSE)
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
-
|
|
|
|
522
|
|
Interest expense
|
|
|
(38,684
|
)
|
|
|
(271,992
|
)
|
Change in fair market value of Series A warrants
|
|
|
-
|
|
|
|
(535,367
|
)
|
Net other income (expense)
|
|
|
568
|
|
|
|
(10,010
|
)
|
Total other income (expense)
|
|
|
(38,116
|
)
|
|
|
(816,847
|
)
|
|
|
|
|
|
|
|
|
|
NET LOSS BEFORE TAX
|
|
|
(1,392,320
|
)
|
|
|
(2,607,861
|
)
|
|
|
|
|
|
|
|
|
|
INCOME TAXES
(see note
12)
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
NET LOSS AFTER TAX
|
|
|
(1,392,320
|
)
|
|
|
(2,607,861
|
)
|
|
|
|
|
|
|
|
|
|
INCOME (LOSS) ATTRIBUTABLE TO NON-CONTROLLING INTEREST
|
|
|
-
|
|
|
|
1,054
|
|
|
|
|
|
|
|
|
|
|
NET LOSS ATTRIBUTABLE TO SHAREHOLDERS
|
|
$
|
(1,392,320
|
)
|
|
$
|
(2,606,807
|
)
|
|
|
|
|
|
|
|
|
|
Loss per share: basic and diluted
|
|
$
|
(0.02
|
)
|
|
$
|
(0.07
|
)
|
Weighted average shares outstanding
|
|
|
62,660,778
|
|
|
|
37,754,324
|
|
The accompanying notes are an integral part of these financial
statements.
ORYON TECHNOLOGIES,
INC. AND SUBSIDIARIES
Consolidated Statements
of Changes in Shareholders' Equity (Deficit)
For the Years Ended December 31, 2013 and 2012
|
|
Shares
|
|
|
Common
Stock, $0.001 par value
|
|
|
Paid
in Capital
|
|
|
Non-Controlling
Interest
|
|
|
Accumulated
Other Comprehensive Income (Loss)
|
|
|
Accumulated
Deficit
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31,
2011
|
|
|
16,502,121
|
|
|
$
|
16,502
|
|
|
$
|
5,365,181
|
|
|
$
|
(3,640
|
)
|
|
$
|
12,119
|
|
|
$
|
(8,069,326
|
)
|
|
$
|
(2,679,164
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Results for
the year ended December 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,054
|
)
|
|
|
|
|
|
|
(2,606,807
|
)
|
|
|
(2,607,861
|
)
|
Issuance of common stock,
financing transactions, pre-merger
|
|
|
1,450,000
|
|
|
|
1,450
|
|
|
|
723,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
725,000
|
|
Issuance of common stock,
financing transactions, post-merger
|
|
|
2,550,000
|
|
|
|
2,550
|
|
|
|
1,272,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,275,000
|
|
Merger consideration-pre-existing
shareholders
|
|
|
15,000,000
|
|
|
|
15,000
|
|
|
|
(15,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
Merger partner capital
accounts
|
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
(10,000
|
)
|
|
|
-
|
|
Issuance of common stock
in conversion of indebtedness
|
|
|
27,158,657
|
|
|
|
27,159
|
|
|
|
2,009,291
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,036,450
|
|
Issuance of warrants
|
|
|
|
|
|
|
|
|
|
|
32,565
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,565
|
|
Foreign currency translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
141
|
|
|
|
|
|
|
|
141
|
|
Liquidation of inactive
subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,694
|
|
|
|
(12,260
|
)
|
|
|
|
|
|
|
(7,566
|
)
|
Stock-based compensation
expense
|
|
|
|
|
|
|
|
|
|
|
192,780
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
192,780
|
|
Change in fair market
value of Series A warrants due to re-pricing
|
|
|
|
|
|
|
|
|
|
|
535,367
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
535,367
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December
31, 2012
|
|
|
62,660,778
|
|
|
$
|
62,661
|
|
|
$
|
10,126,184
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(10,686,133
|
)
|
|
|
(497,288
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Results for
the year ended December 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,392,320
|
)
|
|
|
(1,392,320
|
)
|
Stock-based
compensation expense
|
|
|
|
|
|
|
|
|
|
|
151,681
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
151,681
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at
December 31, 2013
|
|
|
62,660,778
|
|
|
$
|
62,661
|
|
|
$
|
10,277,865
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(12,078,453
|
)
|
|
$
|
(1,737,927
|
)
|
The accompanying notes are an integral part of these financial
statements.
ORYON TECHNOLOGIES, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
For the Years Ended December 31, 2013 and
2012
|
|
For the Year Ended December 31,
|
|
|
|
2013
|
|
|
2012
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,392,320
|
)
|
|
$
|
(2,606,807
|
)
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
Change in fair market value of Series A warrants due to re-pricing
|
|
|
-
|
|
|
|
535,367
|
|
Noncash interest expense on short-term notes
|
|
|
28,708
|
|
|
|
28,364
|
|
Noncash interest expense on notes payable
|
|
|
-
|
|
|
|
91,284
|
|
Noncash interest expense on warrants related to convertible notes
|
|
|
-
|
|
|
|
12,893
|
|
Noncash interest expense - beneficial conversion feature
|
|
|
-
|
|
|
|
136,074
|
|
Non-controlling interest
|
|
|
-
|
|
|
|
(1,054
|
)
|
Stock-based compensation expense
|
|
|
151,681
|
|
|
|
192,780
|
|
Issuance of convertible notes in lieu of rent
|
|
|
-
|
|
|
|
6,597
|
|
Issuance of noncash warrants other than convertible notes related
|
|
|
-
|
|
|
|
32,565
|
|
Depreciation and amortization
|
|
|
31,057
|
|
|
|
40,163
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable -decrease (increase)
|
|
|
(10,461
|
)
|
|
|
(9,615
|
)
|
Inventory - decrease (increase)
|
|
|
(3,475
|
)
|
|
|
(21,688
|
)
|
Other current assets - decrease (increase)
|
|
|
(9
|
)
|
|
|
(1,743
|
)
|
Other long-term assets - decrease (increase)
|
|
|
7,102
|
|
|
|
(2,967
|
)
|
Accounts payable - increase (decrease)
|
|
|
191,136
|
|
|
|
(136,979
|
)
|
Deferred revenues - increase (decrease)
|
|
|
(6,000
|
)
|
|
|
6,000
|
|
Deferred compensation - increase
|
|
|
220,306
|
|
|
|
202
|
|
Other current liabilities - increase (decrease)
|
|
|
(11,789
|
)
|
|
|
16,777
|
|
Due to affiliates - increase (decrease)
|
|
|
-
|
|
|
|
(14,487
|
)
|
Net cash used in operating activities
|
|
|
(794,064
|
)
|
|
|
(1,696,274
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
-
|
|
|
|
(10,962
|
)
|
Liquidation of inactive affiliates
|
|
|
-
|
|
|
|
(7,566
|
)
|
Net cash flows used in investing activities
|
|
|
-
|
|
|
|
(18,528
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Short-term advances
|
|
|
728,838
|
|
|
|
-
|
|
Proceeds from issuance of short-term notes payable
|
|
|
-
|
|
|
|
143,385
|
|
Cancellation of intercompany short-term notes due to merger
|
|
|
-
|
|
|
|
(325,000
|
)
|
Repayment of short-term notes payable
|
|
|
(59,711
|
)
|
|
|
(20,731
|
)
|
Proceeds from issuance of equity
|
|
|
-
|
|
|
|
2,000,000
|
|
Net cash provided by financing activities
|
|
|
669,127
|
|
|
|
1,797,654
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rates on changes in cash
|
|
|
-
|
|
|
|
141
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
(124,937
|
)
|
|
|
82,993
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, beginning of period
|
|
|
169,678
|
|
|
|
86,685
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents, end of period
|
|
$
|
44,741
|
|
|
$
|
169,678
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURES:
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$
|
9,237
|
|
|
$
|
3,377
|
|
Debt and accrued interest converted to equity
|
|
$
|
-
|
|
|
$
|
2,036,450
|
|
The accompanying notes are an integral part of these financial
statements.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
Organization and Basis of Presentation
OryonTechnologies, Inc. (“Oryon” or the “Company”)
has only one direct subsidiary, OryonTechnologies, LLC, a Texas limited liability company (“OTLLC”). The Company is
a developer of a patented electroluminescent (“EL”) lighting technology, trademarked as Elastolite
®
that enables thin, flexible, crushable, water-resistant lighting systems to be incorporated into multiple applications such as
safety apparel, sporting goods, consumer goods and membrane switches, among others. OTLLC is the parent of two wholly-owned companies:
OryonTechnologies Licensing, LLC (“OTLIC”) and OryonTechnologiesDevelopment, LLC (“OTD”), both of which
are also Texas limited liability companies.
OTLLC also previously owned OryonTechnologies International
Pte. Ltd. (“OTI”), a Singapore-based corporation. Operations at OTI were suspended in May 2009 and OTI was liquidated
in November 2012. The operations of OTI were not material to Oryon. OTI originally owned 51% of Oryon-Asia Pacific Safety, Limited
(“OAPS”), which was formed in December 2006 as a Hong Kong limited company. During 2011, the 51% ownership was transferred
to OTLLC. The other 49% of OAPS was owned by two non-affiliated individuals. Operations of OAPS were suspended in February 2011
and OAPS is in the final stage of liquidation. The operations of OAPS were not material to Oryon.
The accompanying audited financial statements of Oryon have
been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”)
and the rules of the Securities and Exchange Commission (“SEC”). Because a precise determination of many assets and
liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use
of estimates, which have been made using careful judgment. Actual results may vary from these estimates.
These financial statements have been prepared in accordance
with GAAP applicable to a going concern, which assume that the Company will be able to meet its obligations and continue its operations
for its next fiscal year. Realization values may be substantially different from carrying values as shown and these financial statements
do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should
the Company be unable to continue as a going concern.
At December 31, 2013, the Company had cash of $44,741 but had
not yet achieved profitable operations, had accumulated losses of $12,078,453 since its inception and expects to incur further
losses in the development of its business, all of which raises substantial doubt about the Company’s ability to continue
as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future
profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal
business operations when they come due.
The Company expects to continue to incur substantial losses
as it executes its business plan and does not expect to attain profitability in the near future. Since its inception, the Company
has funded operations through short-term borrowings and equity investments in order to meet its strategic objectives. The Company’s
future operations are dependent upon external funding and its ability to execute its business plan, realize sales and control expenses.
Management cannot guarantee that sufficient funding will be available from additional borrowings and equity placements to meet
its business objectives, including anticipated cash needs for working capital, for a reasonable period of time. There can be no
assurance that the Company will be able to obtain sufficient funds to continue the development of its business operation, or if
obtained, upon terms favorable to the Company.
These audited financial statements should be read in conjunction
with information provided in the Company’s Annual Report on Form 10-K. In the opinion of management, all adjustments, consisting
of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the
periods presented have been reflected herein.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
Corporate History and the Merger
The Company was incorporated under the laws of the State of
Nevada on August 22, 2007 with the name “Eaglecrest Resources, Inc.” and 100,000,000 authorized common shares with
a par value of $0.001. On August 6, 2010, the Company amended its Articles of Incorporation to increase its number of authorized
shares of common stock to 600,000,000 shares of common stock, par value of $0.006 per share. On November 4, 2011, the Company amended
its Articles of Incorporation to decrease the par value of its common stock from $0.006 to $0.001 per share. On November 25, 2011,
the Company amended its Articles of Incorporation to change its name from “Eaglecrest Resources, Inc.” to “Oryon
Holdings, Inc.” On May 5, 2012, the Company amended its Articles of Incorporation to change its name from “Oryon Holdings,
Inc.” to “Oryon Technologies, Inc.”
The Company was organized for the purpose of acquiring and developing
mineral properties. A mineral claim, with unknown reserves, was acquired in August 2007, became impaired in January 2008 and was
written off, and the Company had limited operations subsequently. The Company never established the existence of a commercially
minable ore deposit and therefore did not reach the exploration stage.
On October 24, 2011, the Company entered into a binding letter
of intent (“LOI”) with OTLLC in connection with a proposed reverse acquisition transaction (the “Merger”)
between the Company and OTLLC whereby OTLLC agreed to merge with Oryon Merger Sub, LLC, a Texas limited liability company and wholly-owned
subsidiary of the Company (“Merger Sub”), in exchange for the issuance to the members of OTLLC of eight (8) shares
of the Company’s common stock for each outstanding membership unit of OTLLC, which was equal to a total of 16,502,121 shares
(assuming that none of OTLLC’s existing Series C Notes were converted before the closing of the Merger).
In accordance with the terms of the LOI, the terms and conditions
of the Merger were thereafter set forth in a formal definitive agreement. To that end, on March 9, 2012, the Company entered into
an agreement and plan of merger by and between the Company, OTLLC and Merger Sub (the “Merger Agreement”). Upon the
closing of the Merger on May 4, 2012 (the “Closing Date”), OTLLC became a wholly-owned subsidiary of the Company, the
Company issued 16,502,121 shares of common stock to the members of OTLLC and the promissory notes receivable from OTLLC became
intercompany obligations within the corporate group (and have been cancelled).
In connection with the Merger, the Company received $2.0 million
in proceeds from the private equity offering, issuing 4.0 million shares of common stock, par value $0.001 (along with warrants
for the purchase an additional 4.0 million shares of common stock at the current exercise price of $0.50 per share and having a
term of five (5) years).
As a result of the Merger, the OTLLC members acquired the majority
of the Company’s issued and outstanding common stock, OTLLC became a wholly-owned subsidiary of the Company, and the Company
acquired the business and operations of OTLLC. In conjunction with the Merger, OTLLC assumed no liabilities from the Company and
all members of the Company’s executive management are from OTLLC. The Company filed a Current Report on Form 8-K, as amended,
dated May 4, 2012, describing the Merger and providing information concerning OTLLC.
The Merger was accounted for as a reverse-merger and recapitalization
in accordance with GAAP. OTLLC is deemed to be the acquirer for financial reporting purposes and the Company is the acquired company.
Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to
the Merger are those of OTLLC and are recorded at the historical cost basis of OTLLC, and the consolidated financial statements
after completion of the Merger include the assets and liabilities of the Company and OTLLC, historical operations of OTLLC and
operations of the Company from the Closing Date. Membership units and the corresponding capital amounts of OTLLC pre-Merger have
been retroactively restated as shares of common stock reflecting the eight (8) to one exchange ratio of the Merger. All references
in the financial statements and notes thereto to equity securities and all equity related historical financial measurements including
weighted average shares outstanding, earnings per share, par value of common stock, additional paid in capital, option exercise
prices and warrant exercise prices have been retroactively restated to reflect the Merger exchange ratio.
The Company’s common stock is quoted on the OTCQB tier
of the U.S. OTC Market under the symbol ORYN.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
1.
Significant Accounting Policies
Principles of Consolidation and Basis of Presentation
The Company uses the accrual method of accounting and all amounts
are denominated in United States dollars.
All significant intercompany accounts and transactions have
been eliminated in the consolidation.
Revenue Recognition
The Company recognizes revenue from products when the goods
are shipped pursuant to a customer’s purchase order. Revenue from royalties is recorded in the period in which the sales
of the underlying products are made. Revenue from license fees is recognized in the period in which they are due and payable.
Cost of Goods Sold
The Company recognizes costs of goods sold as including only
direct production costs such as direct materials, direct labor and freight and does not include any allocation of production overhead.
Use of Estimates
The preparation of the consolidated financial statements in
conformity with GAAP requires management to make estimates that affect the amounts reported in the consolidated financial statements
and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to
an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties.
All of these estimates reflect management’s judgment about current economic and market conditions and their effects based
on information available as of the date of these consolidated financial statements. If such conditions persist longer or deteriorate
further than expected, it is reasonably possible that the judgments and estimates could change, which may result in future impairments
of assets, among other effects.
Significant estimates include the carrying value of intangible
assets and the value of equity instruments, including convertible notes, stock options, warrants, and membership units issued in
lieu of cash.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash held in bank demand
deposits. The Company considers all highly liquid investments purchased with original maturities of three months or less to be
cash equivalents.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable are accounted for at fair value, do not
bear interest, and are short-term in nature. The Company maintains an allowance for doubtful accounts for estimated losses resulting
from the inability to collect on accounts receivable. Based on management’s assessment, the Company provides for estimated
uncollectible amounts through a charge to earnings and a credit to the valuation allowance. Balances that remain outstanding after
the Company has used reasonable collection efforts are written off through a charge to the valuation allowance and a credit to
accounts receivable. The Company does not require collateral.
Concentrations of Credit Risk
Certain balance sheet items that potentially subject the Company
to concentrations of credit risk are primarily accounts receivable. Concentrations of credit risk with accounts receivable are
generally mitigated by the size of the Company’s customers. The Company performs ongoing credit evaluations of its customers
and maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
Inventory
Inventory is carried at the lower of cost or market. A physical
inventory count is taken at the end of each calendar quarter and the accounting records are adjusted to match the physical inventory.
Property and Equipment
Property, equipment, computer hardware and software, and leasehold
improvements are carried at historical cost. Expenditures are capitalized only if the cost of the individual asset exceeds $1,200
and the asset is expected to have a business use for greater than 12 months.
Depreciation is calculated on a straight line basis over the
estimated useful life of the property acquired. Equipment and furniture is depreciated over 60 months. Computer software and hardware
is depreciated over 36 months. Leasehold improvements are amortized over the life of the lease or the life of the improvement,
whichever is shorter.
Research and Development
The Company expenses all costs associated with the development
of applications for the Company’s technology as the costs are incurred.
Intangible Assets
Amortization is computed based on the straight line method over
the life of the patent, which is 180 months beginning with the month when the patent is granted. The amortization is based on the
historical cost of each individual patent. Costs incurred to renew or extend the terms of patents are expensed as incurred.
The Company annually assesses whether the carrying value of
its intangible assets exceeds their fair value and records an impairment loss equal to any excess.
Income Taxes
Income taxes are accounted for under the asset and liability
method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax
assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected
to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rate is recognized in income
in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets
to the amounts more likely than not to be realized.
The Company accounts for uncertain tax
positions in accordance with ASC 740-10. ASC 740-10 provides several clarifications related to uncertain tax positions. Most notably,
a “more likely-than-not” standard for initial recognition of tax positions, a presumption of audit detection and a
measurement of recognized tax benefits based on the largest amount that has a greater than 50 percent likelihood of realization.
ASC 740-10 applies a two-step process to determine the amount of tax benefit to be recognized in the financial statements. First,
the Company must determine whether any amount of the tax benefit may be recognized. Second, the Company determines how much of
the tax benefit should be recognized (this would only apply to tax positions that qualify for recognition.) No additional liabilities
have been recognized as a result of the implementation. Accordingly, the Company has not recognized any penalty, interest or tax
impact related to uncertain tax positions. Federal returns for tax years ended December 31, 2009 and after remain open to examination
as of December 31, 2013. The statute of limitations differ from state to state; however, generally tax years ended December 31,
2009 and after remain open to state examination as of December 31, 2013.
OTI and OAPS are not consolidated into
the Company for purposes of United States tax filings and computations. OTLLC, OTD and OTLIC are limited liability companies and,
as such, do not pay federal or state income taxes. Accordingly, no taxes have been accrued on the Company’s records for periods
prior to the Merger.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
Stock-Based Compensation
The Company utilizes equity based awards as a form of compensation
for employees, consultants, officers and directors. The Company records compensation expense for all awards granted. After having
assessed alternative valuation models and amortization methods, the Company uses the Black-Scholes valuation model and straight-line
amortization of compensation expense over the requisite service period for each grant. The Company will reconsider use of this
model if additional information becomes available in the future that indicates another model would be more appropriate or if grants
issued in future periods have characteristics that cannot be reasonably estimated using this model.
Leases
The Company leases office facilities under a non-cancelable
operating lease. The Company recognizes rent on a straight-line basis over the lease term.
2.
Inventory
Inventory consists of the following:
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2013
|
|
|
2012
|
|
Raw materials
|
|
$
|
88,486
|
|
|
$
|
95,732
|
|
Work in process
|
|
|
6,028
|
|
|
|
-
|
|
Finished goods
|
|
|
6,417
|
|
|
|
884
|
|
Customer projects in process
|
|
|
-
|
|
|
|
840
|
|
Total Inventory
|
|
$
|
100,931
|
|
|
$
|
97,456
|
|
3.
Property and Equipment
Property and equipment consist of the following:
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2013
|
|
|
2012
|
|
|
|
|
|
|
|
|
Leasehold improvements
|
|
$
|
7,279
|
|
|
$
|
7,279
|
|
Furniture and equipment
|
|
|
195,927
|
|
|
|
195,927
|
|
Property and equipment, gross
|
|
|
203,206
|
|
|
|
203,206
|
|
Accumulated depreciation
|
|
|
(189,470
|
)
|
|
|
(181,498
|
)
|
Net property and equipment
|
|
$
|
13,736
|
|
|
$
|
21,708
|
|
Depreciation expense was $7,972 and $17,080 for the years ended
December 31, 2013 and 2012, respectively.
4.
Intangible Assets
As of December 31, 2013 and December 31, 2012, the Company’s
only intangible assets consisted of patents with a gross carrying cost of $320,795 and accumulated amortization of $206,143 and
$183,059, respectively. The remaining weighted average amortization period was 5.0 years at December 31, 2013. The estimated aggregate
amortization expense in each of the years ending December 31, 2014 through December 31, 2016, is $23,083 per year.
The balances as of December 31, 2013, including intangible assets
and accumulated amortization, are detailed as follows:
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
As of December 31, 2013
|
Finite-Lived Intangible Assets
|
|
Amortization Period
(Years)
|
|
|
Gross Carrying
Amount
|
|
|
Accumulated
Amortization
|
|
|
Net
|
|
Patents
|
|
|
15
|
|
|
$
|
320,795
|
|
|
$
|
(206,143
|
)
|
|
$
|
114,652
|
|
The balances as of December 31, 2012, including intangible assets
and accumulated amortization, are detailed as follows:
As of December 31, 2012
|
Finite-Lived Intangible Assets
|
|
Amortization Period
(Years)
|
|
|
Gross Carrying
Amount
|
|
|
Accumulated
Amortization
|
|
|
Net
|
|
Patents
|
|
|
15
|
|
|
$
|
320,795
|
|
|
$
|
(183,059
|
)
|
|
$
|
137,736
|
|
Amortization expense for each of years ended December 31, 2013
and 2012 was $23,083.
5.
Other Long Term Assets
Other long term assets consist of the following:
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2013
|
|
|
2012
|
|
Investment in subsidiaries
|
|
$
|
100
|
|
|
$
|
100
|
|
Other receivables
|
|
|
-
|
|
|
|
7,102
|
|
Security deposits
|
|
|
6,597
|
|
|
|
6,597
|
|
Licenses
|
|
|
10,000
|
|
|
|
10,000
|
|
Total other assets
|
|
$
|
16,697
|
|
|
$
|
23,799
|
|
6.
Deferred Compensation
Deferred compensation consists of the following:
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2013
|
|
|
2012
|
|
Deferred wages
|
|
$
|
231,104
|
|
|
$
|
112,979
|
|
Deferred directors' fees
|
|
|
117,500
|
|
|
|
45,000
|
|
Accrued unpaid wages
|
|
|
20,227
|
|
|
|
-
|
|
Accrued taxes on deferred wages
|
|
|
18,142
|
|
|
|
8,688
|
|
Total deferred compensation
|
|
$
|
386,973
|
|
|
$
|
166,667
|
|
Prior to August 31, 2011, the Company was obligated to issue
membership units to certain senior level employees in lieu of cash wages in connection with employment agreements with those employees.
The employment agreements provided that the employees would receive membership units in lieu of cash compensation until such time
as the Company obtains sufficient capital (as defined in the agreements) to begin paying their agreed-upon compensation in cash.
The obligation for additional issuances was accrued each pay period and the Company was obligated to issue the membership units
at the beginning of each calendar quarter, provided that the employee was still employed by the Company.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
As of December 31, 2010, the Company was obligated to issue
membership units in lieu of $99,094 in wages for the year ended December 31, 2010, (issuable on the first day of the subsequent
quarter) and $13,163 in wages for the year ended December 31, 2009. Accordingly, a total of 898,056 shares were issued on January
1, 2011 at a value of $0.125 per share. An additional 1,553,776 shares were issued on October 1, 2011 at a value of $0.125 per
share under the employment agreements in lieu of compensation earned between January 1, 2011 and August 31, 2011, for a total of
2,451,832 shares issued in 2011 in lieu of cash wages to employees. In addition, 40,000 shares were issued to a former consultant
in settlement for $5,000 in unpaid compensation on December 15, 2011.
Effective September 1, 2011, the agreements were revised to
provide for the indefinite deferral of unpaid wages until sufficient external funding was obtained. Deferred wages due to employees
at December 31, 2013 and December 31, 2012 were $231,104 and $112,979, respectively.
In November 2012, the Compensation Committee
of the Board of Directors and the Board of Directors both approved a program of compensation for independent directors to compensate
non-management directors for their services. Management directors receive no compensation for board service. Compensation for independent
director services was established as $5,000 per calendar quarter, due at the end of each calendar quarter for services rendered
during such period. In addition, the chairman of the Audit Committee receives extra compensation of $1,875 per calendar quarter
and the chairman of the Compensation Committee receives extra compensation of $1,250 per calendar quarter. However, payment of
cash compensation for director services has been deferred by the Board of Directors through December 31, 2013. Directors are not
paid for meetings attended.
7.
Other Short-Term Debt
Other short-term debt consists of the following:
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2013
|
|
|
2012
|
|
Current portion, promissory notes payable
|
|
$
|
53,738
|
|
|
$
|
37,500
|
|
Other short-term debt
|
|
|
318,395
|
|
|
|
322,145
|
|
Short-term advances
|
|
|
706,670
|
|
|
|
-
|
|
Accrued interest
|
|
|
70,718
|
|
|
|
42,010
|
|
Total
|
|
$
|
1,149,521
|
|
|
$
|
401,655
|
|
“Current portion, promissory notes payable”
In December 2012, the Company executed a promissory note (the
“Note”) payable to a former executive and current shareholder in order to consolidate its various obligations to such
individual into a single instrument. The Note had an original balance of $211,418 and matures on September 16, 2016. Interest on
the Note is incurred at WSJPrime plus one percent per annum, which has resulted in a constant interest rate of 4.25% through September
30, 2013. The Note requires monthly principal and interest payments of (a) $3,000 through September 30, 2013, (b) $4,500 from October
1, 2013 through September 30, 2014, (c) $6,000 from October 1, 2014 through September 30, 2015, (d) $7,500 from October 1, 2015
through September 30, 2016 and (e) all remaining principal on September 30, 2016. Through December 31, 2013, the Company has made
$54,000 in payments, consisting of $43,524 in principal (principal repayments of $9,731 in the last quarter of 2012, and $33,793
in 2013) and $10,476 in interest (interest expense of $2,269 in the last quarter of 2012 and $8,207 in 2013). At December 31, 2013,
accrued but unpaid interest was $—0—. The remaining Note principal balance was $167,894 at December 31, 2013, of which
$53,738 is expected to be paid in the twelve months ending December 31, 2014, and is classified as the current portion of promissory
notes payable in the table above. The remaining $114,156 principal balance has been classified as long term notes payable as of
December 31, 2013.
“Other short-term debt” and “Accrued interest”
During the year ended December 31, 2011, OTLLC was unable to
complete a financing deal with a private equity firm that had been expected to provide OTLLC with adequate capital. To fund continuing
operations at a reduced level of expenditures, OTLLC received temporary funding from several sources. The Company has since repaid
one source in full and the Company’s remaining obligation is included in the table above in Other Short-Term Debt. During
2013, the Company made payments totaling $3,750 on this obligation so that, as of December 31, 2013, $31,250 remained payable.
In addition, a vendor previously required that the outstanding accounts payable balance of $287,145 be converted to a promissory
note. Such note accrues interest at 10% annually ($70,718 accrued through December 31, 2013) and is payable upon demand. This note
matured on December 15, 2011 and management has engaged in negotiations with the vendor to extend the note or replace it with a
new promissory note.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
“Short-term advances”
During 2013, the Company’s operating cash flow and available
cash were inadequate to fund operations. While management attempted to raise permanent external financing, certain outside parties
agreed to advance the Company a limited amount of working capital funds to allow the Company to survive until permanent financing
was secured.
In connection with the Merger, the Company received $2.0 million
in proceeds from the private equity offering, issuing 4.0 million shares of common stock, par value $0.001 (along with warrants
for the purchase an additional 4.0 million shares of common stock at the current exercise price of $0.50 per share and having a
term of five (5) years). In the first nine months of 2013, investors holding certain of the warrants provided the Company with
$390,000 in working capital funding by providing interim advances to the Company against the exercise of their warrants at a future
time of the investors’ choice. The balance of those short-term advances was $390,000 as of December 31, 2013. No timing for
the exercise of the warrants has been determined.
The total amount of temporary short-term advances to the Company
in 2013 consisted of $728,838, including the $390,000 discussed above, $310,670 from EFL Tech N.V., and $28,168 from senior officers
of the Company (of which $6,000 remained unpaid at December 31, 2013). At December 31, 2013, the remaining unpaid balance of short-term
advances was $706,670.
Information regarding historical indebtedness
In October 2011, OTLLC signed a binding
letter of intent to negotiate a merger agreement with the Company. Through December 31, 2011, in connection with the letter of
intent, OTLLC issued promissory notes to the Company in the amount of $325,000 in connection with the advance by the Company to
OTLLC of $325,000. The funds for this advance were obtained by the Company pursuant to a private offering whereby for each dollar
invested, the investor(s) making such investment would be issued two (2) shares of common stock of the Company and a warrant to
purchase two (2) shares of common stock of the Company with a current exercise price of $0.50 per share and a term of five (5)
years. The proceeds of the private offering through December 31, 2011, resulted in the obligation to issue 650,000 shares of common
stock (along with warrants for the purchase of an additional 650,000 shares of common stock at a current exercise price of $0.50
per share).
During the three months ended March 31, 2012, OTLLC issued additional
promissory notes to the Company in the amount of $200,000 in connection with the advance by the Company to OTLLC of $200,000, for
a total cumulative amount of $525,000 of promissory notes as of March 31, 2012. In April 2012, OTLLC issued additional promissory
notes to the Company in the amount of $200,000 in connection with the advance by the Company to OTLLC of an additional $200,000,
for a total cumulative amount of $725,000 of promissory notes as of April 30, 2012, and the Closing Date. The funds for these advances
were obtained by OTLLC pursuant to the private offering described above. At the Closing Date and April 30, 2012, $725,000 was included
on the Company’s balance sheet as notes receivable from OTLLC. Subsequent to April 30, 2012, upon the closing of the Merger
on May 4, 2012, all of the promissory notes receivable became intercompany transactions within the consolidated corporate group
and were cancelled.
The proceeds of the private offering between December 31, 2011
and the Closing Date resulted in the obligation to issue 800,000 shares of common stock (along with warrants for the purchase of
an additional 800,000 shares of common stock at the current exercise price of $0.50 per share and a term of five (5) years) in
addition to the obligation to issue 650,000 shares of common stock (along with warrants for the purchase of an additional 650,000
shares of common stock at the current exercise price of $0.50 per share) that existed at December 31, 2011. Of the resulting cumulative
total of 1,450,000 shares that the Company was obligated to issue pursuant to the private offering through April 30, 2012 and the
Closing Date, 800,000 shares (along with the warrants for the purchase of 800,000 additional shares at the current exercise price
of $0.50 per share and a term of five (5) years) were issued on March 12, 2012, so that as of April 30, 2012 and the Closing Date,
the net amount of 650,000 shares (along with warrants for the purchase of an additional 650,000 shares at the current exercise
price of $0.50 per share) remained to be issued by the Company to fulfill subscriptions in an aggregate amount of $325,000.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
8.
Other Current Liabilities
Other current liabilities at December 31, 2013, and December
31, 2012, consist of accrued corporate operating expenses as estimated by management, including accruals for legal, tax return,
office overhead and accounting expenses.
9.
Notes Payable
At December 31, 2013, notes payable of $114,156 consists entirely
of the non-current portion of the promissory notes payable as described above in Note 7, “Current Portion of Promissory Notes
and Other Short-Term Debt”.
The Company, through its wholly-owned subsidiary OTLLC, had
three outstanding series of convertible notes (the Series C-1 notes, the Series C-2 notes, and the Series C-3 notes, collectively
the “Notes”) with a combined total principal obligation of $0 and $2,579,220 at December 31, 2012 and December 31,
2011, respectively. Accrued interest on the Notes as of December 31, 2012 and December 31, 2011, were $0 and $139,727, respectively,
resulting in a total obligation of $0 and $2,718,947 as of December 31, 2012 and December 31, 2011, respectively. Each series of
Notes was convertible under certain circumstances into the Company’s common stock at different conversion rates. On August
31, 2012, as a result of the completion of a “Qualified Financing” as defined in the Notes and as modified by the Group
Modification Agreement approved by the holders of the Notes in March 2012, the Notes and accumulated accrued interest through August
31, 2012, were converted into 27,158,657 shares of the Company’s common stock (the “Conversion”).
Following the Conversion on August 31, 2012, none of the principal
and interest of the Notes remained outstanding, but the holders of the Notes retained the detachable warrants to purchase common
stock at $0.3125 per share that they had received in connection with their investment in the Notes. The following table shows the
number of shares of common stock that would have been issued if all the warrants related to the Notes were exercised as of December
31, 2013 or December 31, 2012:
As of December 31, 2013 and December 31, 2012
|
Convertible Debt
|
|
Conversion
Price
|
|
|
Principal and Interest
Amounts
|
|
|
Potential Shares Issued if
Notes Converted
|
|
|
Shares Issued if Series C
Warrants Exercised @
$0.3125
|
|
Series C-1 Notes
|
|
|
N/A
|
|
|
$
|
-
|
|
|
|
-
|
|
|
|
2,841,440
|
|
Series C-2 Notes
|
|
|
N/A
|
|
|
|
-
|
|
|
|
-
|
|
|
|
3,200,000
|
|
Series C-3 Notes
|
|
|
N/A
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,972,000
|
|
|
|
|
|
|
|
$
|
-
|
|
|
|
-
|
|
|
|
8,013,440
|
|
The Company has not included these share equivalents in earnings
per share calculations as they are anti-dilutive.
Interest on the Notes accrued at the rate of 5% per annum, compounded
annually, and was payable at the election of the Company on the last day of each calendar quarter. Accrued but unpaid interest
was added to the principal. Accrued and unpaid interest was converted to shares of common stock when the related Note principal
was converted to common stock effective August 31, 2012. The Notes were secured by substantially all assets of OTLLC, and, as a
result of the Conversion, the lien on such assets was automatically removed.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
The Series C-1 convertible notes, issued in exchange for the
Series A convertible notes, were determined to have an embedded beneficial conversion feature under the provisions of ASC 470-20,
“
Debt with Conversion and Other Options
” based on the November 2010 market value of $1 per share and an exercise
price of $.50 per share. In accordance with ASC470-20, an embedded conversion feature present in a convertible instrument shall
be recognized separately at issuance by allocating a portion of the proceeds equal to the intrinsic value of that feature to additional
paid-in capital. A discount of $972,070 was recorded at November 2010 for the Series C-1 convertible note issuances and amortization
expense recognized in the amounts of $136,074 and $103,472 for the years ended December 31, 2012, and 2011, respectively. On August
31, 2012, in conjunction with the Conversion, the unamortized discount balance of $731,199 was written off. The unamortized discount
balance as of December 31, 2012 was $—0—.
10.
Leases
The Company’s only lease is for its office and production
facility, consisting of approximately 9,957 square feet in a building located at 4251 Kellway Circle in Addison Texas. The Company
is obligated to pay $6,597 per month through March 31, 2016. The Company began leasing its current facilities in April 2010 under
an operating lease that extends through March 2016.
In August 2011 the Company reached an agreement with the lessor
to issue Series C-3 notes as payment for the July 2011 through January 2012 rent. The Company also agreed to issue an additional
$30,000 Series C-3 convertible note in exchange for the lessor’s acceptance of such agreement. This payment was amortized
over the 7 months of rent paid by the note, increasing rent expense by $12,800 during the year ended December 31, 2011 (for the
July – September 2011 amortization) and $4,300 for the year ended December 31, 2012 (for the January 2012 amortization).
Rent expense relating to the operating lease agreement was $77,860
(including a rent reduction due to utility under-utilization of $2,014, partially offset by late payment fees of $710) and $83,464
for the years ended December 31, 2013 and 2012, respectively.
As of December 31, 2013, the future minimum payments required
under all operating leases with terms in excess of one year were as follows:
For the year ending December 31,
|
|
Amount
|
|
2014
|
|
|
79,164
|
|
2015
|
|
|
79,164
|
|
2016
|
|
|
19,791
|
|
2017
|
|
|
-
|
|
|
|
$
|
178,119
|
|
11.
Commitments and Contingencies
From time to time, the Company is engaged in various legal proceedings
that are routine in nature and incidental to its business. At this time, there are no legal proceedings to which the Company is
a party nor, to management’s knowledge, are any material legal proceedings contemplated.
As of December 31, 2013, only one of the Company’s employees
was covered by an employment agreement. In general, the employment agreement contains non-compete provisions ranging from nine
months to one year following the term of the applicable agreement.
12.
Income Taxes
The tax effects of significant items comprising the Company’s
net deferred tax assets and liabilities at December 31, 2013 are as follows:
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
|
|
December 31, 2013
|
|
|
|
|
|
Net operating loss carryforwards
|
|
$
|
738,641
|
|
|
|
|
|
|
Depreciation
|
|
|
(2,838
|
)
|
|
|
|
|
|
Amortization
|
|
|
11,178
|
|
|
|
|
|
|
Accrued miscellaneous
|
|
|
100,886
|
|
|
|
|
|
|
FMV warrants adjustment
|
|
|
182,025
|
|
|
|
|
|
|
Stock option compensation expense
|
|
|
115,040
|
|
|
|
|
|
|
Interest amortization
|
|
|
33,178
|
|
|
|
|
|
|
Total current deferred tax asset
|
|
|
1,178,110
|
|
|
|
|
|
|
Less: Valuation alllowance
|
|
|
(1,178,110
|
)
|
|
|
|
|
|
Net current deferred tax asset
|
|
$
|
-
|
|
The components of the provision for federal
incomes taxes for the years ended December 31, 2013 and 2012 are as follows:
|
|
2013
|
|
|
2012
|
|
|
|
|
|
|
|
|
Current income tax benefit (expense)
|
|
|
-
|
|
|
|
-
|
|
Deferred income tax benefit (expense)
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
-
|
|
The Company’s effective income tax
rate differed from the U. S. Federal statutory rate as follows:
|
|
2013
|
|
|
2012
|
|
U.S. Federal statutory rate
|
|
|
34.00
|
%
|
|
|
34.00
|
%
|
Permanent differences
|
|
|
-0.05
|
%
|
|
|
-0.03
|
%
|
Valuation allowance
|
|
|
-33.95
|
%
|
|
|
-33.97
|
%
|
States Taxes
|
|
|
0.00
|
%
|
|
|
0.00
|
%
|
State Deferred Tax Asset Adjustment
|
|
|
0.00
|
%
|
|
|
0.00
|
%
|
Other
|
|
|
0.00
|
%
|
|
|
0.00
|
%
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
0.00
|
%
|
|
|
0.00
|
%
|
The Company has net operating loss carry
forwards of approximately $2,172,000 at December 31, 2013, which begin expiring in 2030. In assessing the reliability of deferred
tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not
be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during periods
in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities,
projected future taxable income and tax planning strategies in making this assessment. Management has recorded a valuation allowance
for all deferred tax assets at December 31, 2013.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
The Company has filed its tax returns as
a corporation since inception. OTLLC is a limited liability company and, as such, does not pay income taxes. Prior to the Merger,
OTLLC filed separate tax returns for each subsidiary that is a limited liability company and provided the applicable investors
with appropriate personally individualized documentation. All returns for OTLLC, OTD and OTLIC are current through the 2012 tax
year, including the partial year return for OTLLC for operations through the date of the Merger.
OTI was taxed in Singapore. All returns for OTI are current.
OTI generated substantial tax losses during its existence and therefore received a tax refund of $5,181 in 2011 for estimated taxes
paid prior to 2009. No anticipated tax liability existed at December 31, 2013.
OAPS was taxed in Hong Kong. All returns for OAPS are current.
OAPS generated substantial tax losses during its existence and no anticipated tax liability existed at December 31, 2013.
13.
Capital
The Company was incorporated under the laws of the State of
Nevada on August 22, 2007 with 100,000,000 authorized common shares with a par value of $0.001. On August 6, 2010, the Company
effected a forward split of its shares of common stock on the basis of six new shares for one existing share, and amended its Articles
of Incorporation to increase its number of authorized shares of common stock to 600,000,000 shares of common stock, with a par
value of $0.006 per share. On October 31, 2011, certain shareholders, including two executive officers, surrendered, in aggregate,
30,000,000 shares of the Company’s common stock for cancellation. On November 17, 2011, an additional 1,000,000 shares were
surrendered for cancellation. On November 4, 2011, the Board of Directors reduced the par value of the common shares from $0.006
to $0.001 per share. As of December 31, 2011 and January 31, 2012, 29,000,000 post-split common shares were issued and outstanding.
The post-split common shares are shown as split from the date of inception. On April 19 and 30, 2012, certain shareholders surrendered
for cancellation, in aggregate, an additional 14,000,000 shares of the Company’s common stock, leaving the remaining number
of 15,000,000 post-split common shares.
During the year ended December 31, 2011, the Company entered
into subscription agreements for units of the Company, at $0.50 per unit. The subscription agreements were in connection with the
financing agreement (the “Financing Agreement”) that the Company signed on November 2, 2011, with Maxum Overseas Fund
(“Maxum”) under which Maxum agreed to: (i) invest $100,000 in the common equity of the Company and (ii) either invest
an additional amount up to $1,900,000 in the common equity of the Company or assist the Company in securing all or a portion of
such $1,900,000 investment from alternate sources. Under the terms of the Financing Agreement, for each dollar invested, the investor(s)
making such investment will be issued two (2) shares of common stock of the Company and a warrant to purchase two (2) shares of
common stock of the Company with a current exercise price of $0.50 per share and a term of five (5) years.
At both December 31, 2011 and January 31, 2012, the Company
had received $325,000 for subscriptions representing the obligation to issue 650,000 shares (along with warrants having the right
to purchase an additional 650,000 shares, each with the current exercise price of $0.50 per share and a term of five years).
During the three months ended March 31, 2012, the Company received
an additional $200,000 in subscriptions pursuant to the Financing Agreement representing the obligation to issue 400,000 shares
(along with warrants having the right to purchase an additional 400,000 shares, each with the current exercise price of $0.50 per
share and a term of five years). In April 2012, the Company received an additional $200,000 in subscriptions pursuant to the Financing
Agreement representing the obligation to issue an additional 400,000 shares (along with warrants having the right to purchase an
additional 400,000 shares, each with the current exercise price of $0.50 per share and a term of five years). The cumulative result
of the subscriptions through April 30, 2012 and the Closing Date was the obligation to issue 1,450,000 shares (650,000 for subscriptions
prior to December 31, 2011 plus 800,000 for subscriptions between January 1 and April 30, 2012) along with warrants having a five
(5) year term to purchase 1,450,000 shares at the current exercise price of $0.50 per share. On March 12, 2012, the Company fulfilled
subscription agreements in the aggregate amount of $400,000 resulting in the issuance of 800,000 shares of common stock (along
with warrants having a five (5) year term to purchase an additional 800,000 shares at the current exercise price of $0.50 per share).
As a result, as of April 30, 2012, the Company had the remaining obligation to fulfill $325,000 in subscriptions to issue the 650,000
shares (along with warrants having the right to purchase an additional 650,000 shares, each with a current exercise price of $0.50
per share and a five (5) year term). Using the Black-Scholes stock price valuation model, $90,535 of the $400,000 proceeds related
to the issued equity securities was allocated to the issuance of the warrants to purchase 800,000 shares.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
On May 10, 2012 and May 15, 2012, the Company received a total
of $775,000 from subscriptions resulting in the obligation to issue an aggregate of an additional 1,550,000 shares of common stock
(along with warrants having the right to purchase 1,550,000 additional common shares, each with a current exercise price of at
$0.50 per share).
On March 19, 2012, the Company amended its Articles of Incorporation
to authorize 50,000,000 shares of preferred stock, par value $0.001 per share. The Company’s shareholders approved the Restated
Articles at a special meeting of shareholders held on March 19, 2012. No preferred stock has been subscribed for or issued as of
the date hereof.
At April 30, 2012, 15,800,000 shares of common stock were issued
and outstanding, consisting of the 15,000,000 post-split common shares plus the 800,000 shares issued in the fulfillment of the
$400,000 in subscriptions on March 12, 2012. At the Closing of the Merger on May 4, 2012, the Company issued 16,502,121 additional
shares to the former OTLLC members.
In June 2012, an additional 2,200,000 shares were issued in
the fulfillment of the $1,100,000 in the remaining subscriptions received but had not yet been fulfilled. On August 31, 2012, the
Conversion of the Notes (see Note 9) required the Company to issue 27,158,657 shares of common stock to the holders of the Notes.
In September 2012, an additional 1,000,000 shares were issued in the fulfillment of the $500,000 in subscriptions received during
July and August. There were 62,660,778 common shares outstanding as of December 31 of both 2013 and 2012.
14.
Equity Options and Warrants
Stock Options
OTLLC adopted the 2004 Unit Option Plan under which officers,
employees, advisors and managers could be awarded membership unit option grants. Under the 2004 Unit Option Plan, OTLLC’s
board could fix the term and vesting schedule of each option. Vested options generally could remain exercisable for up to three
months after a participant’s termination of service or up to 12 months after a participant’s death or disability. Typically,
the exercise price of a nonqualified option must not be less than the fair market value of the units on the grant date. The exercise
price of each unit option granted under the 2004 Plan must be paid in cash when the option is exercised. Generally, options are
not transferable except by will or the laws of descent and distribution.
In connection with the Merger, the Company’s Board of
Directors adopted the 2012 Equity Incentive Plan, previously filed as Exhibit 99.1 to the Company’s Current Report on Form
8-K filed on March 21, 2012. In connection with the Merger, each currently outstanding option to purchase an OTLLC unit was converted
into an option to purchase eight (8) shares of the Company’s common stock under the Company’s 2012 Equity Incentive
Plan. Immediately prior to Closing, there were 345,388 options to purchase OTLLC units outstanding, which, if exercised could result
in the issuance of 2,763,104 shares of the Company’s common stock at prices ranging from $0.13 per share to $0.63 per share.
In January 2012, options for 400,000 shares, exercisable at
$0.125 per share, with 25% annual vesting, were granted.
On May 4, 2012, the date of the closing of the Merger, all of
the unvested options (except for the 400,000 granted in January 2012) became fully vested because the Merger was a “change
of control” as defined in the 2004 Unit Option Plan.
In September 2012, an option for 500,000 shares, exercisable
at $0.745 per share, with 50% vested immediately and 50% vested on the first anniversary of the grant date, was granted to the
Company’s chief executive officer under the 2012 Equity Incentive Plan. The grant date fair market value of this option grant
was $114,534 of which $77,838 was expensed in 2012.
On November 6, 2012, non-executive directors were issued options
for 266,667 shares, exercisable at $0.395 per share, 100% vested on the grant date, as compensation for such independent directors’
prior service. The grant date fair market value of these option grants was $33,765, all of which was expensed in 2012.
On January 16, 2013, options for 423,796 shares were granted
to employees and consultants for past services rendered, exercisable at $0.3425 per share and 100% vested on the grant date. The
aggregate grant date fair market value of these option grants was $44,320, which was expensed in the first quarter of 2013.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
In September 2013, an option for 500,000 shares, exercisable
at $0.1096 per share, with 100% vested on the first anniversary of the grant date, was granted to the Company’s chief executive
officer under the 2012 Equity Incentive Plan. The grant date fair market value of this option grant was $18,820 of which $6,016
was expensed in 2013.
On May 2, 2013, non-executive directors were issued options
for 300,000 shares, exercisable at $0.21 per share, 100% vested on the grant date, as compensation for such independent directors’
prior service. The $19,590 grant date fair market value of these option grants was expensed in the second quarter of 2013.
On November 2, 2013, non-executive directors were issued options
for 300,000 shares, exercisable at $0.0418 per share, 100% vested on the grant date, as compensation for such independent directors’
prior service. The grant date fair market value of these option grants was $3,687, all of which was expensed in the fourth quarter
of 2013.
As of December 31, 2013, there were options exercisable for
5,897,274 shares outstanding at an average exercise price of $0.207 per share, consisting of fully vested options for 5,397,274
shares at an average exercise price of $0.216 per share and an unvested option for 500,000 shares at an average exercise price
of $0.1096 per share.
The Company has used the modified Black-Scholes model to estimate
the fair value of employee options on the date of grant utilizing the assumptions noted below. The risk-free rate is based on the
U.S. Treasury bill yield curve in effect at the time of grant for the expected term of the option. The expected term of options
granted represents the period of time that the options are expected to be outstanding. Expected volatilities are based on historical
volatilities of selected technology stock mutual funds. The dividend yield was zero since the Company will not be paying dividends
for the foreseeable future. For stock option grants in 2013, the following assumptions were used:
Range of risk-free interest rates
|
|
|
0.650% – 3.018%
|
|
Expected term of options in years
|
|
|
5.003 – 10.006
|
|
Range of expected volatility
|
|
|
30.68% – 35.05%
|
|
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
A summary of option activity for the years ended December 31,
2013 and December 31, 2012, follows:
|
|
For the year ended December 31,
|
|
|
|
2013
|
|
|
2012
|
|
|
|
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at the beginning of the year
|
|
|
3,529,771
|
|
|
$
|
0.275
|
|
|
|
2,363,104
|
|
|
$
|
0.188
|
|
Granted
|
|
|
2,607,503
|
|
|
$
|
0.125
|
|
|
|
1,166,667
|
|
|
$
|
0.452
|
|
Exercised
|
|
|
-
|
|
|
$
|
-
|
|
|
|
-
|
|
|
$
|
-
|
|
Forfeited and expired
|
|
|
(240,000
|
)
|
|
$
|
0.311
|
|
|
|
-
|
|
|
$
|
-
|
|
Outstanding at the end of the year
|
|
|
5,897,274
|
|
|
$
|
0.207
|
|
|
|
3,529,771
|
|
|
$
|
0.275
|
|
Exercisable at the end of the year
|
|
|
5,397,274
|
|
|
$
|
0.216
|
|
|
|
2,879,771
|
|
|
$
|
0.255
|
|
The Company recognized total compensation expense related to
the stock options (excluding independent director option grants) of $128,404 and $159,014 for the years ended December 31, 2013,
and 2012, respectively. The acceleration of the vesting of unvested options as a result of the change in control that occurred
on the Closing of the Merger on May 4, 2012, significantly increased the option compensation expense in the first half of 2012.
Compensation expense is included in selling, general and administrative expenses in the consolidated statement of operations. Total
unrecognized compensation expense related to unvested unit options was $12,804 and $46,143 at December 31, 2013 and 2012, respectively.
The weighted average grant date fair value of share options
granted during the year ended December 31, 2013, was $0.054 per share.
Common stock options outstanding and exercisable at December
31, 2013, were as follows:
As of December 31, 2013
|
|
|
|
|
Options Outstanding
|
|
|
Options Exercisable
|
|
Exercise Prices
|
|
|
Number Outstanding
|
|
|
Weighted Average
Years of Remaining
Contractual Life
|
|
|
Number
Outstanding
|
|
$
|
0.030
|
|
|
|
765,000
|
|
|
|
10.01
|
|
|
|
765,000
|
|
$
|
0.042
|
|
|
|
300,000
|
|
|
|
9.84
|
|
|
|
300,000
|
|
$
|
0.080
|
|
|
|
227,500
|
|
|
|
9.75
|
|
|
|
227,500
|
|
$
|
0.110
|
|
|
|
500,000
|
|
|
|
9.69
|
|
|
|
-
|
|
$
|
0.125
|
|
|
|
1,943,104
|
|
|
|
6.88
|
|
|
|
1,943,104
|
|
$
|
0.153
|
|
|
|
53,922
|
|
|
|
9.50
|
|
|
|
53,922
|
|
$
|
0.185
|
|
|
|
81,081
|
|
|
|
9.35
|
|
|
|
81,081
|
|
$
|
0.210
|
|
|
|
300,000
|
|
|
|
9.34
|
|
|
|
300,000
|
|
$
|
0.250
|
|
|
|
240,000
|
|
|
|
5.01
|
|
|
|
240,000
|
|
$
|
0.325
|
|
|
|
260,000
|
|
|
|
0.32
|
|
|
|
260,000
|
|
$
|
0.343
|
|
|
|
340,000
|
|
|
|
9.05
|
|
|
|
340,000
|
|
$
|
0.375
|
|
|
|
120,000
|
|
|
|
6.61
|
|
|
|
120,000
|
|
$
|
0.395
|
|
|
|
266,667
|
|
|
|
8.85
|
|
|
|
266,667
|
|
$
|
0.745
|
|
|
|
500,000
|
|
|
|
8.68
|
|
|
|
500,000
|
|
|
Total
|
|
|
|
5,897,274
|
|
|
|
7.96
|
|
|
|
5,397,274
|
|
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
The stock options exercisable at December 31, 2013 had an aggregate
intrinsic value of $354,314. No options were exercised during 2013 or 2012.
The Company has not included these common stock equivalents
in earnings per share calculations as they are anti-dilutive due to the Company’s net losses incurred for the periods presented.
Warrants
On March 12, 2012, as discussed in Note 13 above, the Company
fulfilled subscriptions for the issuance of 800,000 shares along with warrants having the right to purchase 800,000 shares of common
stock at the current exercise price of $0.50 per share, expiring in 5 years from the date of issuance. In June 2012, the Company
fulfilled subscriptions for the issuance of 2,200,000 shares along with warrants having the right to purchase 2,200,000 shares
of common stock at the current exercise price of $0.50 per share, expiring in 5 years from the date of issuance. In September 2012,
the Company fulfilled subscriptions for the issuance of 1,000,000 shares along with warrants having the right to purchase 1,000,000
shares of common stock at the current exercise price of $0.50 per share, expiring in 5 years from the date of issuance. Also in
September 2012, the Company issued to a consultant warrants having the right to purchase 133,335 shares of common stock at the
current exercise price of $0.50 per share, expiring in 5 years from the date of issuance. Therefore, shares that may potentially
be issued upon the exercise of warrants as a result of subscriptions received by the Company and issued to consultants through
December 31, 2013 are as follows:
|
|
Number of
shares
potentially
issuable
|
|
|
Weighted
average
exercise
price
|
|
Balance, December 31, 2012
|
|
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
Issued in fulfillment of subscriptions
|
|
|
4,000,000
|
|
|
|
0.50
|
|
Issued to consultant
|
|
|
133,335
|
|
|
|
0.50
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2013
|
|
|
4,133,335
|
|
|
|
0.50
|
|
|
|
|
|
|
|
|
|
|
When subscriptions were fulfilled by the Company, the
warrants related to each individual subscription were dated as of the date the subscription funds were received by the Company,
regardless of the date on which the obligation is ultimately fulfilled. Therefore, all warrants have a term of five years from
date the subscription funds were received.
At December 31, 2013, the remaining number of years to expiration
and the weighted average term to expiration for the 4,133,335 outstanding warrants related to subscriptions that had been fulfilled
through that date were as follows:
Expiration Date
|
|
Number of shares
potentially issuable
|
|
|
Remaining years to
expiration and
weighted average
|
|
|
Fair Value of
Warrants (at $0.50
exercise price)
|
|
|
|
|
|
|
|
|
|
|
|
October 26, 2016
|
|
|
200,000
|
|
|
|
2.82
|
|
|
$
|
107,446
|
|
November 1, 2016
|
|
|
50,000
|
|
|
|
2.84
|
|
|
|
26,862
|
|
December 4, 2016
|
|
|
200,000
|
|
|
|
2.93
|
|
|
|
107,446
|
|
December 27, 2016
|
|
|
200,000
|
|
|
|
2.99
|
|
|
|
107,446
|
|
February 13, 2017
|
|
|
50,000
|
|
|
|
3.12
|
|
|
|
26,862
|
|
February 27, 2017
|
|
|
100,000
|
|
|
|
3.16
|
|
|
|
53,723
|
|
March 12, 2017
|
|
|
250,000
|
|
|
|
3.20
|
|
|
|
134,308
|
|
April 4, 2017
|
|
|
150,000
|
|
|
|
3.26
|
|
|
|
80,585
|
|
April 22, 2017
|
|
|
250,000
|
|
|
|
3.31
|
|
|
|
134,308
|
|
May 9, 2017
|
|
|
500,000
|
|
|
|
3.36
|
|
|
|
268,616
|
|
May 14, 2017
|
|
|
1,050,000
|
|
|
|
3.37
|
|
|
|
564,094
|
|
July 22, 2017
|
|
|
500,000
|
|
|
|
3.56
|
|
|
|
268,616
|
|
August 30, 2017
|
|
|
500,000
|
|
|
|
3.67
|
|
|
|
268,616
|
|
August 30, 2017
|
|
|
133,335
|
|
|
|
3.67
|
|
|
|
71,632
|
|
|
|
|
4,133,335
|
|
|
|
3.34
|
|
|
$
|
2,220,560
|
|
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
Using the Black-Scholes stock price valuation model, $561,194
of the $2,000,000 proceeds related to the fulfillment of the subscriptions during 2012 was originally attributed to the warrants
to purchase 4,133,335 shares. However, in September 2012, the board of directors authorized the re-pricing of the warrants’
exercise price from the original $0.75 per share to the current $0.50 per share. This resulted in an increase of $535,367 in allocation
of the proceeds to paid-in capital and a matching expense on the income statement.
The following assumptions were used for the Black-Scholes valuation
of the warrants issued:
|
|
Assumption
|
|
|
|
|
|
Dividend rate
|
|
|
0
|
%
|
Annualized volatility
|
|
|
39.00
|
%
|
Risk free interest rate
|
|
|
0.59%- 1.20
|
%
|
Expected life of warrants (years)
|
|
|
5.00
|
|
At both December 31, 2013 and December 31, 2012, the Company
had issued warrants for 8,013,440 shares of common stock to the holders of the Notes (see Note 9) and additional warrants for 107,672
shares of common stock to other individuals for a total of 8,121,112 warrants outstanding. Of the warrants outstanding, 42,672
were issued in 2009, exercisable at $0.375 per share and had a weighted average grant date fair value of $0.009. In 2010, 7,768,440
warrants were issued, exercisable at $0.3125 per share, having a weighted average grant date fair value of $0.01. The remaining
310,000 warrants were issued in 2011, also exercisable at $0.3125 per share, having a weighted average grant date fair value of
$0.008. The Company used the modified Black-Scholes model to estimate the fair value of the warrants on the date of issuance. Under
the provisions of FASB ASC 470-20-25, the Company allocated the fair value of the warrants at issuance and recorded debt discount
and additional paid in capital in the amounts of $0 and $2,812 for the years ended December 31, 2012, and 2011, respectively. Noncash
interest expense reflecting the amortization of debt discount related to the warrant issuances of $12,893 was recorded for the
year ended December 31, 2012.
The Company has not included these common stock equivalents
in earnings per share calculations as they are anti-dilutive due to the Company’s net losses incurred for the periods presented.
15.
Benefit Plans
The Company had established a 401(k) Plan (the “Plan”)
for eligible employees of the Company, but in December 2012, the Company announced the termination of the Plan, primarily due the
high cost relative to the inadequate employee participation. The Company was permitted to make discretionary contributions but
no contributions have been made since 2009. In the year ended December 31, 2012, the Company paid $3,510 in maintenance fees.
16.
Going Concern
The Company has accumulated losses from inception through December
31, 2013 of $12, 078,453, has minimal assets, and has negative working capital. These factors raise substantial doubt about the
Company’s ability to continue as a going concern. These factors may have potential adverse effects on the Company including
the ceasing of operations.
On May 4, 2012, the Company completed the Merger with a publicly-traded
company. See Note 13 above. During 2013, the Company survived only as a consequence of the receipt of $728,838 in temporary short
term advances. Management believes that it will receive additional equity capital in 2014 although such funding is not guaranteed,
nor is it guaranteed to be adequate for the Company’s requirements. If capital raising efforts are unsuccessful, discontinuance
of operations is possible. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
17.
Related Party Transactions
At April 30, 2012, and January 31, 2012, advances in the amount
of $150,505 were due to former officers and directors of the Company.
These advances were non-interest bearing and payable
on demand. In connection with the Closing of the Merger on May 4, 2012, these obligations were forgiven by the former officers
and directors of the Company. In addition, under the terms of the Merger, the former officers and directors of the Company were
responsible for personally settling all outstanding accounts payable and accrued liabilities as shown on the Company’s April
30, 2012, balance sheet in the total amount of $54,434 and any additional costs incurred up to the date of their resignations.
18.
Subsequent Events
The Company has evaluated subsequent events that occurred after
December 31, 2013 through March 6, 2014, the date this report was available to be issued. Any material subsequent events that occurred
during that time period have been properly recognized or disclosed in the Company’s financial statements.
On January 21, 2014,
the Company entered into a Subscription Agreement (the “Subscription Agreement”) with EFL Tech B.V., a Netherlands
corporation (“EFL Tech”). At the closing of the first tranche of issuances of shares of the Company’s common
stock, par value $0.001 (the “Common Stock”) pursuant to the Subscription Agreement, on January 21, 2014 (the “First
Closing”), the Company issued to EFL Tech an aggregate of 85,271,779 shares of Common Stock, and EFL Tech delivered $1,000,000
(of the net $1.5 million cash portion of the consideration for all share issuances under the Subscription Agreement) to the Company.
Subsequent to the First Closing, on January 21, 2014, EFL Tech held 51.0% of the Company’s issued and outstanding Common
Stock (46.0% on a fully diluted basis).
Other consideration provided
to the Company at the First Closing for the sale of shares of Common Stock to EFL Tech consists of the following agreements, each
of which was entered into and delivered by the Company and EFL Holdings Tech B.V., a Netherlands corporation (“EFL Holdings”),
and an affiliate of EFL Tech, on January 21, 2014: (a) License Agreement granting the Company an exclusive, worldwide, perpetual,
sub-licensable, royalty-free, paid-up license (the “License Agreement”) for all of EFL Holding’s EL-related patents,
trademarks and other intellectual property, both U.S. and international (the “EFL Holdings IP”); (b) Equipment Lease
Agreement for certain printing equipment used in the production of electroluminescent (“EL”) lamps, the Company’s
principal product, which EFL Holdings valued at $1.5 million, at no cost to Oryon (the “Equipment Lease”); and (c)
Business Relationship Agreement pursuant to which EFL Holdings covenants that it will not, directly or indirectly, provide services
to or otherwise engage in the business of manufacturing, designing, marketing, selling or distributing EL, or any products incorporating
the EFL Holdings IP, other than through the ownership, management and control of the Company by EFL Tech. The above-referenced
agreements contemplate that the Company will license, and will manufacture and market products incorporating, its EL-related intellectual
property and the EFL Holdings IP as a combined intellectual property portfolio.
At the closing of the
second tranche under the Subscription Agreement, on or before February 28, 2014 (the “Second Closing”), EFL Tech is
required to deliver to the Company additional funds in the amount of $250,000. At the Second Closing, the Company is required to
issue to EFL Tech an additional 85,133,871 shares of Common Stock, at which time EFL Tech’s cumulative ownership will be
170,405,650 shares of Common Stock, constituting 63.0% of the Common Stock on a fully diluted basis. Additionally, at the closing
of the third and final tranche under the Subscription Agreement, on or before March 31, 2014 (the “Third Closing”),
EFL Tech is required to deliver to the Company additional funds in the amount of $250,000 (bringing the total amount of the cash
component paid by EFL Tech to the Company in consideration for the issuance by the Company of shares of Common Stock to EFL Tech
under the Subscription Agreement to $1,500,000). At the Third Closing, the Company is required to issue to EFL Tech an additional
129,832,877 shares of Common Stock, at which time EFL Tech’s cumulative ownership will be 300,238,527 shares of Common Stock,
constituting 75.0% of the Common Stock on a fully diluted basis.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
As required by the Subscription
Agreement, on January 21, 2014, the Company entered into certain exchange and release agreements (each an “Exchange Agreement”
and collectively, the “Exchange Agreements”) by and between the Company and each member of a group of unsecured creditors
of the Company (including current directors and executive officers). At the First Closing, pursuant to the Exchange Agreements
the Company issued an aggregate of 19,267,010 shares of Common Stock, constituting 10.39% of the Common Stock on a fully diluted
basis, in exchange for the settlement and release of $695,250 in unpaid and accrued debt to such creditors. Under the Exchange
Agreements, the per-share exchange price for such debt was determined by the average of the closing prices of the Common Stock
on the trading days commencing on December 1, 2013, and ending on January 20, 2014 (the day prior to the First Closing), which
resulted in an exchange price of $0.036085 per share of Common Stock. The Company also paid the sum of $122,125 in cash to such
creditors under the Exchange Agreement for the settlement and release of such amount of debt (for the settlement and release of
a total of $817,375 of debt pursuant to the Exchange and Release Agreements).
The proceeds from the
foregoing funding of $1,500,000 ($1,000,000 at the First Closing, consisting of $689,330 in cash plus the forgiveness of the obligation
to repay the $310,670 in temporary unsecured advances that EFL Tech provided to the Company in periods prior to the First Closing,
and the additional $250,000 payments by EFL Tech at each of the Second Closing and the Third Closing)
will be used for
general corporate purposes and the repayment of debt, including, but not limited to, the cash payments of $122,125 required to
be made under the Exchange Agreements. At the First Closing, the Company paid the sum of $122,125 in cash, and issued an aggregate
of 19,267,010 shares of Common Stock, to certain creditors, including directors and executive officers, for the settlement
and release of a total of $817,375 of the Company's debt, pursuant to the Exchange Agreements.
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
The following table shows
the effects of the First Closing of the EFL transaction on the December 31, 2013, balance sheet. For purposes of this pro forma
table, no value has been attributed to the Equipment Agreement or the License Agreement. The pro forma adjustments reflected on
the balance sheet consist of:
|
(a)
|
The receipt of $1.25 million from EFL Tech (consisting of $689,330 received at the First Closing
plus $310,670 in short term advances that EFL Tech had made to the Company in the months prior to the First Closing plus $250,000
from EFL Tech at the Second Closing);
|
|
(b)
|
The issuance of 189,603,379 shares of common stock, $0.001 par value, consisting of 85,271,779
shares issued to EFL Tech for the First Closing, 85,133,871 shares issued to EFL Tech for the Second Closing, and 19,197,729 shares
issued in exchange for the settlement of $692,750 in obligations of the Company (actual issuance as of January 21, 2014, was 19,267,010
shares in settlement of $695,250 in Company obligations incurred through such date);
|
|
(c)
|
The pro forma cash payment of $121,500 as of December 31, 2013, (actual cash payment at January
21, 2014, was $122,125) in conjunction with the issuance of shares described in (b) above (for the aggregate settlement of obligations
in the total amount of $814,250 as of December 31, 2013, and $817,375 as of January 21, 2014);
|
|
(d)
|
The reversal of $41,667 in deferred director’s fees that were waived by a former director;
|
|
(e)
|
The payment of $24,304 in accrued payroll taxes on compensation that had been accrued or deferred
but settled as part of (b) and (c) above; and
|
|
(f)
|
The payment of $125,000 in principal of the Notes Payable, applied to the longest maturity portion
of the promissory notes, and the payment of $31,250 in other short term debt.
|
ORYON TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements
For the Years Ended December 31, 2013
and 2012
|
|
Actual as of
|
|
|
|
|
|
Pro Forma as of
|
|
|
|
December 31,
|
|
|
EFL Tech
|
|
|
December 31,
|
|
|
|
2013
|
|
|
Adjustments
|
|
|
2013
|
|
ASSETS
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
44,741
|
|
|
$
|
637,275
|
|
|
$
|
682,016
|
|
Accounts Receivable, net of allowance for
|
|
|
|
|
|
|
|
|
|
|
|
|
doubtful accounts of $0 and $0, respectively
|
|
|
21,182
|
|
|
|
-
|
|
|
|
21,182
|
|
Inventory
|
|
|
100,931
|
|
|
|
-
|
|
|
|
100,931
|
|
Other current assets
|
|
|
8,716
|
|
|
|
-
|
|
|
|
8,716
|
|
Total current assets
|
|
|
175,570
|
|
|
|
637,275
|
|
|
|
812,845
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROPERTY AND EQUIPMENT, NET
|
|
|
13,736
|
|
|
|
-
|
|
|
|
13,736
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTANGIBLE ASSETS, NET
|
|
|
114,652
|
|
|
|
-
|
|
|
|
114,652
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER LONG-TERM ASSETS
|
|
|
16,697
|
|
|
|
-
|
|
|
|
16,697
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS
|
|
$
|
320,655
|
|
|
$
|
637,275
|
|
|
$
|
957,930
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
378,184
|
|
|
$
|
(97,249
|
)
|
|
$
|
280,935
|
|
Deferred compensation
|
|
|
386,973
|
|
|
|
(386,973
|
)
|
|
|
-
|
|
Current portion of promissory notes and other short-term debt
|
|
|
1,149,521
|
|
|
|
(748,764
|
)
|
|
|
400,757
|
|
Other current liabilities
|
|
|
29,748
|
|
|
|
-
|
|
|
|
29,748
|
|
Total current liabilities
|
|
|
1,944,426
|
|
|
|
(1,232,986
|
)
|
|
|
711,440
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOTES PAYABLE, NET
|
|
|
114,156
|
|
|
|
(114,156
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
2,058,582
|
|
|
|
(1,347,142
|
)
|
|
|
711,440
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, $0.001 par value, 50,000,000 shares authorized, none
|
|
|
|
|
|
|
|
|
|
|
|
|
issued and outstanding
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Common stock, $0.001 par value, 600,000,000 shares authorized, 62,660,778
|
|
|
|
|
|
|
|
|
|
|
|
|
shares issued and outstanding
|
|
|
62,661
|
|
|
|
189,604
|
|
|
|
252,265
|
|
Paid in capital
|
|
|
10,277,865
|
|
|
|
1,753,146
|
|
|
|
12,031,011
|
|
Accumulated deficit
|
|
|
(12,078,453
|
)
|
|
|
41,667
|
|
|
|
(12,036,786
|
)
|
Total equity (deficit)
|
|
|
(1,737,927
|
)
|
|
|
1,984,417
|
|
|
|
246,490
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
$
|
320,655
|
|
|
$
|
637,275
|
|
|
$
|
957,930
|
|
The Company is currently evaluating the tax impacts, if any,
of the ownership change. The federal and state net operating loss carryovers of the Company may be limited in the amount that can
be recognized in any one year. The full impact of this evaluation has not been determined as of the date of issuance of the 2013
financial statements.
INDEX TO EXHIBITS
2.1
|
|
Agreement & Plan of Merger dated March 9, 2012 (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
|
|
3.1
|
|
Amended & Restated Articles of Incorporation (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 21, 2012)
|
|
|
3.2
|
|
Amended & Restated Bylaws (approved on January 21, 2014) *
|
|
|
4.1
|
|
Form of Common Stock Certificate (incorporated by reference to the Registrant’s Registration Statement on Form S-1 filed on October 4, 2012)
|
|
|
10.1
|
|
Subscription Agreement, dated January 21, 2014, between EFL Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 2 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.2
|
|
Registration Right Agreement – Subscription Shares, dated January 21, 2014, between EFL Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 3 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.3
|
|
License Agreement, dated January 21, 2014, between EFL Holdings Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 4 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.4
|
|
Equipment Lease Agreement, dated January 21, 2014, between EFL Holdings Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 5 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.5
|
|
Business Relationship Agreement, dated January 21, 2014, between EFL Holdings Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 10.5 to the Registrant’s Current Report on Form 8-K filed on February 7, 2014)
|
|
|
|
10.6
|
|
Form of Exchange and Release Agreement, dated January 21, 2014, between the Registrant and certain creditors of the Registrant (incorporated herein by reference to Exhibit 10.6 to the Registrant’s Current Report on Form 8-K filed on February 7, 2014)
|
|
|
|
10.7
|
|
Form of Registration Rights Agreement – Exchange Shares, dated January 21, 2014, between the Registrant and certain creditors of the Registrant (incorporated herein by reference to Exhibit 10.7 to the Registrant’s Current Report on Form 8-K filed on February 7, 2014)
|
|
|
|
10.8
|
|
Form of Series A Warrant (incorporated by reference to Exhibit B-2 to the Agreement & Plan of Merger dated March 9, 2012 filed as Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
|
|
10.9
|
|
Form of Series C Warrant (incorporated by reference to Exhibit B-1 to the Agreement & Plan of Merger dated March 9, 2012 filed as Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
|
|
10.10
|
|
Form of Securities Purchase Agreement and Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.11
|
|
Commercial Lease Agreement by and between 4257 Kellway General Partnership and OryonTechnologies, LLC dated April 1, 2010 (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.12
|
|
Form of OryonTechnologies, LLC Series C-1 Convertible Note (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.13
|
|
Form of OryonTechnologies, LLC Series C-2 Convertible Note (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.14
|
|
Form of OryonTechnologies, LLC Series C-3 Convertible Note (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.15
|
|
Form of Indemnification Agreement for Directors of Oryon Holdings, Inc. (incorporated by reference to Exhibit G-1 to the Agreement & Plan of Merger dated March 9, 2012 filed as Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
10.16
|
|
Resignation and Release—Rizalyn Cabrillas (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
|
10.17
|
|
Resignation and Release—Crystal Coranes (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
|
10.18
|
|
Employment Agreement effective as of September 6, 2012 by and between Oryon Technologies, Inc. and Thomas P. Schaeffer (incorporated by reference to Company’s Current Report on Form 8-K filed on September 12, 2012)**
|
|
|
|
10.19
|
|
Letter Amendment to Employment Agreement (Exhibit 10.18) from Thomas P. Schaeffer to the Registrant, dated January 21, 2014 **
|
|
|
|
16.1
|
|
Letter of Madsen & Associates CPA’s Inc. (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
|
21
|
|
List of Subsidiaries (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
|
23.1
|
|
Consent of Montgomery Coscia Greilich LLP*
|
|
|
|
24.1
|
|
Power of Attorney (included on the signature page hereto)
|
|
|
|
31.1
|
|
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
|
|
|
31.2
|
|
Certification of Principal Financial and Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
|
|
|
32.1
|
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
|
|
32.2
|
|
Certification of Principal Financial and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
|
|
101.INS
|
|
XBRL Instance Document *+
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document *+
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document*+
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document *+
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document *+
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document *+
|
|
|
|
*
|
|
Filed herewith
|
|
|
|
**
|
|
Management contract
|
|
|
|
+
|
|
Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement of prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933,
as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Addison, and the State of Texas, on March 7, 2014.
|
ORYON TECHNOLOGIES, INC.
|
|
|
|
|
By:
|
/s/ Thomas P. Schaeffer
|
|
|
Thomas P. Schaeffer
|
|
|
Chief Executive Officer
|
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Thomas P. Schaeffer and Mark E. Pape, and each of them, his true and lawful attorneys-in-fact
and agents, with full power of substitution and resubstitution, for him in his name, place and stead, in any and all capacities,
to sign any or all amendments to this annual report on Form 10-K, and to file the same, with all exhibits thereto, and all other
documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents,
and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in
and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause
to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933,
this report been signed by the following persons in the capacities and on the dates indicated.
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Thomas P. Schaeffer
|
|
Chairman of the Board and
|
|
March 7, 2014
|
Thomas P. Schaeffer
|
|
Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ Mark E. Pape
|
|
Chief Financial Officer
|
|
March 7, 2014
|
Mark E. Pape
|
|
(Principal Financial Officer and Principal
|
|
|
|
|
Accounting Officer), Secretary and Director
|
|
|
|
|
|
|
|
/s/ Clifton K-F. Shen
|
|
Director
|
|
March 7, 2014
|
Clifton K-F. Shen
|
|
|
|
|
|
|
|
|
|
/s/ Richard K. Hoesterey
|
|
Director
|
|
March 7, 2014
|
Richard K. Hoesterey
|
|
|
|
|
|
|
|
|
|
/s/ Larry L. Sears
|
|
Director
|
|
March 7, 2014
|
Larry L. Sears
|
|
|
|
|
INDEX TO EXHIBITS
2.1
|
|
Agreement & Plan of Merger dated March 9, 2012 (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
|
|
3.1
|
|
Amended & Restated Articles of Incorporation (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 21, 2012)
|
|
|
3.2
|
|
Amended & Restated Bylaws (approved on January 21, 2014) *
|
|
|
4.1
|
|
Form of Common Stock Certificate (incorporated by reference to the Registrant’s Registration Statement on Form S-1 filed on October 4, 2012)
|
|
|
10.1
|
|
Subscription Agreement, dated January 21, 2014, between EFL Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 2 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.2
|
|
Registration Right Agreement – Subscription Shares, dated January 21, 2014, between EFL Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 3 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.3
|
|
License Agreement, dated January 21, 2014, between EFL Holdings Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 4 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.4
|
|
Equipment Lease Agreement, dated January 21, 2014, between EFL Holdings Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 5 of Schedule 13D, filed on January 31, 2014)
|
|
|
|
10.5
|
|
Business Relationship Agreement, dated January 21, 2014, between EFL Holdings Tech B.V. and the Registrant (incorporated herein by reference to Exhibit 10.5 to the Registrant’s Current Report on Form 8-K filed on February 7, 2014)
|
|
|
|
10.6
|
|
Form of Exchange and Release Agreement, dated January 21, 2014, between the Registrant and certain creditors of the Registrant (incorporated herein by reference to Exhibit 10.6 to the Registrant’s Current Report on Form 8-K filed on February 7, 2014)
|
|
|
|
10.7
|
|
Form of Registration Rights Agreement – Exchange Shares, dated January 21, 2014, between the Registrant and certain creditors of the Registrant (incorporated herein by reference to Exhibit 10.7 to the Registrant’s Current Report on Form 8-K filed on February 7, 2014)
|
|
|
|
10.8
|
|
Form of Series A Warrant (incorporated by reference to Exhibit B-2 to the Agreement & Plan of Merger dated March 9, 2012 filed as Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
|
|
10.9
|
|
Form of Series C Warrant (incorporated by reference to Exhibit B-1 to the Agreement & Plan of Merger dated March 9, 2012 filed as Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
|
|
10.10
|
|
Form of Securities Purchase Agreement and Warrant (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.11
|
|
Commercial Lease Agreement by and between 4257 Kellway General Partnership and OryonTechnologies, LLC dated April 1, 2010 (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.12
|
|
Form of OryonTechnologies, LLC Series C-1 Convertible Note (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.13
|
|
Form of OryonTechnologies, LLC Series C-2 Convertible Note (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.14
|
|
Form of OryonTechnologies, LLC Series C-3 Convertible Note (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.15
|
|
Form of Indemnification Agreement for Directors of Oryon Holdings, Inc. (incorporated by reference to Exhibit G-1 to the Agreement & Plan of Merger dated March 9, 2012 filed as Exhibit 2.1 to the Registrant’s Current Report on Form 8-K filed on March 14, 2012)
|
|
|
10.16
|
|
Resignation and Release—Rizalyn Cabrillas (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
10.17
|
|
Resignation and Release—Crystal Coranes (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
10.18
|
|
Employment Agreement effective as of September 6, 2012 by and between Oryon Technologies, Inc. and Thomas P. Schaeffer (incorporated by reference to Company’s Current Report on Form 8-K filed on September 12, 2012)**
|
|
|
10.19
|
|
Letter Amendment to Employment Agreement (Exhibit 10.18) from Thomas P. Schaeffer to the Registrant, dated January 21, 2014 **
|
|
|
|
16.1
|
|
Letter of Madsen & Associates CPA’s Inc. (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
21
|
|
List of Subsidiaries (incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 7, 2012)
|
|
|
23.1
|
|
Consent of Montgomery Coscia Greilich LLP*
|
|
|
24.1
|
|
Power of Attorney (included on the signature page hereto)
|
|
|
31.1
|
|
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
|
|
31.2
|
|
Certification of Principal Financial and Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
|
|
|
32.1
|
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
|
32.2
|
|
Certification of Principal Financial and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
|
101.INS
|
|
XBRL Instance Document *+
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document *+
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document*+
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document *+
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document *+
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document *+
|
|
|
|
*
|
|
Filed herewith
|
|
|
|
**
|
|
Management contract
|
|
|
|
+
|
|
Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement of prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.
|